Sentence,class,file
Rab1 recruitment of p115 into a cis-SNARE complex: programming budding COPII vesicles for fusion.Science2000; 289:444-8; PMID:10903204; http://dx.doi.org/10.1126/science.289.5478.44417.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
A novel 115-kD peripheral membrane protein is required for intercis-ternal transport in the Golgi stack.J Cell Biol1992; 118:1015-26; P M I D : 1 5 1 2 2 8 7; http://dx.doi.org/10.1083/jcb.118.5.101518.,Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
ER to Golgi transport: Requirement for p115 at a pre-Golgi VTC stage.J Cell Biol1999; 147:1205-22; PM I D :10 6 01335; http://dx.doi.org/10.1083/jcb.147.6.120519.,Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Role of vesicle tethering factors in the ER-Golgi membrane traffic.FEBS Lett2009; 583:3770-83; P M I D : 1 9 8 8 7 0 6 9; http://dx.doi.org/10.1016/j.febslet.2009.10.08321.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Sequential tethering of Golgins and catalysis of SNAREpin assembly by the vesicle-tethering protein p115.J Cell Biol2002; 157:45-62; PMID:11927603; http://dx.doi.org/10.1083/jcb.20011212722.,Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Coupled ER to Golgi transport reconsti-tuted with purified cytosolic proteins.J Cell Biol1997; 139:1097-108; P M I D : 9 3 8 2 8 5 9; http://dx.doi.org/10.1083/jcb.139.5.109723.,Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Initial docking of ER-derived vesicles requires Uso1p and Ypt1p but is independent of SNARE proteins.EMBO J1998; 17:2156-65; P M I D : 9 5 4 5 2 2 9; http://dx.doi.org/10.1093/emboj/17.8.215624.,Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
The RabGTPase Ypt1p and tethering factors couple protein sorting at the ER to vesicle targeting to the Golgi apparatus.Dev Cell2002; 2:307-17; PMID:11879636; http://dx.doi.org/10.1016/S1534-5807(02)00133-825.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
"The interac-tion of two tethering factors, p115 and COG com-plex, is required for Golgi integrity.Traffic2007; 8:270-84; P M I D : 1 7 2 7 4 7 9 9; http://dx.doi.org/10.1111/j.1600-0854.2006.00530.x26.",OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Coat-tether interaction in Golgi organization.MolBiol Cell2008; 19:2830-43; P M I D : 1 8 4 3 4 5 9 7; http://dx.doi.org/10.1091/mbc.E07-12-123627.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Tethering factor P115: A new model for tether-SNARE interactions.Bioarchitecture2012; 2:2; P M I D: 2 2 9 9 2 7 5 1; http://dx.doi.org/10.4161/bioa.2170228.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Identification of a functional domain within the p115 tethering factor that is required for Golgi ribbon assembly and membrane trafficking.J Cell Sci2012; 125:1896-909; P M I D : 2 2 3 2 8 5 1 1; http://dx.doi.org/10.1242/jcs.09057129.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
A cryptic Rab1-binding site in the p115 tethering protein.J BiolChem2005; 280:25840-8; P M I D : 1 5 8 7 8 8 7 3; http://dx.doi.org/10.1074/jbc.M50392520030.,Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Structural and functional analysis of the globular head domain of p115 provides insight into membrane tethering.J MolBiol2009; 391:26-41; P M I D: 1 9 4 1 4 0 2 2; http://dx.doi.org/10.1016/j.jmb.2009.04.06231.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
"The membrane-tethering protein p115 interacts with GBF1, an ARF guanine-nucleotide-exchange factor.EMBO Rep2003; 4:320-5; P M I D : 1 2 6 3 4 8 5 3; http://dx.doi.org/10.1038/sj.embor.embor76232.",Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Evidence that Golgi structure depends on a p115 activity that is independent of the vesicle tether components giantin and GM130.J Cell Biol2001; 155:227-38; P M I D : 1 1 5 9 1 7 2 9; http://dx.doi.org/10.1083/jcb.20010500533.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
COPII-Golgi protein interac-tions regulate COPII coat assembly and Golgi size.J Cell Biol2006; 174:53-63; PMID:16818719; http://dx.doi.org/10.1083/jcb.20060405834.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
"Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa.MolBiol Cell1993; 4:679-93; P M I D : 7 6 9 1 2 7 6; http://dx.doi.org/10.1091/mbc.4.7.67935.",Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
A bifunctional bacterial protein links GDI displacement to Rab1 activation.Science2007; 318:974-7; P M I D : 1 7 9 4 7 5 4 9; http://dx.doi.org/10.1126/science.114912136.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Cdc42 GEF Tuba regulates the junctional configuration of simple epithelial cells.J Cell Biol2006; 175:135-46; P M I D : 1 7 0 1 5 6 2 0; http://dx.doi.org/10.1083/jcb.20060501237.,Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Assembly of the ER to Golgi SNARE complex requires Uso1p.J Cell Biol1996; 132:755-67; PMID:8603910; http://dx.doi.org/10.1083/jcb.132.5.75539.,Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
TRAPP stimu-lates guanine nucleotide exchange on Ypt1p.J Cell Biol2000; 151:289-96; PMID:11038176; http://dx.doi.org/10.1083/jcb.151.2.28940.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
"mTrs130 is a component of a mammalian TRAPPII complex, a Rab1 GEF that binds to COPI-coated vesicles.MolBiol Cell2009; 20:4205-15; PMID:19656848; http://dx.doi.org/10.1091/mbc.E09-05-038741.",Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
"The vesicle docking protein p115 binds GM130, a cis-Golgi matrix protein, in a mitoti-cally regulated manner.Cell1997; 89:445-55; PMID:9150144; http://dx.doi.org/10.1016/S0092-8674(00)80225-142.",OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
GM130 and GRASP65-dependent lateral cisternal fusion allows uniform Golgi-enzyme distribution.Nat Cell Biol2006; 8:238-48; P M I D : 1 6 4 8 9 3 4 4; http://dx.doi.org/10.1038/ncb136643.,Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Yip3 catalyses the dissociation of endosomalRab-GDI complexes.Nature2003; 425:856-9; P M I D : 1 4 5 7 4 4 1 4; http://dx.doi.org/10.1038/nature0205744.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Targeting RabGTPases to dis-tinct membrane compartments.Nat Rev Mol Cell Biol2004; 5:886-96; P M I D : 1 5 5 2 0 8 0 8; http://dx.doi.org/10.1038/nrm150045.,Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Legionella pneumophila proteins that regulate Rab1 membrane cycling.Nature2007; 450:365-9; P M I D : 1 7 9 5 2 0 5 4; http://dx.doi.org/10.1038/nature0633646.,Non-OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
RabGDI displacement by DrrA from Legionella is a consequence of its guanine nucleo-tide exchange activity.Mol Cell2009; 36:1060-72; PMID:20064470; http://dx.doi.org/10.1016/j.molcel.2009.11.014,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Role of Rab1b in COPII dynam-ics and function.Eur J Cell Biol2011; 90:301-11; PMID:21093099; http://dx.doi.org/10.1016/j.ejcb.2010.10.00148.,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
Rab1b regulates COPI and COPII dynamics in mammalian cells.Cell Logist2011; 1:159-63; PMID:22279615; http://dx.doi.org/10.4161/cl.1.4.18221,OADS,/arxiv_data1/oa_pdf/1a/bc/cl-3-e27687.PMC4187009.pdf
The number of up- and down-regulated genes is shown in Venn diagrams 28(http://bioinfogp.cnb.csic.es/tools/venny/index.,OADS,/arxiv_data1/oa_pdf/0a/ef/srep06536.PMC4187010.pdf
"cDNA preparation and Illumina deep-sequencing .Illumina sequencing was performed at the Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China (http://www.genomics.cn/index.php) according to the manufacturer’s instructions(Illumina, San Diego, CA, USA) 49.",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/srep06536.PMC4187010.pdf
",http://bioinfogp.cnb.csic.es/tools/venny/index.html .",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/srep06536.PMC4187010.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0a/ef/srep06536.PMC4187010.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6536 | DOI: 10.1038/srep06536 10",Non-OADS,/arxiv_data1/oa_pdf/0a/ef/srep06536.PMC4187010.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/97/a1/srep06540.PMC4187013.pdf
"Deutsche s Institut für Medizinische Dokumentation  und Information (DIMDI) (ed): Köln, 2013. http://portal.dimdi.d e/de/hta/hta_berichte/hta298_bericht_ de.pdf (accessed February 11, 2014).",Non-OADS,/arxiv_data1/oa_pdf/3c/3a/dee-0004-0195.PMC4187252.pdf
A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uplo ads/how_to_apply/ADNI_Acknowledgement_List.pdf.,OADS,/arxiv_data1/oa_pdf/5e/1a/dee-0004-0184.PMC4187257.pdf
The  data acquisition protocols for each imaging modality are detail ed on the UCLA laboratory of  Neuroimaging website (http://www.loni.ucla.edu/ADNI/Data/ADNI_D ata.shtml).,OADS,/arxiv_data1/oa_pdf/5e/1a/dee-0004-0184.PMC4187257.pdf
"Region of interest extraction We used the MarsBar tool for SPM (http://marsbar.sourceforge.net/) to extract activations from the spherical regions of interest (ROIs) centered on the peak coordinates for the significant caudate, hippo- campus and OFC contrasts (arrows in Figures 3 and 4).",OADS,/arxiv_data1/oa_pdf/bb/14/nst147.PMC4187272.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs312/en/ index.html.,Non-OADS,/arxiv_data1/oa_pdf/c9/52/JMSS-4-181.PMC4187353.pdf
"He authored one book in Software Testing, four book  chapters, 20 journal papers and more than 40 international  and internal conference papers (http://ce.kashanu.ac.ir/ babamir/Publication.htm).",Non-OADS,/arxiv_data1/oa_pdf/c9/52/JMSS-4-181.PMC4187353.pdf
"In this section,  the performance of this method is investigated by using  PIDER breast MRI dataset (see https://www.imaging.nci.",Non-OADS,/arxiv_data1/oa_pdf/bd/81/JMSS-4-202.PMC4187355.pdf
Available  from: http://www.isi.uu.nl/Research/Databases/DRIVE/.,OADS,/arxiv_data1/oa_pdf/04/dd/JMSS-4-223.PMC4187357.pdf
Available from: http://www.parl.clemson.edu/stare/probing/.,Non-OADS,/arxiv_data1/oa_pdf/04/dd/JMSS-4-223.PMC4187357.pdf
"XR-100T-CdTe X-Ray & Gamma Ray Detector, available from:  http://www.amptek.com/products/xr-100t-cdte-x-ray-and-gamma- raydetector/.",Non-OADS,/arxiv_data1/oa_pdf/0e/79/JMSS-4-231.PMC4187358.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006337).,Non-OADS,/arxiv_data1/oa_pdf/08/21/bmjopen-2014-006337.PMC4187452.pdf
"How to compare the costs and benefits: evaluation of the economic evidence.Canberra, 2001. http://www.nhmrc.gov.au/publications/synopses/_files/cp73.pdf 33.",Non-OADS,/arxiv_data1/oa_pdf/08/21/bmjopen-2014-006337.PMC4187452.pdf
"Australian refined diagnosis-related groups (AR-DRG) data cubes, 2013. http://www.aihw.gov.au/hospitals-data/ar-drg-data-cubes/ 34.",Non-OADS,/arxiv_data1/oa_pdf/08/21/bmjopen-2014-006337.PMC4187452.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005860).,Non-OADS,/arxiv_data1/oa_pdf/4f/9d/bmjopen-2014-005860.PMC4187453.pdf
2014. http://www.who.int/mental_health/prevention/en/ (accessed May 2014).,Non-OADS,/arxiv_data1/oa_pdf/4f/9d/bmjopen-2014-005860.PMC4187453.pdf
2014. http://apps.who.int/iris/bitstream/10665/131056/1/9789241564779_eng.pdf?ua=1 (accessed Sep2014).,OADS,/arxiv_data1/oa_pdf/4f/9d/bmjopen-2014-005860.PMC4187453.pdf
FORUT Norway & FORUT Sri Lanka; 2004. http://www.add-resources.org/alcohol-and-poverty-in-sri-lanka.444180 –76584.,Non-OADS,/arxiv_data1/oa_pdf/4f/9d/bmjopen-2014-005860.PMC4187453.pdf
2004. http://www.shppsl.net/shn/site/wp-content/uploads/2011/12/reproductive-health-studies-paper.pdf (accessed Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/4f/9d/bmjopen-2014-005860.PMC4187453.pdf
2009. http://www.nata.gov.lk (accessed Dec2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/9d/bmjopen-2014-005860.PMC4187453.pdf
2013. http://melmedura.org/ (accessed Dec 2013).,OADS,/arxiv_data1/oa_pdf/4f/9d/bmjopen-2014-005860.PMC4187453.pdf
2009. http://www.adicsrilanka.org(accessed Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/9d/bmjopen-2014-005860.PMC4187453.pdf
2013. http://healthylanka.lk/ (accessed Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/9d/bmjopen-2014-005860.PMC4187453.pdf
2013. http://www.fisd.lk/ (accessedDec 2013).,OADS,/arxiv_data1/oa_pdf/4f/9d/bmjopen-2014-005860.PMC4187453.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-005787).,Non-OADS,/arxiv_data1/oa_pdf/b6/c8/bmjopen-2014-005787.PMC4187454.pdf
2014. http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/b6/c8/bmjopen-2014-005787.PMC4187454.pdf
2014. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/02/news_detail_002031.jsp&mid=WC0b01ac58001d126 8.,Non-OADS,/arxiv_data1/oa_pdf/b6/c8/bmjopen-2014-005787.PMC4187454.pdf
2012. http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000560/WC500131789.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/b6/c8/bmjopen-2014-005787.PMC4187454.pdf
2012. http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000560/WC500131790.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/b6/c8/bmjopen-2014-005787.PMC4187454.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005961).,Non-OADS,/arxiv_data1/oa_pdf/83/46/bmjopen-2014-005961.PMC4187455.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005096).,Non-OADS,/arxiv_data1/oa_pdf/8a/f6/bmjopen-2014-005096.PMC4187456.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8a/f6/bmjopen-2014-005096.PMC4187456.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006226).,Non-OADS,/arxiv_data1/oa_pdf/0c/f9/bmjopen-2014-006226.PMC4187457.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0c/f9/bmjopen-2014-006226.PMC4187457.pdf
2013. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=347752 24.,OADS,/arxiv_data1/oa_pdf/0c/f9/bmjopen-2014-006226.PMC4187457.pdf
http://www.pbs.gov.au/pbs/home (accessed 27 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/0c/f9/bmjopen-2014-006226.PMC4187457.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005413).,Non-OADS,/arxiv_data1/oa_pdf/f5/8e/bmjopen-2014-005413.PMC4187458.pdf
http://onlinelibrary.wiley.com/o/cochrane/clcentral/ articles/892/CN-00557892/frame.html 105.,OADS,/arxiv_data1/oa_pdf/33/33/bmjopen-2014-006108.PMC4187461.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov Unique identi ﬁer: NCT.No.PO1506.,Non-OADS,/arxiv_data1/oa_pdf/ec/25/jah3-3-e000679.PMC4187468.pdf
Available at: http://linkinghub.elsevier.com/retrieve/pii/S0140673613612490.,Non-OADS,/arxiv_data1/oa_pdf/c4/73/jah3-3-e000697.PMC4187469.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/72/b9/jah3-3-e000560.PMC4187476.pdf
Available at: http://www.fda.gov/downloads/drugs/guidancecompli- anceregulatoryinformation/guidances/ucm070244.pdf.,Non-OADS,/arxiv_data1/oa_pdf/72/b9/jah3-3-e000560.PMC4187476.pdf
"*An accompanying Data S1, which lists the Utstein Osaka Project Investigators, is available at http://jaha.ahajournals.org/content/3/2/ e000533/suppl/DC1 Correspondence to: Taku Iwami, MD, PhD, Kyoto University Health Service, Yoshida Honmachi, Sakyo-ku, Kyoto 606-8501, Japan.",OADS,/arxiv_data1/oa_pdf/d0/7d/jah3-3-e000533.PMC4187486.pdf
Available at: http://aed-hyogo.sakura.ne.jp/wpm/archi- vepdf/23/2_11a.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/7d/jah3-3-e000533.PMC4187486.pdf
Available at: http://www.mlit.go.jp/k-toukei/10/ annual/index.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/7d/jah3-3-e000533.PMC4187486.pdf
Available at: http://www.mlit.go.jp/k-toukei/ search/pdf/11/11201100cc0000.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/7d/jah3-3-e000533.PMC4187486.pdf
Available at: http://www.mext.go.jp/compo-nent/a_menu/education/detail/__icsFiles/a ﬁeldﬁle/2012/04/04/ 1289307_04.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/7d/jah3-3-e000533.PMC4187486.pdf
"Available at: http://www.stat.go.jp/ data/jyutaku/2008/pdf/kgiy00.pdf Accessed May 07, 2013 (in Japanese).",OADS,/arxiv_data1/oa_pdf/d0/7d/jah3-3-e000533.PMC4187486.pdf
"Measurement of CRP, Glucose, and Lipids CRP, glucose, total cholesterol, high-density lipoprotein (HDL), and triglycerides (TGs) were measured using the Cholestech LDX system (http://www.cholestech.com).",OADS,/arxiv_data1/oa_pdf/de/98/jah3-3-e000651.PMC4187488.pdf
Available at: http://www.bostonscienti ﬁc-international.com/templatedata/imports/HTML/ CRM/A_Closer_Look/pdfs/ACL_Using_Magnet_Inhibit_Change_Tachy_Ther- apy_030909.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9a/18/jah3-3-e000746.PMC4187492.pdf
Press release 2013. http://www.biotronik.com/wps/wcm/con- nect/int_web/biotronik/newsroom/press_releases/press_releases.,Non-OADS,/arxiv_data1/oa_pdf/9a/18/jah3-3-e000746.PMC4187492.pdf
Available at: http://apps.who.int/ bmi/index.jsp?introPage=intro_3.html.,Non-OADS,/arxiv_data1/oa_pdf/a4/11/jah3-3-e000672.PMC4187494.pdf
An accompanying Table S1 is available at http://jaha.ahajournals.org/ content/3/2/e000638/suppl/DC1 A list of the members of the French Addictovigilance Network Working Group on Cannabis Disorders is given in the Acknowledgments.,Non-OADS,/arxiv_data1/oa_pdf/80/c7/jah3-3-e000638.PMC4187498.pdf
Disponible sur: http://www.unodc.org/documents/data-and-analysis/WDR2012/WDR_ 2012_web_small.pdf.,OADS,/arxiv_data1/oa_pdf/80/c7/jah3-3-e000638.PMC4187498.pdf
Disponible sur: http://www.medicinescom- plete.com/mc/martindale/current/18906-r.htm?q=cannabinoid&t=search&ss=text&p=3#_hit.,Non-OADS,/arxiv_data1/oa_pdf/80/c7/jah3-3-e000638.PMC4187498.pdf
Available from: http://www.legifrance.gouv.fr/af ﬁchCodeArticle.do;jsessionid=619DB47C93 353C5E7CC664DB9F25526F.tpdjo02v_1?idArticle=LEGIARTI000006915744 &cidTexte=LEGITEXT000006072665&dateTexte=20120514.,Non-OADS,/arxiv_data1/oa_pdf/80/c7/jah3-3-e000638.PMC4187498.pdf
Disponible sur: http://www.inpes.sante.fr/CFESBases/catalogue/pdf/ 1109.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/c7/jah3-3-e000638.PMC4187498.pdf
"Accompanying Figures S1 through S6 are available at http://jaha.ahajour- nals.org/content/3/2/e000837/suppl/DC1 Correspondence to: Yu Wang, PhD, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Level 2, Laboratory Block, 21 Sassoon Road, Pokfulam, Hong Kong, China.",Non-OADS,/arxiv_data1/oa_pdf/19/44/jah3-3-e000837.PMC4187505.pdf
Calculated Binding Af ﬁnities Between Lipocalin-2 and Various Fatty Acids by Molecular Docking Ligand DG (kcal/mol) Kd (nmol/L) Arachidonic acid /C06.1 35.8 20-Hydroxyeicosatetraenoic acid /C06.2 30.2 12-Hydroxyeicosatetraenoic acid /C04.0 1026.7 5-Hydroxyeicosatetraenoic acid /C04.4 620.4 Prostaglandin F2 /C06.2 30.2 Prostaglandin H2 /C05.9 50.1 Prostaglandin D2 /C04.6 443.4 Linoleic acid /C07.3 4.7 Oleic acid /C04.2 867.9 Palmitic acid /C03.2 4649.3 Arachidic acid /C03.1 5499.1 Stearic acid /C03.2 4649.3 Enterochelin* /C08.7 0.5 *A ligand of lipocalin-2 (http://www.rcsb.org/pdb/explore.do?structureId=3CMP) was included as the reference control.,Non-OADS,/arxiv_data1/oa_pdf/19/44/jah3-3-e000837.PMC4187505.pdf
"Accompanying Figures S1 through S8 are available at http://jaha.ahajournals.org/content/3/2/e000759/suppl/DC1Correspondence to: George Thanassoulis MD, MSc, FRCPC, Department of Medicine, Preventive and Genomic Cardiology, McGill University Health Centre, 687 Pine Ave W, Montreal, Quebec, Canada.",Non-OADS,/arxiv_data1/oa_pdf/40/52/jah3-3-e000759.PMC4187506.pdf
http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/ nhanes_analytic_guidelines_dec_2005.pdf.,OADS,/arxiv_data1/oa_pdf/40/52/jah3-3-e000759.PMC4187506.pdf
"Accompanying Videos S1 through S7 are available at http://jaha.ahajour- nals.org/content/3/2/e000693/suppl/DC1 Correspondence to: Gou Young Koh, MD, PhD, Graduate School of Medical Science and Engineering, KAIST, 291 Daehark-ro, Yuseong-gu, Daejeon, 305-701, Korea.",Non-OADS,/arxiv_data1/oa_pdf/9d/1b/jah3-3-e000693.PMC4187507.pdf
"Images were analyzed using Image J software (http://imagej.nih.- gov/ij/, 1.47V, National Institutes of Health [NIH]).",OADS,/arxiv_data1/oa_pdf/9d/1b/jah3-3-e000693.PMC4187507.pdf
"Developed images were scanned on a ﬂatbed scanner (Umax PowerLook 1100) and analyzed using Image J software (http://imagej.nih.gov/ij/, 1.47V, NIH).",OADS,/arxiv_data1/oa_pdf/9d/1b/jah3-3-e000693.PMC4187507.pdf
Accompanying Figures S1 and S2 are available at http://jaha.ahajournals.org/content/1/3/e000340/suppl/DC1 *Drs.,OADS,/arxiv_data1/oa_pdf/85/91/jah3-3-e000340.PMC4187508.pdf
"Accompanying Table S1 and Figure S1 are available at http://jaha.ahajour- nals.org/content/3/2/e000718/suppl/DC1 Correspondence to: Val/C19erie Santschi, PharmD, PhD, La Source, School of Nursing Sciences, University of Applied Sciences Western Switzerland, Lausanne, Avenue Vinet 30, 1004 Lausanne, Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/fc/13/jah3-3-e000718.PMC4187511.pdf
Available at: http://www.thecommunity- guide.org/cvd/supportingmaterials/IS-team-based-care.html.,Non-OADS,/arxiv_data1/oa_pdf/fc/13/jah3-3-e000718.PMC4187511.pdf
A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/ pi.htm.,Non-OADS,/arxiv_data1/oa_pdf/58/ab/jah3-3-e000519.PMC4187512.pdf
"An exhaustive description of the survey design, data collection strategies, and instruments is available online (http://www.cdc.gov/ nchs/nhanes/nhanes2009-2010/nhanes09_10.htm).",OADS,/arxiv_data1/oa_pdf/ee/68/jah3-3-e000157.PMC4187514.pdf
"Details of blood pressure measurement, calibration protocol and quality control measures are available (http://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/ BP.pdf).",OADS,/arxiv_data1/oa_pdf/ee/68/jah3-3-e000157.PMC4187514.pdf
Exhaustive technical details of these assays including calibration and standardization proto- cols are available in the NHANES Laboratory/Medical Tech- nologists Procedures Manual (http://www.cdc.gov/nchs/ nhanes/nhanes2009-2010/labdoc_f.htm;accessed).,OADS,/arxiv_data1/oa_pdf/ee/68/jah3-3-e000157.PMC4187514.pdf
"“How the census bureau measures poverty ”Retrieved January 25, 2012, from http://www.census.gov/hhes/www/poverty/about/ overview/measure.html.",OADS,/arxiv_data1/oa_pdf/ee/68/jah3-3-e000157.PMC4187514.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/35/a9/jah3-3-e000588.PMC4187515.pdf
Available at: http://bmctoday.net/ citoday/2010/04/article.asp?f=overcoming-anatomic-challenges-to-transra- dial-access.,Non-OADS,/arxiv_data1/oa_pdf/35/a9/jah3-3-e000588.PMC4187515.pdf
"*Accompanying Data S1, which lists the ROCKET AF Investigators, are available at http://jaha.ahajournals.org/content/3/2/e000521/suppl/DC1Correspondence to: Jonathan P. Piccini, MD, MHS, Duke Clinical Research Institute, Duke University Medical Center, P.O.",OADS,/arxiv_data1/oa_pdf/0f/19/jah3-3-e000521.PMC4187517.pdf
Clinical Trial Registration- —URL: http://clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/22/e6/jah3-3-e000700.PMC4187519.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005490).,Non-OADS,/arxiv_data1/oa_pdf/e1/62/bmjopen-2014-005490.PMC4187655.pdf
"Received 16 April 2014 Revised 29 August 2014 Accepted 11 September 2014 1Rehabilitation Unit, Odense University Hospital, Odense, Fyn, Denmark 2Institute of Clinical Research, University of Southern Denmark, Odense, Denmark 3Institute of Sports Science and Clinical Biomechanics, University of SouthernDenmark, Odense, Denmark 4Department of Neurology, Herlev University Hospital, University of Copenhagen, Copenhagen, Denmark Correspondence to Anders Hansen; anders.hansen@rsyd.dk, http://www.ouh.dkABSTRACT Introduction: Gliomas are among the biggest challenges in neurological and oncology rehabilitationand optimising treatment is of major clinicalimportance in this population.",Non-OADS,/arxiv_data1/oa_pdf/e1/62/bmjopen-2014-005490.PMC4187655.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/05/bmjopen-2014-005701.PMC4187658.pdf
Social mobility in Japan: a new approach to modeling trend in mobility 2008. http://www.stanford.edu/group/scspi/grusky/article_files/social_mobility_japan.pdf(accessed 15 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/dc/05/bmjopen-2014-005701.PMC4187658.pdf
http://www.mhlw.go.jp/seisakunitsuite/bunya/koyou_roudou/part_haken/genjou/ (accessed 15 Apr 2014).,OADS,/arxiv_data1/oa_pdf/dc/05/bmjopen-2014-005701.PMC4187658.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005920).,Non-OADS,/arxiv_data1/oa_pdf/65/3a/bmjopen-2014-005920.PMC4187660.pdf
"Trial registration number: Clinical Trials, NCT01040429; The Norwegian Study of Chronic FatigueSyndrome in Adolescents: Pathophysiology andIntervention Trial (NorCAPITAL) http://www.clinicaltrials.gov.",Non-OADS,/arxiv_data1/oa_pdf/65/3a/bmjopen-2014-005920.PMC4187660.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005502).,Non-OADS,/arxiv_data1/oa_pdf/3d/d1/bmjopen-2014-005502.PMC4187993.pdf
Secondary Hospital value-basedpurchasing (HVBP) program 2013. http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/hospital-value-based-purchasing/index.html 23.,Non-OADS,/arxiv_data1/oa_pdf/3d/d1/bmjopen-2014-005502.PMC4187993.pdf
http://www.oecd.org/els/health-systems/oecdhealthdata.htm 49.,Non-OADS,/arxiv_data1/oa_pdf/3d/d1/bmjopen-2014-005502.PMC4187993.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005491).,Non-OADS,/arxiv_data1/oa_pdf/83/96/bmjopen-2014-005491.PMC4187994.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006142).,Non-OADS,/arxiv_data1/oa_pdf/06/0b/bmjopen-2014-006142.PMC4187995.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006356).,Non-OADS,/arxiv_data1/oa_pdf/9d/8f/bmjopen-2014-006356.PMC4187996.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdEDITORIAL Yabe and Seino http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/33/60/jdi-5-475.PMC4188101.pdf
5 September 2014 477EDITORIAL http://onlinelibrary.wiley.com/journal/jdi Yabe and Seino,Non-OADS,/arxiv_data1/oa_pdf/33/60/jdi-5-475.PMC4188101.pdf
5 September 2014 479REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Epidemic trend of diabetes in China,Non-OADS,/arxiv_data1/oa_pdf/5c/0b/jdi-5-478.PMC4188102.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Chen and Yang http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/5c/0b/jdi-5-478.PMC4188102.pdf
3. http://www.diapedia.org/introduction/kelly-west-1925-19804.,Non-OADS,/arxiv_data1/oa_pdf/5c/0b/jdi-5-478.PMC4188102.pdf
6. http://www.idf.org/sites/defa ult/files/5E_IDFAtlasPoster_ 2012_EN.pdf 7 .,Non-OADS,/arxiv_data1/oa_pdf/5c/0b/jdi-5-478.PMC4188102.pdf
5 September 2014 481REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Epidemic trend of diabetes in China,Non-OADS,/arxiv_data1/oa_pdf/5c/0b/jdi-5-478.PMC4188102.pdf
5 September 2014 483COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Commentary,Non-OADS,/arxiv_data1/oa_pdf/90/d6/jdi-5-482.PMC4188103.pdf
"5 September 2014 485ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Endurance training, RBP4 tissue expression",Non-OADS,/arxiv_data1/oa_pdf/65/ec/jdi-5-484.PMC4188104.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/65/ec/jdi-5-484.PMC4188104.pdf
"5 September 2014 487ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Endurance training, RBP4 tissue expression",Non-OADS,/arxiv_data1/oa_pdf/65/ec/jdi-5-484.PMC4188104.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/65/ec/jdi-5-484.PMC4188104.pdf
"5 September 2014 489ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Endurance training, RBP4 tissue expression",Non-OADS,/arxiv_data1/oa_pdf/65/ec/jdi-5-484.PMC4188104.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/65/ec/jdi-5-484.PMC4188104.pdf
"5 September 2014 491ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Endurance training, RBP4 tissue expression",Non-OADS,/arxiv_data1/oa_pdf/65/ec/jdi-5-484.PMC4188104.pdf
5 September 2014 493ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi hHPCs in regenerative medicine,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jdi-5-492.PMC4188105.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jdi-5-492.PMC4188105.pdf
5 September 2014 495ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi hHPCs in regenerative medicine,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jdi-5-492.PMC4188105.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jdi-5-492.PMC4188105.pdf
5 September 2014 497ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi hHPCs in regenerative medicine,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jdi-5-492.PMC4188105.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jdi-5-492.PMC4188105.pdf
5 September 2014 499ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi hHPCs in regenerative medicine,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jdi-5-492.PMC4188105.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/59/3f/jdi-5-492.PMC4188105.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/60/jdi-5-501.PMC4188106.pdf
5 September 2014 503ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Low HDLC level is a risk factor for type 2 DM,Non-OADS,/arxiv_data1/oa_pdf/a3/60/jdi-5-501.PMC4188106.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/60/jdi-5-501.PMC4188106.pdf
5 September 2014 505ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Low HDLC level is a risk factor for type 2 DM,Non-OADS,/arxiv_data1/oa_pdf/a3/60/jdi-5-501.PMC4188106.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/60/jdi-5-501.PMC4188106.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/47/d0/jdi-5-507.PMC4188107.pdf
5 September 2014 509ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Diabetes mellitus in productive age,Non-OADS,/arxiv_data1/oa_pdf/47/d0/jdi-5-507.PMC4188107.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/47/d0/jdi-5-507.PMC4188107.pdf
5 September 2014 511ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Diabetes mellitus in productive age,Non-OADS,/arxiv_data1/oa_pdf/47/d0/jdi-5-507.PMC4188107.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/47/d0/jdi-5-507.PMC4188107.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3d/2c/jdi-5-513.PMC4188108.pdf
5 September 2014 515SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi hs-CRP in a Japanese MODY3 patient,Non-OADS,/arxiv_data1/oa_pdf/3d/2c/jdi-5-513.PMC4188108.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3d/2c/jdi-5-513.PMC4188108.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/5d/a8/jdi-5-517.PMC4188109.pdf
5 September 2014 519ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Postprandial C-peptide to glucose ratio,Non-OADS,/arxiv_data1/oa_pdf/5d/a8/jdi-5-517.PMC4188109.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/5d/a8/jdi-5-517.PMC4188109.pdf
5 September 2014 521ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Postprandial C-peptide to glucose ratio,Non-OADS,/arxiv_data1/oa_pdf/5d/a8/jdi-5-517.PMC4188109.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/5d/a8/jdi-5-517.PMC4188109.pdf
5 September 2014 523ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Postprandial C-peptide to glucose ratio,Non-OADS,/arxiv_data1/oa_pdf/5d/a8/jdi-5-517.PMC4188109.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/5d/a8/jdi-5-517.PMC4188109.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e6/09/jdi-5-525.PMC4188110.pdf
5 September 2014 527ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Sasang constitutional medicine and type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/e6/09/jdi-5-525.PMC4188110.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e6/09/jdi-5-525.PMC4188110.pdf
5 September 2014 529ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Sasang constitutional medicine and type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/e6/09/jdi-5-525.PMC4188110.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e6/09/jdi-5-525.PMC4188110.pdf
5 September 2014 531ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Sasang constitutional medicine and type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/e6/09/jdi-5-525.PMC4188110.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e6/09/jdi-5-525.PMC4188110.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/cb/65/jdi-5-533.PMC4188111.pdf
5 September 2014 535ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi IFG phenotypes from OGTT computation,Non-OADS,/arxiv_data1/oa_pdf/cb/65/jdi-5-533.PMC4188111.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/cb/65/jdi-5-533.PMC4188111.pdf
5 September 2014 537ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi IFG phenotypes from OGTT computation,Non-OADS,/arxiv_data1/oa_pdf/cb/65/jdi-5-533.PMC4188111.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/cb/65/jdi-5-533.PMC4188111.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/48/4c/jdi-5-539.PMC4188112.pdf
5 September 2014 541ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Insulin regimens in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/48/4c/jdi-5-539.PMC4188112.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/48/4c/jdi-5-539.PMC4188112.pdf
5 September 2014 543ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Insulin regimens in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/48/4c/jdi-5-539.PMC4188112.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/48/4c/jdi-5-539.PMC4188112.pdf
5 September 2014 545ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Insulin regimens in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/48/4c/jdi-5-539.PMC4188112.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/48/4c/jdi-5-539.PMC4188112.pdf
5 September 2014 547ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Insulin regimens in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/48/4c/jdi-5-539.PMC4188112.pdf
5 September 2014 549ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Effect of sitagliptin in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/1f/28/jdi-5-548.PMC4188113.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/1f/28/jdi-5-548.PMC4188113.pdf
5 September 2014 551ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Effect of sitagliptin in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/1f/28/jdi-5-548.PMC4188113.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/1f/28/jdi-5-548.PMC4188113.pdf
5 September 2014 553ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Effect of sitagliptin in type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/1f/28/jdi-5-548.PMC4188113.pdf
5 September 2014 555ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Exenatide with preserved C-peptide,Non-OADS,/arxiv_data1/oa_pdf/4c/1a/jdi-5-554.PMC4188114.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/4c/1a/jdi-5-554.PMC4188114.pdf
5 September 2014 557ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Exenatide with preserved C-peptide,Non-OADS,/arxiv_data1/oa_pdf/4c/1a/jdi-5-554.PMC4188114.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/4c/1a/jdi-5-554.PMC4188114.pdf
5 September 2014 559ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Exenatide with preserved C-peptide,Non-OADS,/arxiv_data1/oa_pdf/4c/1a/jdi-5-554.PMC4188114.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/4c/1a/jdi-5-554.PMC4188114.pdf
5 September 2014 561ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Exenatide with preserved C-peptide,Non-OADS,/arxiv_data1/oa_pdf/4c/1a/jdi-5-554.PMC4188114.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/4c/1a/jdi-5-554.PMC4188114.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/02/91/jdi-5-563.PMC4188115.pdf
5 September 2014 565ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Factors of glycemic control in diabetics,Non-OADS,/arxiv_data1/oa_pdf/02/91/jdi-5-563.PMC4188115.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/02/91/jdi-5-563.PMC4188115.pdf
5 September 2014 567ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Factors of glycemic control in diabetics,Non-OADS,/arxiv_data1/oa_pdf/02/91/jdi-5-563.PMC4188115.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/02/91/jdi-5-563.PMC4188115.pdf
5 September 2014 569ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Factors of glycemic control in diabetics,Non-OADS,/arxiv_data1/oa_pdf/02/91/jdi-5-563.PMC4188115.pdf
"The U-CPR indexw a sc a l c u l a t e da st h eU - C P R( lg/day) / FPG (mg/dL), as pre- viously reported 10,13.T h eH O M A - band HOMA-IR were cal- culated as previously reported7.F u r t h e r m o r e ,w ea l s o calculated the HOMA of insulin secretion and HOMA of insulin sensitivity using HOMA2 calculator (http://www.dtu.ox.",OADS,/arxiv_data1/oa_pdf/1d/66/jdi-5-570.PMC4188116.pdf
5 September 2014 571ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi SUIT and insulin requirement,Non-OADS,/arxiv_data1/oa_pdf/1d/66/jdi-5-570.PMC4188116.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/1d/66/jdi-5-570.PMC4188116.pdf
5 September 2014 573ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi SUIT and insulin requirement,Non-OADS,/arxiv_data1/oa_pdf/1d/66/jdi-5-570.PMC4188116.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/1d/66/jdi-5-570.PMC4188116.pdf
5 September 2014 575ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi SUIT and insulin requirement,Non-OADS,/arxiv_data1/oa_pdf/1d/66/jdi-5-570.PMC4188116.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/1d/66/jdi-5-570.PMC4188116.pdf
5 September 2014 577ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi SUIT and insulin requirement,Non-OADS,/arxiv_data1/oa_pdf/1d/66/jdi-5-570.PMC4188116.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/1d/66/jdi-5-570.PMC4188116.pdf
5 September 2014 579ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi SUIT and insulin requirement,Non-OADS,/arxiv_data1/oa_pdf/1d/66/jdi-5-570.PMC4188116.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/1d/66/jdi-5-570.PMC4188116.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/cc/14/jdi-5-581.PMC4188117.pdf
5 September 2014 583ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Changes in OAD use in Japan 2002 –2011,Non-OADS,/arxiv_data1/oa_pdf/cc/14/jdi-5-581.PMC4188117.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/cc/14/jdi-5-581.PMC4188117.pdf
5 September 2014 585ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Changes in OAD use in Japan 2002 –2011,Non-OADS,/arxiv_data1/oa_pdf/cc/14/jdi-5-581.PMC4188117.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/cc/14/jdi-5-581.PMC4188117.pdf
5 September 2014 587ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Changes in OAD use in Japan 2002 –2011,Non-OADS,/arxiv_data1/oa_pdf/cc/14/jdi-5-581.PMC4188117.pdf
"5 September 2014 589ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Sudomotor, sweat glands and CNF in T2DM",Non-OADS,/arxiv_data1/oa_pdf/02/4d/jdi-5-588.PMC4188118.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/02/4d/jdi-5-588.PMC4188118.pdf
"5 September 2014 591ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Sudomotor, sweat glands and CNF in T2DM",Non-OADS,/arxiv_data1/oa_pdf/02/4d/jdi-5-588.PMC4188118.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/02/4d/jdi-5-588.PMC4188118.pdf
"5 September 2014 593ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Sudomotor, sweat glands and CNF in T2DM",Non-OADS,/arxiv_data1/oa_pdf/02/4d/jdi-5-588.PMC4188118.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/02/4d/jdi-5-588.PMC4188118.pdf
"5 September 2014 595ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Sudomotor, sweat glands and CNF in T2DM",Non-OADS,/arxiv_data1/oa_pdf/02/4d/jdi-5-588.PMC4188118.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/02/4d/jdi-5-588.PMC4188118.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jdi-5-597.PMC4188119.pdf
5 September 2014 599ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Renal and cognitive impairment,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jdi-5-597.PMC4188119.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jdi-5-597.PMC4188119.pdf
5 September 2014 601ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Renal and cognitive impairment,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jdi-5-597.PMC4188119.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jdi-5-597.PMC4188119.pdf
5 September 2014 603ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Renal and cognitive impairment,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jdi-5-597.PMC4188119.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jdi-5-597.PMC4188119.pdf
5 September 2014 605ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Renal and cognitive impairment,Non-OADS,/arxiv_data1/oa_pdf/e3/9b/jdi-5-597.PMC4188119.pdf
5 September 2014 607ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Cardiovascular risk prediction in diabetic patients,Non-OADS,/arxiv_data1/oa_pdf/92/74/jdi-5-606.PMC4188120.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/92/74/jdi-5-606.PMC4188120.pdf
5 September 2014 609ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Cardiovascular risk prediction in diabetic patients,Non-OADS,/arxiv_data1/oa_pdf/92/74/jdi-5-606.PMC4188120.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/92/74/jdi-5-606.PMC4188120.pdf
5 September 2014 611ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Cardiovascular risk prediction in diabetic patients,Non-OADS,/arxiv_data1/oa_pdf/92/74/jdi-5-606.PMC4188120.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/92/74/jdi-5-606.PMC4188120.pdf
"Diabetes Atlas, 5rd edn http://www.idf.org/diabetesatlas/2012.",Non-OADS,/arxiv_data1/oa_pdf/92/74/jdi-5-606.PMC4188120.pdf
Available from: http://www.idf.org/diabetesatlas/.,Non-OADS,/arxiv_data1/oa_pdf/92/74/jdi-5-606.PMC4188120.pdf
5 September 2014 613ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Cardiovascular risk prediction in diabetic patients,Non-OADS,/arxiv_data1/oa_pdf/92/74/jdi-5-606.PMC4188120.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/92/74/jdi-5-606.PMC4188120.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c8/cc/jdi-5-615.PMC4188121.pdf
5 September 2014 617ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi F M Di ny o u t hw i t hd i a b e t e s,Non-OADS,/arxiv_data1/oa_pdf/c8/cc/jdi-5-615.PMC4188121.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c8/cc/jdi-5-615.PMC4188121.pdf
5 September 2014 619ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi F M Di ny o u t hw i t hd i a b e t e s,Non-OADS,/arxiv_data1/oa_pdf/c8/cc/jdi-5-615.PMC4188121.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c8/cc/jdi-5-615.PMC4188121.pdf
"jnci.oxfordjournals.org This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution,   and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/35/dju241.PMC4188123.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2014 |  88  | e51583 | Page 1 of 8Video Article Non-chromatographic Purification of Recombinant Elastin-like Polypeptides and their Fusions with Peptides and Proteins from Escherichia coli Sarah R. MacEwan*1,2, Wafa Hassouneh*1,2, Ashutosh Chilkoti1,2 1Department of Biomedical Engineering, Duke University 2Research Triangle MRSEC, Duke University *These authors contributed equally Correspondence to: Ashutosh Chilkoti at chilkoti@duke.edu URL: http://www.jove.com/video/51583 DOI: doi:10.3791/51583 Keywords: Molecular Biology, Issue 88, elastin-like polypeptides, lower critical solution temperature, phase separation, inverse transition cycling, protein purification, batch purification Date Published: 6/9/2014 Citation: MacEwan, S.R., Hassouneh, W., Chilkoti, A. Non-chromatographic Purification of Recombinant Elastin-like Polypeptides and their Fusions with Peptides and Proteins from Escherichia coli .",Non-OADS,/arxiv_data1/oa_pdf/da/4f/jove-88-51583.PMC4188175.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51583/ Introduction Elastin-like polypeptides (ELPs) are biopolymers composed of the repeating pentapeptide VPGXG where X, the guest residue, is any amino acid except proline.",Non-OADS,/arxiv_data1/oa_pdf/da/4f/jove-88-51583.PMC4188175.pdf
Available from: http://clinicaltrials.gov/ct/show/ NCT01791530?order=1,Non-OADS,/arxiv_data1/oa_pdf/5f/e4/rbti-26-03-0212.PMC4188458.pdf
Available at http://www.cc-ims.net/revman/ gradepro 2012.,Non-OADS,/arxiv_data1/oa_pdf/84/75/rbti-26-03-0215.PMC4188459.pdf
Avaliable from http://www.asha.org/policy/GL2000-00047.htm   174.,Non-OADS,/arxiv_data1/oa_pdf/84/75/rbti-26-03-0215.PMC4188459.pdf
Disponível em http://www.amib.org.br/fileadmin/user_upload/amib/ RECOMENDACOES_PARA_HIGIENE_BUCAL_DO_PACIENTE_ADULTO_ EM_UTI_-_AMIB.pdf   199.,OADS,/arxiv_data1/oa_pdf/84/75/rbti-26-03-0215.PMC4188459.pdf
Disponível en: http://med.unne.edu.ar/posgrado/cursomedgral/clases/ La%20f%EDsica%20de%20los%20ultrasonidos.doc.,Non-OADS,/arxiv_data1/oa_pdf/23/17/rbti-26-03-0240.PMC4188460.pdf
Disponível en: http://www.acnweb.org/guia/g8cap6.pdf  23.,Non-OADS,/arxiv_data1/oa_pdf/23/17/rbti-26-03-0240.PMC4188460.pdf
Available from: http://www.elso.org/index.php?option=com_content&vi ew=article&id=85&Itemid=653.,Non-OADS,/arxiv_data1/oa_pdf/17/e7/rbti-26-03-0253.PMC4188461.pdf
"In this  case, greater intra-abdominal pressure, due to increased CO2 in- sufflation pressure, impeded venous return, even in the cerebral  venous system, dissolved CO2 gas-generated intense vascular  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 161-163  http://dx.doi.org/10.4097/kjae.2014.67.3.161 Editorial",Non-OADS,/arxiv_data1/oa_pdf/54/71/kjae-67-161.PMC4188759.pdf
"Tel: 82-2-2258-6163, Fax: 82-2-537-1951, E-mail:  0910momo@naver.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 164-170  http://dx.doi.org/10.4097/kjae.2014.67.3.164  Introduction Postoperative nausea and vomiting (PONV) has attracted a  great deal of attention since Kapur described it as the big “little  problem ” in 1991 [1].",Non-OADS,/arxiv_data1/oa_pdf/f0/82/kjae-67-164.PMC4188760.pdf
"Tel: 82-31-219-5574, Fax: 82-31-219-5579, E-mail: kjyeop@ajou.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 171-174  http://dx.doi.org/10.4097/kjae.2014.67.3.171",Non-OADS,/arxiv_data1/oa_pdf/31/fe/kjae-67-171.PMC4188761.pdf
"Tel: 82-62-220-3223, Fax: 82-62-223-2333, E-mail: than@chosun.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 175-180  http://dx.doi.org/10.4097/kjae.2014.67.3.175",Non-OADS,/arxiv_data1/oa_pdf/3b/8a/kjae-67-175.PMC4188762.pdf
"Tel: 82-2-2650-5558, Fax: 82-2-2655-2924, E-mail: kdyeon@ewha.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 181-185  http://dx.doi.org/10.4097/kjae.2014.67.3.181",Non-OADS,/arxiv_data1/oa_pdf/38/7e/kjae-67-181.PMC4188763.pdf
"Tel: 82-2-3410-0360, Fax: 82-2-3410-0361, E-mail: gskim@ skku.edu     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 186-192  http://dx.doi.org/10.4097/kjae.2014.67.3.186",Non-OADS,/arxiv_data1/oa_pdf/ef/fb/kjae-67-186.PMC4188764.pdf
Available from http://www.konos.go.kr/konosis.,Non-OADS,/arxiv_data1/oa_pdf/ef/fb/kjae-67-186.PMC4188764.pdf
"Tel: 82-53-250-7288, Fax: 82-53-250-7240, E-mail: pain1004@dsmc.or.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 193-197  http://dx.doi.org/10.4097/kjae.2014.67.3.193",Non-OADS,/arxiv_data1/oa_pdf/16/7a/kjae-67-193.PMC4188765.pdf
"Tel: 82-2-709-9291, Fax: 82-2-790-0394, E-mail: sunnypark97@gmail.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 198-204  http://dx.doi.org/10.4097/kjae.2014.67.3.198",Non-OADS,/arxiv_data1/oa_pdf/c3/a7/kjae-67-198.PMC4188766.pdf
"She was diagnosed with missed abortion  with a hydatidiform mole in a local clinic and transferred to our  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 205-208  http://dx.doi.org/10.4097/kjae.2014.67.3.205 Case Report",Non-OADS,/arxiv_data1/oa_pdf/39/f2/kjae-67-205.PMC4188767.pdf
"Here we  report a case of asystole that occurred during the operation of a  relatively small-sized (< 10 mm) pituitary adenoma as a result  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 209-212  http://dx.doi.org/10.4097/kjae.2014.67.3.209 Case Report",Non-OADS,/arxiv_data1/oa_pdf/ac/8c/kjae-67-209.PMC4188768.pdf
"Modern  neurosurgical anesthetic technique is designed to allow postop - erative neurologic evaluation promptly using volatile anesthetic  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 213-216  http://dx.doi.org/10.4097/kjae.2014.67.3.213 Case Report",Non-OADS,/arxiv_data1/oa_pdf/a2/ed/kjae-67-213.PMC4188769.pdf
"She was diag - Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 217-220  http://dx.doi.org/10.4097/kjae.2014.67.3.217 Case Report",Non-OADS,/arxiv_data1/oa_pdf/aa/6e/kjae-67-217.PMC4188770.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 September 67(3): 221-224  http://dx.doi.org/10.4097/kjae.2014.67.3.221 Case Report",Non-OADS,/arxiv_data1/oa_pdf/76/df/kjae-67-221.PMC4188771.pdf
"139 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 49 ㆍNumber 3 ㆍSeptember 2014 http://dx.doi.org/10.5045/br.2014.49.3.139 Editorial Way to go to exploit NK cellsÊ versatile talents for cancer  immunotherapy Duck Cho, M.D.",Non-OADS,/arxiv_data1/oa_pdf/22/97/br-49-139.PMC4188774.pdf
"(Accessed  September 19, 2014, at http://www.nkcells.info/index.php?title=NK_cell_expansion) 3.",OADS,/arxiv_data1/oa_pdf/22/97/br-49-139.PMC4188774.pdf
"141 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 49 ㆍNumber 3 ㆍSeptember 2014 http://dx.doi.org/10.5045/br.2014.49.3.141 Perspective Is a cure for CML without  allogeneic stem cell transplantation around the corner?",Non-OADS,/arxiv_data1/oa_pdf/46/fe/br-49-141.PMC4188775.pdf
"144 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 49 ㆍNumber 3 ㆍSeptember 2014 http://dx.doi.org/10.5045/br.2014.49.3.144 Perspective Management of hemophilia in  Korea: the past, present, and future Eun Jin Choi, M.D., Ph.D. Hemophilia Working Party, Ko rean Society of Hematology,  Department of Pediatrics, Daegu Catholic Universi ty School of  Medicine, Daegu, Korea   Hemophilia is a bleeding disorder.",Non-OADS,/arxiv_data1/oa_pdf/87/39/br-49-144.PMC4188776.pdf
"146 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial us e, distribution, and reproduction in any medium, provided the original work is prop erly cited.Blood Research Educational Material BLOOD RESEARCH Volume 49 ㆍNumber 3 ㆍSeptember 2014 http://dx.doi.org/10.5045/br.2014.49.3.146 Primary systemic amyloidosis with sole cutaneous involvement Prakas Kumar Mandal1, Tuphan Kanti Dolai2 1Department of Pathology, I. P.G.M.E.& R., Kolkata-700020, 2Department of Hematology, N.R.S.",Non-OADS,/arxiv_data1/oa_pdf/06/cf/br-49-146.PMC4188777.pdf
"147 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial us e, distribution, and reproduction in any medium, provided the original work is prop erly cited.Blood Research Educational Material BLOOD RESEARCH Volume 49 ㆍNumber 3 ㆍSeptember 2014 http://dx.doi.org/10.5045/br.2014.49.3.147 Reed-Sternberg-like cells in follicular lymphoma Eun-mi Son, Jooryung Huh Department of Pathology, Asan Me dical Center, University of Ulsan College of Medicine, Seoul, Korea  Correspondence to Jooryung Huh, M.D., Ph.D., Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88,  Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea, E-mail: jrhuh@amc.seoul.kr A 32-year-old woman presented with abdo minal bloating and postprandial disc omfort for 3 weeks.",Non-OADS,/arxiv_data1/oa_pdf/0d/0a/br-49-147.PMC4188778.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 3 September 2014REVIEW  ARTICLE Serum beta-2 microglobulin in malignant lymphomas: an old but  powerful prognostic factor Changhoon Yoo#, Dok Hyun Yoon#, Cheolwon Suh Department of Oncology, Asan Medical Center, Univer sity of Ulsan College of  Medicine, Seoul, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.3.148Blood Res 2014;49:148-53.",Non-OADS,/arxiv_data1/oa_pdf/c1/aa/br-49-148.PMC4188779.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 3 September 2014ORIGINAL ARTICLE Development of NK cell expansion methods using feeder cells from  human myelogenous leukemia cell line Duk Seong Bae, Jae Kwon Lee Department of Biology Educ ation, College of Education, Chungbuk National University, Cheongju, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.3.154Blood Res 2014;49:154-61.",Non-OADS,/arxiv_data1/oa_pdf/95/eb/br-49-154.PMC4188780.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 3 September 2014ORIGINAL  ARTICLE Influence of NK cell count on the surv ival of patients with diffuse large  B-cell lymphoma treated with R-CHOP Joong-Keun Kim, Joo-Seop Chung, Ho-Jin Shin, Mo o-Kon Song, Ji-Won Yi, Dong-Hun Shin, Dae-Sung  Lee, Sung-Min Baek Department of Hematology-Onc ology, Pusan National Univer sity Hospital Medical Resear ch Institute, Busan, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.3.162Blood Res 2014;49:162-9.",Non-OADS,/arxiv_data1/oa_pdf/de/02/br-49-162.PMC4188781.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 3 September 2014ORIGINAL  ARTICLE Treatment of primary testicular diffuse large B cell lymphoma without  prophylactic intrathecal chemotherapy: a single center experience Jeongseok Kim1, Dok Hyun Yoon1, Inkeun Park4, Shin Kim1, Jung Sun Park1, Sang-Wook Lee2, Jooryung  Huh3, Chan-Sik Park3, Cheolwon Suh1 Departments of  1Oncology, 2Radiation Oncology and 3Pathology, Asan Medical Center, University of Ulsan College of Medicine,  Seoul, 4Division of Hematology and Oncology, De partment of Internal Medicine, Gachon University Gil Medical Center, Incheon,  Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.3.170Blood Res 2014;49:170-6.",Non-OADS,/arxiv_data1/oa_pdf/94/85/br-49-170.PMC4188782.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 3 September 2014ORIGINAL  ARTICLE T otal extract of Korean red ginseng facilitates human bone marrow  hematopoietic colony formation in vitro Sang-Gyung Kim1, A-Jin Lee1, Sung Hwa Bae2, Seong-Mo Kim3, Ji-Hye Lee1, Min Ji Kim1, Hae-Bong Jang1 1Department of Laboratory Medicine, 2Division of Hematology/Oncolog y, Department of Internal Me dicine, Catholic University o f  Daegu, School of Medicine, 3Department of Oriental Internal Medicine of Hepatology, College of Oriental Medicine and Daegu  Hanny University, Daegu, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.3.177Blood Res 2014;49:177-81.",Non-OADS,/arxiv_data1/oa_pdf/81/76/br-49-177.PMC4188783.pdf
"Farideh Moussavi1, Mounes Aliyari Ghasabeh2, Shahla Roodpeyma3, Samin Alavi4, Majid Shakiba2, Riaz  Gheiratmand1, Maryam Omidghaemi1 1Department of Pediat ric Hematology, Shohada Hospit al, Shahid Beheshti Univer sity of Medical Sciences, 2Advanced Diagnostic an d  Interventional Radiology Research Center, Imam Khomeini Hospital, Keshavarz Boulevard, Tehran University of Medical Sciences,  3Pediatric cardiology division, Moda rres Hospital, Shahid Beheshti University of Medical Sciences, 4Department of Pediatric  Hematology, Mofid Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.3.182Blood Res 2014;49:182-6.",Non-OADS,/arxiv_data1/oa_pdf/9c/b1/br-49-182.PMC4188784.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 3 September 2014ORIGINAL  ARTICLE Natural course of childhood chronic immune thrombocytopenia  using the revised terminology and definitions of the international working group: a single center experience Ye Jee Shim1, Uk Hyun Kim2, Jin Kyung Suh3, Kun Soo Lee4 1Hanyoung Children's Hospital, Daegu, 2Incheon Medical Center Beakryung Hospital, Beakryung-do, 3Division of Pediatric  Hematology/Oncology, Asan Medical Center Children's Hospital , Department of Pediatrics, Univer sity of Ulsan College of Medicine ,  Seoul, 4Department of Pediatrics, Kyun gpook National University Hospital and Kyungp ook National Un iversity School of Medicine,  Daegu, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.3.187Blood Res 2014;49:187-91.",Non-OADS,/arxiv_data1/oa_pdf/58/0b/br-49-187.PMC4188785.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 3 September 2014CASE  REPORT Hereditary hemorrhagic telangiectasia treated with low dose  intravenous bevacizumab Jee Wan Wee, Young Woo Jeon, Jun Young Eun, Han Jo Kim, Sang Byung Bae, Kyu Taek Lee Department of Internal Medici ne, Soonchunhyang University Cheonan Hospital, Cheonan, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.3.192Blood Res 2014;49:192-5.",Non-OADS,/arxiv_data1/oa_pdf/0e/10/br-49-192.PMC4188786.pdf
"11, 2014 http://dx.doi.org/10.5045/br.2014.49.3.196 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/eb/f2/br-49-196.PMC4188787.pdf
"11, 2014 http://dx.doi.org/10.5045/br.2014.49.3.196 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/88/5a/br-49-198.PMC4188788.pdf
"15, 2014; Revised on May 25, 2014; Accepted on Aug. 25, 2014 http://dx.doi.org/10.5045/br.2014.49.3.198  AuthorsÊ Disclosures of Potential Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/88/5a/br-49-198.PMC4188788.pdf
"15, 2014; Revised on May 25, 2014; Accepted on Aug. 25, 2014 http://dx.doi.org/10.5045/br.2014.49.3.198  AuthorsÊ Disclosures of Potential Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/a6/bd/br-49-200.PMC4188789.pdf
"8, 2014; Revised on May 26, 2014; Accepted on Aug. 22, 2014 http://dx.doi.org/10.5045/br.2014.49.3.200 AuthorsÊ Disclosures of Potential Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/a6/bd/br-49-200.PMC4188789.pdf
"(Accessed March 10, 2014, at http://cgap.nci.nih.gov/ Chromosomes/Mitelman) 6.",Non-OADS,/arxiv_data1/oa_pdf/a6/bd/br-49-200.PMC4188789.pdf
"(Accessed March 10, 2014, at http://cgap.nci.nih.gov/ Chromosomes/Mitelman) 6.",Non-OADS,/arxiv_data1/oa_pdf/25/a3/br-49-203.PMC4188790.pdf
"25, 2014; Accepted on Aug. 25, 2014 http://dx.doi.org/10.5045/br.2014.49.3.203 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/25/a3/br-49-203.PMC4188790.pdf
"25, 2014; Accepted on Aug. 25, 2014 http://dx.doi.org/10.5045/br.2014.49.3.203 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/72/90/br-49-205.PMC4188791.pdf
"Kun Soo Lee 1, Ye Jee Shim2,  Kyoung Mi Jang1, Shin Young Hyun3 1Department of Pediatrics, Kyungpook National University  Hospital and Kyungpook National University School of  Medicine, 2Hanyoung Children's Hospital, Daegu,  3Department of Medicine, Yonsei University Wonju College  of Medicine, Wonju, Korea Correspondence to:  Kun Soo Lee Department of Pediatrics, Kyungpook National University  Hospital and School of Medicine, 130 Dongdukro,  Jung-gu, Daegu 700-721, Korea E-mail: kslee@knu.ac.kr   Received on Aug. 6, 2014; Revised on Aug. 22, 2014; Accepted on Sep. 19, 2014 http://dx.doi.org/10.5045/br.2014.49.3.205   *This research was supported by the Kyungpook National  University Research Fund, 2012.",Non-OADS,/arxiv_data1/oa_pdf/72/90/br-49-205.PMC4188791.pdf
"104 Lab Anim Res 2014: 30(3), 104-111 http://dx.doi.org/10.5625/lar.2014.30.3.104 Evaluation of the genotoxicity of ginseng  leaf extract UG0712 Ji-Young Kim1#, Yu Ri2#, Seon-Gil Do3, Young-Chul Lee3, Sang-Joon Park2* 1Laboratory of Genetic Toxicology, Korea Institute of Toxicology, KRICT, Daejeon, Korea 2Department of Histology, College of Veterinary Medicine, Kyungpook National University, 1370 Sankyuk-dong, Bukgu, Daegu, Korea 3Unigen Inc., Cheonan, Korea Although ginseng (genus Panax ) leaf extract contains high concentrations of bioactive constituents, its effects have been reported in few preclinical studies, and information regarding its toxicity is not sufficient to allow for its clinical use.",Non-OADS,/arxiv_data1/oa_pdf/c8/ae/lar-30-104.PMC4188829.pdf
"112 Lab Anim Res 2014: 30(3), 112-122 http://dx.doi.org/10.5625/lar.2014.30.3.112 13-week subchronic toxicity study  of a novel ginsenoside  composition from ginseng leaves in rats Won-Ho Shin1#, Yu Ri1#, Seon-Gil Do2, Young-Chul Lee2, Sang-Joon Park1* 1Department of Histology, College of Veterinary Medicine, Kyungpook National University, Daegu, Korea 2Unigen Inc., Cheonan, Korea UG0712 is a new ginsenoside extract processed from ginseng leaves.",Non-OADS,/arxiv_data1/oa_pdf/ae/59/lar-30-112.PMC4188830.pdf
"123 Lab Anim Res 2014: 30(3), 123-130 http://dx.doi.org/10.5625/lar.2014.30.3.123 Adverse effects of 4-tert-o ctylphenol on the production of oxytocin and hCG in pregnant rats Jun Kim1, Eun-Jin Kang1, Mee-Na Park1, Jae-Eon Lee1, So-Hye Hong1, Sung-Min An1, Seung-Chul Kim2, Dae-Youn Hwang1, Beum-Soo An1* 1Department of Biomaterials Science, College of Natural Resources & Life Science/Life and Industry Convergence Research Institute, Pusan National University, Miryang, Korea 2Department of Obstetrics and Gynecology, Biomedical Research Institute, Pusan National University School of Medicine,  Busan, Korea Endocrine-disrupting chemicals (EDCs) are exogenous substances that alter the structure or function of the endocrine system.",Non-OADS,/arxiv_data1/oa_pdf/5b/5a/lar-30-123.PMC4188831.pdf
"131 Lab Anim Res 2014: 30(3), 131-135 http://dx.doi.org/10.5625/lar.2014.30.3.131 Anti-Helicobacter pylori  activities of FEMY-R7 composed of  fucoidan and evening primrose extract in mice and humans Tae -Su Kim1, Ehn-Kyoung Choi2, Jihyun Kim2, Kyungha Shin2, Sung-Pyo Lee1, Youngjin Choi2, Joseph H. Jeon3, Yun-Bae Kim2* 1Misuba RTech Co., Ltd., Asan, Korea 2College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea 3Haewon Biotech Inc., Seoul, Korea Helicobacter pylori -eliminating effects of FEMY-R7, composed of fucoidan and evening primrose extract, were investigated in mice and humans.",Non-OADS,/arxiv_data1/oa_pdf/03/75/lar-30-131.PMC4188832.pdf
"136 Lab Anim Res 2014: 30(3), 136-141 http://dx.doi.org/10.5625/lar.2014.30.3.136 Experimental model of tympani c colic (acute abdomen) in  chinchillas ( Chinchilla lanigera ) Malcon Andrei Martinez-Pereira1,2, Raphaela da Cunha Franceschi2,3, Bárbara Paranhos Coelho2, Gustavo da Rosa Fünkler2, Denise Maria Zancan2,3* 1Centro Ciências da Saúde, Universidade de Cruz Alta, Cruz Alta, Brazil 2Laboratório de Neurobiologia Comparada, Departamento de Fisiologia, Instituto de Ciências Básicas da Saúde,  Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil 3Programa de Pós-Graduação em Neurociências, Instituto de Ciências Básicas da Saúde (ICBS), Universidade Federal do Rio  Grande do Sul, Porto Alegre, Brazil Digestive disorders caused by sudden changes in diet or inappropriate diet are among the most common disorders of the digestive system.",Non-OADS,/arxiv_data1/oa_pdf/18/7c/lar-30-136.PMC4188833.pdf
"95 Lab Anim Res 2014: 30(3), 95-103 http://dx.doi.org/10.5625/lar.2014.30.3.95 Characterization of allergic response induced by repeated dermal exposure of IL-4/Luc/CNS-1 transgenic mice to low dose formaldehyde Moon-Hwa Kwak1, Ji-Eun Kim1, Jun Go1, Eun-Kyoung Koh1, Sung-Hwa Song1, Ji-Eun Sung1, Seung-Yun Yang1,  Beum-Soo An1, Young-Jin Jung1, Jae-Ho Lee1, Yong Lim2, Dae-Youn Hwang1* 1Department of Biomaterials Science, College of Natural Resources & Life Science/Life and Industry Convergence Research Institute, Pusan National University, Miryang, Korea 2Department of Clinical Laboratory Science, Dong-Eui University, Busan, Korea Although formaldehyde (FA) is known to be a major allergen responsible for allergic contact dermatitis, there are conflicting reports regarding correlation between FA exposure and interleukin (IL-4) expression.",Non-OADS,/arxiv_data1/oa_pdf/8b/d5/lar-30-95.PMC4188834.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2014, 58: 24848 - http://dx.doi.org/10.3402/fnr.v58.24848 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/04/76/FNR-58-24848.PMC4189009.pdf
"The animal experiment wasYadong Zhong and Margareta Nyman 2 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24848 - http://dx.doi.org/10.3402/fnr.v58.24848",Non-OADS,/arxiv_data1/oa_pdf/04/76/FNR-58-24848.PMC4189009.pdf
"None of the probiotic strains affected the fermentability of the dietary fibre to any greater extent.The only significance seen was the higher degree of fer-mentation with malt and Paracasei compared with malt and CURE 21 or Lr 271 when suing another statistical test, that is, student’s t-test, than one-way ANOV A. Caecal content, tissue weight and pH The rats appeared to be healthy throughout the study and ate most of the food provided during the experimental period (11.2 /C111.8 g/day), which corresponded to 93 /C198%SCFAs and amino acids with malt and probiotics Citation: Food & Nutrition Research 2014, 58: 24848 - http://dx.doi.org/10.3402/fnr.v58.24848 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/04/76/FNR-58-24848.PMC4189009.pdf
"Results are given as means9SEM, n/C306 for malt /C27CURE 21 and n/C307 for all other groups.Yadong Zhong and Margareta Nyman 4 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24848 - http://dx.doi.org/10.3402/fnr.v58.24848",Non-OADS,/arxiv_data1/oa_pdf/04/76/FNR-58-24848.PMC4189009.pdf
"Mean values were significantly different from those for rats fed with malt: * PB0.05, ** PB0.01, *** PB0.001.SCFAs and amino acids with malt and probiotics Citation: Food & Nutrition Research 2014, 58: 24848 - http://dx.doi.org/10.3402/fnr.v58.24848 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/04/76/FNR-58-24848.PMC4189009.pdf
"Dominant lactobacilli and their incidence in the caecum of rats fed malt and malt with Paracasei, HEAL 9, HEAL 19, CURE 21 or Lr 271 Malt/C27Paracasei/C27HEAL 9/C27HEAL 19/C27CURE 21/C27Lr 271 Probiotic strain/C1 4/7 3/7 7/7 /C1 7/7 L. reuteri strain7/7 4/7 4/7 3/7 6/7 5/7 L. animalis strain6/7 3/7 7/7 0/7 5/7 4/7 Values are presented as incidence of specific strain per number of test rats.Yadong Zhong and Margareta Nyman 6 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24848 - http://dx.doi.org/10.3402/fnr.v58.24848",Non-OADS,/arxiv_data1/oa_pdf/04/76/FNR-58-24848.PMC4189009.pdf
"Eur J Clin Nutr 2006; 62: 712/C120.SCFAs and amino acids with malt and probiotics Citation: Food & Nutrition Research 2014, 58: 24848 - http://dx.doi.org/10.3402/fnr.v58.24848 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/04/76/FNR-58-24848.PMC4189009.pdf
"Box 124, SE-221 00 Lund, SwedenEmail: Yadong.Zhong@appliednutrition.lth.seYadong Zhong and Margareta Nyman 8 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24848 - http://dx.doi.org/10.3402/fnr.v58.24848",Non-OADS,/arxiv_data1/oa_pdf/04/76/FNR-58-24848.PMC4189009.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2014, 58: 24825 - http://dx.doi.org/10.3402/fnr.v58.24825 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/94/FNR-58-24825.PMC4189011.pdf
"2 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24825 - http://dx.doi.org/10.3402/fnr.v58.24825",Non-OADS,/arxiv_data1/oa_pdf/cf/94/FNR-58-24825.PMC4189011.pdf
"found similar results in adults and con-clude that it is possible to reduce the sodium content insoup by about 30% without significantly changing accept- ability and pointed to the masking of other ingredients, partial adaptation, as well as the decreased absolutesensitivity and increased differential sensitivity as possible reasons (13).Salt reduction in vegetable soup Citation: Food & Nutrition Research 2014, 58: 24825 - http://dx.doi.org/10.3402/fnr.v58.24825 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/94/FNR-58-24825.PMC4189011.pdf
"4 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24825 - http://dx.doi.org/10.3402/fnr.v58.24825",Non-OADS,/arxiv_data1/oa_pdf/cf/94/FNR-58-24825.PMC4189011.pdf
"Conflict of interest and funding The authors declare no conflict of interest.Salt reduction in vegetable soup Citation: Food & Nutrition Research 2014, 58: 24825 - http://dx.doi.org/10.3402/fnr.v58.24825 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/94/FNR-58-24825.PMC4189011.pdf
"6 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24825 - http://dx.doi.org/10.3402/fnr.v58.24825",Non-OADS,/arxiv_data1/oa_pdf/cf/94/FNR-58-24825.PMC4189011.pdf
"*Carla Gonc ¸alves Faculty of Nutrition and Food SciencesUniversity of Porto Rua Roberto Frias, PT -4200-465 Porto, Portugal Email: carlagoncalves.pt@gmail.comSalt reduction in vegetable soup Citation: Food & Nutrition Research 2014, 58: 24825 - http://dx.doi.org/10.3402/fnr.v58.24825 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cf/94/FNR-58-24825.PMC4189011.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2014, 9: 25451 - http://dx.doi.org/10.3402/ljm.v9.25451 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/52/a2/LJM-9-25451.PMC4189012.pdf
"2 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 25451 - http://dx.doi.org/10.3402/ljm.v9.25451",Non-OADS,/arxiv_data1/oa_pdf/52/a2/LJM-9-25451.PMC4189012.pdf
"Antibiotic resistance of various Gram negative bacterial isolates from mobile phones of patients Percentage of resistance Name of antibiotic Enterobacter cloacae complex (7)* Pseudomonas stutzeri (3)* Sphingomonas paucimobilis (3)* Ampicillin 100 0 33.33 Amoxicillin/clavulanic acid 0 0 0Piperacillin/sulbactam 0 0 0Piperacillin/tazobactam 100 0 0Cefalothin 0 66.6 33.3Cefuroxime 85.7 66.6 33.3Cefuroxime axetil 100 66.6 33.3Cefoxitin 100 66.6 0 Cefpodoxime 0 66.6 0 Cefotaxime 0 0 0Ceftazidime 0 0 0Imipenem 0 0 0Meropenem 0 0 0Amikacin 0 0 0Gentamicin 0 0 33.3Tobramycin 0 0 0 Ciprofloxacin 0 0 0 Norfloxacin 0 0 0Tetracycline 0 0 0Nitrofurantoin 0 66.6 33.3Trimethoprim/sulfamethoxazole 0 33.3 0 *Total number of bacterial isolates in parenthesis.Antibacterial resistant bacterial contaminants from mobile phones Citation: Libyan J Med 2014, 9: 25451 - http://dx.doi.org/10.3402/ljm.v9.25451 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/52/a2/LJM-9-25451.PMC4189012.pdf
Available from: http://www.cdc.gov/hicpac/pdf/guidelines/Disinfection_Nov_2008.pdf [cited 29 December 2009].,Non-OADS,/arxiv_data1/oa_pdf/52/a2/LJM-9-25451.PMC4189012.pdf
"4 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 25451 - http://dx.doi.org/10.3402/ljm.v9.25451",Non-OADS,/arxiv_data1/oa_pdf/52/a2/LJM-9-25451.PMC4189012.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2014, 58: 24465 - http://dx.doi.org/10.3402/fnr.v58.24465 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a7/dc/FNR-58-24465.PMC4189013.pdf
"2 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24465 - http://dx.doi.org/10.3402/fnr.v58.24465",Non-OADS,/arxiv_data1/oa_pdf/a7/dc/FNR-58-24465.PMC4189013.pdf
"The composition of the whole meals from the ﬁrst part of the study including either dairy yoghurt or LOO with milk powder T otal meal Placebo/yoghurt LOO and milk powder Weight (g) 521 604 Energy (KJ) 2,892 3,056Energy (Kcal) 690 730Protein (g) 19.3 18.9 Carbohydrates (g) 65.4 65.7 T otal fat (g) 38.7 43.4Saturated fat (g) 24 9.1Monounsaturated fat (g) 8.6 13.6Polyunsaturated fat (g) 0.7 17.9Cholesterol (mg) 115.1 9.8Plant sterols (mg) 0 900Fiber (g) 3.4 4.6 Calcium (mg) 407 443Intake of liposomes made from fractionated oat oil Citation: Food & Nutrition Research 2014, 58: 24465 - http://dx.doi.org/10.3402/fnr.v58.24465 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a7/dc/FNR-58-24465.PMC4189013.pdf
"4 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24465 - http://dx.doi.org/10.3402/fnr.v58.24465",Non-OADS,/arxiv_data1/oa_pdf/a7/dc/FNR-58-24465.PMC4189013.pdf
"Data are presented as mM cholesterol and mean 9SEM, n /C3019.Intake of liposomes made from fractionated oat oil Citation: Food & Nutrition Research 2014, 58: 24465 - http://dx.doi.org/10.3402/fnr.v58.24465 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/a7/dc/FNR-58-24465.PMC4189013.pdf
"6 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24465 - http://dx.doi.org/10.3402/fnr.v58.24465",Non-OADS,/arxiv_data1/oa_pdf/a7/dc/FNR-58-24465.PMC4189013.pdf
"*Values after 3 h were signiﬁcantly different (p B0.05).Intake of liposomes made from fractionated oat oil Citation: Food & Nutrition Research 2014, 58: 24465 - http://dx.doi.org/10.3402/fnr.v58.24465 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a7/dc/FNR-58-24465.PMC4189013.pdf
"8 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24465 - http://dx.doi.org/10.3402/fnr.v58.24465",Non-OADS,/arxiv_data1/oa_pdf/a7/dc/FNR-58-24465.PMC4189013.pdf
"*Values at all postprandial time points were signiﬁcantly different (p B0.05).Intake of liposomes made from fractionated oat oil Citation: Food & Nutrition Research 2014, 58: 24465 - http://dx.doi.org/10.3402/fnr.v58.24465 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a7/dc/FNR-58-24465.PMC4189013.pdf
"10 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24465 - http://dx.doi.org/10.3402/fnr.v58.24465",Non-OADS,/arxiv_data1/oa_pdf/a7/dc/FNR-58-24465.PMC4189013.pdf
"*Lena Ohlsson Department of Clinical Science, Section of Medicine Lund UniversityBiomedical Center A13, S221 SW-84 Lund,Sweden Email: Lena.Ohlsson@med.lu.seIntake of liposomes made from fractionated oat oil Citation: Food & Nutrition Research 2014, 58: 24465 - http://dx.doi.org/10.3402/fnr.v58.24465 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a7/dc/FNR-58-24465.PMC4189013.pdf
"81, 3058–3060, doi:doi:http://dx.doi.org/10.1063/1.1515115 (2002).",Non-OADS,/arxiv_data1/oa_pdf/8c/72/srep06547.PMC4189019.pdf
"Database of zeolite structure ,,http://izasc.ethz.",OADS,/arxiv_data1/oa_pdf/8c/72/srep06547.PMC4189019.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6547 | DOI: 10.1038/srep06547 4",Non-OADS,/arxiv_data1/oa_pdf/8c/72/srep06547.PMC4189019.pdf
Preprint at http://arxiv.org/ abs/hep-ex/0701029 (2007).,Non-OADS,/arxiv_data1/oa_pdf/2b/d4/srep06549.PMC4189022.pdf
Preprint at http://arxiv.org/abs/1303.4667 (2013).,Non-OADS,/arxiv_data1/oa_pdf/2b/d4/srep06549.PMC4189022.pdf
Preprint at http://arxiv.org/abs/1303.2571 (2013).,Non-OADS,/arxiv_data1/oa_pdf/2b/d4/srep06549.PMC4189022.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2b/d4/srep06549.PMC4189022.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6549 | DOI: 10.1038/srep06549 8",Non-OADS,/arxiv_data1/oa_pdf/2b/d4/srep06549.PMC4189022.pdf
(2013) (Date of access:21/10/2013) http://arxiv.org/abs/1310.5586v1.,Non-OADS,/arxiv_data1/oa_pdf/d5/f1/srep06548.PMC4189023.pdf
"(2013), (Date of access: 22/07/2013), http://arxiv.org/abs/1307.5603v1.",Non-OADS,/arxiv_data1/oa_pdf/d5/f1/srep06548.PMC4189023.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d5/f1/srep06548.PMC4189023.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6548 | DOI: 10.1038/srep06548 7",Non-OADS,/arxiv_data1/oa_pdf/d5/f1/srep06548.PMC4189023.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/45/main.PMC4189049.pdf
Histology  showed  an http://dx.doi.org/10.1016/j.ijscr.2014.08.012 2210-2612/© 2014  The  Authors.,OADS,/arxiv_data1/oa_pdf/a9/45/main.PMC4189049.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/45/main.PMC4189049.pdf
This  is  an open access  article  under  the  CC  BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/48/main.PMC4189050.pdf
A  mildly  raised  lactate http://dx.doi.org/10.1016/j.ijscr.2014.07.024 2210-2612/Crown Copyright  ©  2014  Published  by  Elsevier  Ltd.  on  behalf  of  Surgical  Associates  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/02/48/main.PMC4189050.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-SA  license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/48/main.PMC4189050.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/f7/main.PMC4189051.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.07.012 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/f7/main.PMC4189051.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/f7/main.PMC4189051.pdf
National  Insti- tute for  Health  and  Clinical  Excellence  2014  [cited  12.07.2014];  Available  from: http://guidance.nice.org.uk/CG27/NICEGuidance/pdf/English 2.,Non-OADS,/arxiv_data1/oa_pdf/a4/f7/main.PMC4189051.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/80/main.PMC4189053.pdf
He http://dx.doi.org/10.1016/j.ijscr.2014.08.023 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/80/main.PMC4189053.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/80/main.PMC4189053.pdf
This  is  an  open access article  under  the  CC  BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/d3/main.PMC4189054.pdf
"The  left  salpinx,  ovary  were  normal  on  inspection  and http://dx.doi.org/10.1016/j.ijscr.2014.07.020 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/6a/d3/main.PMC4189054.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-SA  license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/d3/main.PMC4189054.pdf
This  is  an  open access article under the CC  BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/1c/main.PMC4189055.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.07.005 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/1c/main.PMC4189055.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-SA  license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/1c/main.PMC4189055.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/c2/main.PMC4189056.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.08.014 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/c2/main.PMC4189056.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/c2/main.PMC4189056.pdf
"J  Thorac  Cardiovasc  Surg  1999; 117 (June  (6)):1150, http://dx.doi.org/10.1016/S0022-5223(99)70252-7 .",Non-OADS,/arxiv_data1/oa_pdf/be/c2/main.PMC4189056.pdf
This  is  an  open  access  article  under  the CC BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/69/main.PMC4189057.pdf
"MRI  showed  a  T2  bright  left  groin  mass  with  edema  along the  fascial  planes,  and  lower  extremity  angiogram  demonstrated http://dx.doi.org/10.1016/j.ijscr.2014.05.018 2210-2612/Published by  Elsevier  Ltd.  on  behalf  of  Surgical  Associates  Ltd.",Non-OADS,/arxiv_data1/oa_pdf/02/69/main.PMC4189057.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-SA  license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/69/main.PMC4189057.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/4d/main.PMC4189058.pdf
"Discussion Esophageal  perforations  are  well  known  to  bear  severe  mortality and  morbidity.2We  report  an  intramural,  intrathoracic  esophageal http://dx.doi.org/10.1016/j.ijscr.2014.04.008 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/48/4d/main.PMC4189058.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/4d/main.PMC4189058.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/ef/main.PMC4189059.pdf
"His  previous medical history was signiﬁcant  for  arterial  hyper- tension, autoimmune  thyroiditis  and  type  2  diabetes  mellitus http://dx.doi.org/10.1016/j.ijscr.2014.03.010 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/19/ef/main.PMC4189059.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/ef/main.PMC4189059.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/3b/main.PMC4189060.pdf
"ﬁbrous  dysplasia,  giant  cell  tumor,  aneurysmal  bone  cysts, non-ossiﬁed  ﬁbroma,  chondroblastoma,  ﬁbrous  histiocytoma,  and xanthogranulomatous osteomyelitis.1 http://dx.doi.org/10.1016/j.ijscr.2014.07.016 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/28/3b/main.PMC4189060.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/3b/main.PMC4189060.pdf
"Skeletal  Radiol  2008; 37(December  (12)):1153–6, http://dx.doi.org/10.1007/s00256-008-0594-5 .",Non-OADS,/arxiv_data1/oa_pdf/28/3b/main.PMC4189060.pdf
"Acta  Orthop  Traumatol  Turc  2011; 45(3):203–7, http://dx.doi.org/10.3944/AOTT.",Non-OADS,/arxiv_data1/oa_pdf/28/3b/main.PMC4189060.pdf
This  is  an  open access article  under  the  CC  BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/55/main.PMC4189061.pdf
"During  his  stay  in the  intensive  care  unit,  hypotension  persisted  despite  parenteral http://dx.doi.org/10.1016/j.ijscr.2014.08.024 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/cc/55/main.PMC4189061.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-SA  license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/55/main.PMC4189061.pdf
"Biomed  Imaging  Interv  J  2009; 5(3):e18, http://dx.doi.org/10.2349/biij.5.3.e18 .",Non-OADS,/arxiv_data1/oa_pdf/cc/55/main.PMC4189061.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/af/main.PMC4189062.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.06.019 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/af/main.PMC4189062.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/af/main.PMC4189062.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/6a/main.PMC4189063.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.07.023 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/17/6a/main.PMC4189063.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/6a/main.PMC4189063.pdf
http://dx.doi.org/10.1016/j.ijscr.2013.10.016,OADS,/arxiv_data1/oa_pdf/89/6b/main.PMC4189064.pdf
/angbracketlefthttp://www.uptodate.com/contents/infections-due-to-the- streptococcus-anginosus-group?source=search  result&search=Streptococcus +anginosus+infection&selectedTitle=1%7E9#H14 /angbracketright [accessed  14.04.13.].,Non-OADS,/arxiv_data1/oa_pdf/89/6b/main.PMC4189064.pdf
This  is  an  open access article under  the  CC  BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/c8/main.PMC4189065.pdf
The  inverted  femoral  hernia  sac  was  then  ligated http://dx.doi.org/10.1016/j.ijscr.2014.03.022 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/c8/main.PMC4189065.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-SA  license (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/c8/main.PMC4189065.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/a5/main.PMC4189066.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.07.017 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/a5/main.PMC4189066.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/a5/main.PMC4189066.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/f4/main.PMC4189067.pdf
The  granulomatous  tissue  which  was  located http://dx.doi.org/10.1016/j.ijscr.2014.07.026 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/f4/main.PMC4189067.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/f4/main.PMC4189067.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/65/main.PMC4189068.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.06.009 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/65/main.PMC4189068.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/65/main.PMC4189068.pdf
12.  http://www.sicob.org/attivita/linee  guida.aspx 13.,Non-OADS,/arxiv_data1/oa_pdf/e0/65/main.PMC4189068.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/a6/main.PMC4189069.pdf
It  was http://dx.doi.org/10.1016/j.ijscr.2014.08.005 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/a6/main.PMC4189069.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/a6/main.PMC4189069.pdf
"J  Gastroenterol  Hepatol  2012:27, http://dx.doi.org/10.1111/j.1440-1746.2012.07058.x .6.",Non-OADS,/arxiv_data1/oa_pdf/ab/a6/main.PMC4189069.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/3f/main.PMC4189070.pdf
"After  the  stimulation,  the  testosterone level  was  found  at  <20  ng/dl  again  and  no  testes  were  palpated  in http://dx.doi.org/10.1016/j.ijscr.2014.07.025 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/6c/3f/main.PMC4189070.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/3f/main.PMC4189070.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/f8/main.PMC4189071.pdf
Intraoperative  urine  production  was http://dx.doi.org/10.1016/j.ijscr.2014.08.010 2210-2612/© 2014  The  Authors.,OADS,/arxiv_data1/oa_pdf/df/f8/main.PMC4189071.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/f8/main.PMC4189071.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/4a/main.PMC4189072.pdf
At  the  time  of  the  initial  IPP  removal  the http://dx.doi.org/10.1016/j.ijscr.2014.06.023 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/4a/main.PMC4189072.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/4a/main.PMC4189072.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/e8/main.PMC4189073.pdf
"As such,  the  patient  was  consented for  an  endovascular  repair,  being  counselled  that  the  risk  of  an http://dx.doi.org/10.1016/j.ijscr.2014.08.008 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/d0/e8/main.PMC4189073.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/e8/main.PMC4189073.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/0d/main.PMC4189074.pdf
No  postoperative http://dx.doi.org/10.1016/j.ijscr.2014.09.003 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/0d/main.PMC4189074.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/0d/main.PMC4189074.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/48/main.PMC4189075.pdf
"Indeed,  the  incidence  of http://dx.doi.org/10.1016/j.ijscr.2014.08.001 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/53/48/main.PMC4189075.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/48/main.PMC4189075.pdf
"2010;  2010,  http://dx.doi.org/10.1155/2010/650829 .",Non-OADS,/arxiv_data1/oa_pdf/53/48/main.PMC4189075.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/7e/main.PMC4189076.pdf
"A  colonic biopsy from  the  swollen  wall  showed  a  nonspe- ciﬁc  inﬂammation  with  lymphoid  aggregates,  with  no  evidence http://dx.doi.org/10.1016/j.ijscr.2014.08.003 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/f1/7e/main.PMC4189076.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/7e/main.PMC4189076.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/54/main.PMC4189077.pdf
"The  presentation  in  adult  life  is  a  rarity,  with  an  incidence between  the  diagragmatic  hernias  of  0.17–6%,  with  only  about  130 cases  reported  in  the  literature.3The  diagnose  usually  is  in  the context  of  other  gastrointestinal  complications  like  incarceration, with  laparotomy  as  the  procedure  to  damage  control  and  hernia repair.2,4,5 http://dx.doi.org/10.1016/j.ijscr.2014.08.017 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/1e/54/main.PMC4189077.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/54/main.PMC4189077.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/d4/main.PMC4189078.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.02.014 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/d4/main.PMC4189078.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/d4/main.PMC4189078.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/a4/main.PMC4189080.pdf
"Clin- ical  symptoms  of  SMV  thrombosis  are  untypical,  obscure  and characterized  by  slow  progress,  all  this  covered  by  early  postop- erative  period.2Because  of  these  obscure  symptoms,  it  was  not http://dx.doi.org/10.1016/j.ijscr.2014.09.004 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/8b/a4/main.PMC4189080.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/a4/main.PMC4189080.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/16/main.PMC4189085.pdf
Endoscopic  retrograde  cholangiography http://dx.doi.org/10.1016/j.ijscr.2014.08.007 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/16/main.PMC4189085.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/16/main.PMC4189085.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/8c/main.PMC4189088.pdf
Three- dimensional  reconstruction  of  CT  imaging  (3D-CT)  showed  that  an http://dx.doi.org/10.1016/j.ijscr.2014.07.019 2210-2612/© 2014  The  Authors.,OADS,/arxiv_data1/oa_pdf/62/8c/main.PMC4189088.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/8c/main.PMC4189088.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/71/main.PMC4189090.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.08.021 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/71/main.PMC4189090.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/71/main.PMC4189090.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/86/main.PMC4189091.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.08.018 2210-2612/© 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/86/main.PMC4189091.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/86/main.PMC4189091.pdf
"The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence ,http://creativecommons.org/licenses/by-nc-sa/3.0/ ..",Non-OADS,/arxiv_data1/oa_pdf/ed/84/S0007114514001640a.PMC4189119.pdf
"Supplementary material To view supplementary material for this article, please visithttp://dx.doi.org/10.1017/S0007114514001640 Acknowledgements The authors thank Tzu Han Chuck Chen and Byung Jun Songfor their exceptional technical assistance.Aspects of the present study have been presented at Exper- imental Biology, San Diego, CA, 21–25 April 2012.",Non-OADS,/arxiv_data1/oa_pdf/ed/84/S0007114514001640a.PMC4189119.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.3.199 Infect Chemother 2014;46(3):199-203 pISSN 2093-2340 · eISSN 2092-6448 Received:  March 6, 2013   Revised:  September 23, 2013  Accepted:  September 27, 2013 Corresponding Author : Dong-Gun Lee, MD, PhD Department of Internal Medicine, The Catholic Blood and Marrow Transplantation  Center, Seoul St. Mary’s Hospital, College of Medicine The Catholic University of Korea,  222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel: +82-2-2258-6003, Fax: +82-2-535-2494 E-mail: symonlee@catholic.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/d3/ic-46-199.PMC4189134.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.199  •  Infect Chemother 2014;46(3) :199-203 www.icjournal.org 201 was 83% at the room air.,Non-OADS,/arxiv_data1/oa_pdf/44/d3/ic-46-199.PMC4189134.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.199  •  Infect Chemother 2014;46(3) :199-203 www.icjournal.org 203 Hematol 2002;70:145-8.,Non-OADS,/arxiv_data1/oa_pdf/44/d3/ic-46-199.PMC4189134.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.3.194 Infect Chemother 2014;46(3):194-198 pISSN 2093-2340 · eISSN 2092-6448 Received:  June 2, 2014   Revised:  July 27, 2014  Accepted:  July 27, 2014 Corresponding Author : Hee Jin Cheong, MD, PhD  Division of Infectious Diseases, Department of Internal Medicine, Korea University  Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu,  Seoul 152-703, Korea Tel: +82-2-2626-3050, Fax: +82-2-2626-1105 E-mail: heejinmd@korea.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/df/ic-46-194.PMC4189135.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.194  •  Infect Chemother 2014;46(3) :194-198 www.icjournal.org 195 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/47/df/ic-46-194.PMC4189135.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.194  •  Infect Chemother 2014;46(3) :194-198 www.icjournal.org 197 ant health concern and were aware that the HZ vaccine was  recently approved for individuals ≥ 50 years old.,Non-OADS,/arxiv_data1/oa_pdf/47/df/ic-46-194.PMC4189135.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.3.182 Infect Chemother 2014;46(3):182-188 pISSN 2093-2340 · eISSN 2092-6448 Received: August 4 , 2014   Revised:  September 12, 2014  Accepted: September 12, 2014 Corresponding Author : Moon-Hyun Chung Department of Internal Medicine, Inha University School of Medicine,   27 Inhang-ro, Jung-gu, Incheon 400-712, Korea Tel: +82-32-890-2202, Fax: +82-32-882-6578 E-mail: mhchungid@daum.net Alternate Corresponding Author : Dongwook Son  PHclinic, 394 Yongsin-ro, Sangrok-gu, Ansan 426-180, Korea  Tel: +82-31-505-2222, Fax: +82-70-4741-7179    E-mail: klineroa@gmail.com These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/31/db/ic-46-182.PMC4189136.pdf
"This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/db/ic-46-182.PMC4189136.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.182  •  Infect Chemother 2014;46(3) :182-188 www.icjournal.org 183 have revealed that treatment with doxycycline and chloram - phenicol presents acceptable clinical responses, even though  these antibiotics are bacteriostatic to O. tsutsugamushi .",Non-OADS,/arxiv_data1/oa_pdf/31/db/ic-46-182.PMC4189136.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.182  •  Infect Chemother 2014;46(3) :182-188 www.icjournal.org 185 more IF-positive foci in AFSC-4-infected cells (Mann –Whitney  U test, P = 0.08) in medium containing neither antibiotics nor  chloroquine.",Non-OADS,/arxiv_data1/oa_pdf/31/db/ic-46-182.PMC4189136.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.182  •  Infect Chemother 2014;46(3) :182-188 www.icjournal.org 187 confirmation of Rickettsia  by endomyocardial biopsy.,Non-OADS,/arxiv_data1/oa_pdf/31/db/ic-46-182.PMC4189136.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.3.209 Infect Chemother 2014;46(3):209-215 pISSN 2093-2340 · eISSN 2092-6448 Received:  July 9, 2013   Revised:  September 24, 2013  Accepted:  September 26, 2013 Corresponding Author : Eun-Jeong Joo, MD Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan  University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 110-746, Korea Tel: +82-2-2001-8533, Fax: +82-2-2001-1596 E-mail: eunjeong.joo@samsung.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/5b/ic-46-209.PMC4189137.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.209  •  Infect Chemother 2014;46(3) :209-215 www.icjournal.org 211 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/64/5b/ic-46-209.PMC4189137.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.209  •  Infect Chemother 2014;46(3) :209-215 www.icjournal.org 213 and administered G-CSF until the recovery of neutropenia.,Non-OADS,/arxiv_data1/oa_pdf/64/5b/ic-46-209.PMC4189137.pdf
"• AT and influenza A in an AIDS patient www.icjournal.org 214 ncbi.nlm.nih.gov/pubmed) and KoreaMed (http://www.ko - reamed.org) with the terms “ Aspergillus tracheobronchitis” ,  “tracheobronchial aspergillosis” or “bronchial aspergillosis”  and “HIV” or “ AIDS” to identify articles pertaining to the sub - ject published between January 1985 and July 2013.",Non-OADS,/arxiv_data1/oa_pdf/64/5b/ic-46-209.PMC4189137.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.209  •  Infect Chemother 2014;46(3) :209-215 www.icjournal.org 215 nosis.,OADS,/arxiv_data1/oa_pdf/64/5b/ic-46-209.PMC4189137.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.3.204 Infect Chemother 2014;46(3):204-208 pISSN 2093-2340 · eISSN 2092-6448 Received:  April 15, 2013   Revised:  September 16, 2013  Accepted:  September 16, 2013 Corresponding Author : Seong-Heon Wie, MD, PhD Division of Infectious Diseases, Department of Internal Medicine, St. Vincent’s  Hospital, The Catholic University of Korea College of Medicine, 3 Jungbu-daero,  Paldal-gu, Suwon 442-723, Korea  Tel: +82-31-249-8169, Fax: +82-31-253-8898 E-mail: wiesh@chol.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/36/ic-46-204.PMC4189138.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.204  •  Infect Chemother 2014;46(3) :204-208 www.icjournal.org 205 um in adults is most frequently iatrogenic, arising as a compli - cation of invasive procedures such as mechanical ventilation  or placement of central vein catheters [4].",Non-OADS,/arxiv_data1/oa_pdf/a8/36/ic-46-204.PMC4189138.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.204  •  Infect Chemother 2014;46(3) :204-208 www.icjournal.org 207 with right pneumothorax (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a8/36/ic-46-204.PMC4189138.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.3.172 Infect Chemother 2014;46(3):172-181 pISSN 2093-2340 · eISSN 2092-6448 Received: June 9, 2014   Revised:  September 2, 2014  Accepted: September 2, 2014 Corresponding Author : Hong Bin Kim, MD, PhD Department of Internal Medicine, Seoul National University Bundang Hospital,   173 Gumi-ro, Bundang-gu, Seongnam 463-707, Korea Tel: +82-31-787-7021, Fax: +82-31-787-4052 E-mail: hbkimmd@snu.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/d4/ic-46-172.PMC4189139.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.172  •  Infect Chemother 2014;46(3) :172-181 www.icjournal.org 173 Introduction Although methicillin-resistant Staphylococcus aureus   (MRSA) has been recognized as a predominant cause of nos - ocomial infection, it has become an increasingly common  cause of community-associated infections [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/4a/d4/ic-46-172.PMC4189139.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.172  •  Infect Chemother 2014;46(3) :172-181 www.icjournal.org 175 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/4a/d4/ic-46-172.PMC4189139.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.172  •  Infect Chemother 2014;46(3) :172-181 www.icjournal.org 177 were 15.9% (17/107) and 9.3% (10/107) respectively.,OADS,/arxiv_data1/oa_pdf/4a/d4/ic-46-172.PMC4189139.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.172  •  Infect Chemother 2014;46(3) :172-181 www.icjournal.org 179 pend on local susceptibility patterns, which implies that the  results of our study may not be representative of the larger  population with CA-MRSA infections.",Non-OADS,/arxiv_data1/oa_pdf/4a/d4/ic-46-172.PMC4189139.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.172  •  Infect Chemother 2014;46(3) :172-181 www.icjournal.org 181 19.,Non-OADS,/arxiv_data1/oa_pdf/4a/d4/ic-46-172.PMC4189139.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.3.216 Infect Chemother 2014;46(3):216-217 pISSN 2093-2340 · eISSN 2092-6448 Corresponding Author : Hong Bin Kim, MD Division of Infectious Diseases, Department of Internal Medicine, Seoul National  University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam 463-707, Korea Tel: +82-31-787-7021, Fax: +82-31-787-4052  E-mail: hbkimmd@snu.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/51/ic-46-216.PMC4189140.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.216  •  Infect Chemother 2014;46(3) :216-217 www.icjournal.org 217 programs including poster campaign, monitoring and feed - back, and education have been actively conducted.",Non-OADS,/arxiv_data1/oa_pdf/76/51/ic-46-216.PMC4189140.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.3.149 Infect Chemother 2014;46(3):149-164 pISSN 2093-2340 · eISSN 2092-6448 Received:  August 11, 2014 Corresponding Author : Yohei Doi  Division of Infectious Diseases, Department of Medicine, University of Pittsburgh  Medical Center, S829 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA Tel: +1-412-648-9445, Fax: +1-412-648-8521  Email: yod4@pitt.edu This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/5b/ic-46-149.PMC4189141.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.149  •  Infect Chemother 2014;46(3) :149-164 www.icjournal.org 151 foperazone-sulbactam) are often used alone or in various  combinations.,Non-OADS,/arxiv_data1/oa_pdf/f3/5b/ic-46-149.PMC4189141.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.149  •  Infect Chemother 2014;46(3) :149-164 www.icjournal.org 153 7) Other combination therapy In an observational study of 250 XDR A. baumannii blood - stream infections, 36 patients received colistin monotherapy  and 214 patients received colistin-based combination thera - py, including 102 with a carbapenem, 69 with ampicillin-sul - bactam or sulbactam, and 43 with other agents [28].",Non-OADS,/arxiv_data1/oa_pdf/f3/5b/ic-46-149.PMC4189141.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.149  •  Infect Chemother 2014;46(3) :149-164 www.icjournal.org 155 may involve several combined mechanisms including modifi - cations to outer membrane permeability and up-regulation of  efflux systems, the recent surge in CRE is mostly mediated by  production of carbapenemases.",Non-OADS,/arxiv_data1/oa_pdf/f3/5b/ic-46-149.PMC4189141.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.149  •  Infect Chemother 2014;46(3) :149-164 www.icjournal.org 157 8) Combination therapy Studies addressing the clinical outcome of CRE infections  have been reviewed recently by Tzouvelekis et al.,Non-OADS,/arxiv_data1/oa_pdf/f3/5b/ic-46-149.PMC4189141.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.149  •  Infect Chemother 2014;46(3) :149-164 www.icjournal.org 159 infection, and bacteremia.",Non-OADS,/arxiv_data1/oa_pdf/f3/5b/ic-46-149.PMC4189141.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.149  •  Infect Chemother 2014;46(3) :149-164 www.icjournal.org 161 2014;33:1311-22.,Non-OADS,/arxiv_data1/oa_pdf/f3/5b/ic-46-149.PMC4189141.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.149  •  Infect Chemother 2014;46(3) :149-164 www.icjournal.org 163 mycin used as adjunct therapy in KPC Klebsiella pneumo - niae  bacteraemia: report of three cases.,Non-OADS,/arxiv_data1/oa_pdf/f3/5b/ic-46-149.PMC4189141.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.3.189 Infect Chemother 2014;46(3):189-193 pISSN 2093-2340 · eISSN 2092-6448 Received:  March 23, 2014   Revised:  June 18, 2014  Accepted:  June 18, 2014 Corresponding Author : Moon-Hyun Chung, MD, PhD Department of Internal Medicine, Inha University Hospital, 27 Inhang-ro,   Jung-gu, Incheon 400-712, Korea Tel: +82-32-890-2202, Fax: +82-32-882-6578 E-mail: mhchungid@daum.net Alternate corresponding author : Jin-Soo Lee, MD, PhD Department of Internal Medicine, Inha University Hospital, 27 Inhang-ro,  Jung-gu, Incheon 400-712, Korea Tel: +82-32-890-2202, Fax: +82-32-882-6578 E-mail: ljinsoo@inha.ac.kr *These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/60/1b/ic-46-189.PMC4189142.pdf
"This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/1b/ic-46-189.PMC4189142.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.189  •  Infect Chemother 2014;46(3) :189-193 www.icjournal.org 191 their moderate in vitro effect, fluoroquinolones would be ex - pected to have marginal clinical efficacy against scrub typhus.",Non-OADS,/arxiv_data1/oa_pdf/60/1b/ic-46-189.PMC4189142.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.189  •  Infect Chemother 2014;46(3) :189-193 www.icjournal.org 193 tured in vitro.,OADS,/arxiv_data1/oa_pdf/60/1b/ic-46-189.PMC4189142.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.3.143 Infect Chemother 2014;46(3):143-148 pISSN 2093-2340 · eISSN 2092-6448 Received:  September 16, 2014 Corresponding Author : Yang Ree Kim, MD, PhD Division of Infectious Diseases, Department of Internal Medicine, Uijeongbu St.  Mary’s Hospital, 271 Cheonbo-ro, Uijeongbu 480-821, Korea Tel: +82-31-820-3798, Fax: +82-31-847-8077 E-mail: yrkim@catholic.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/10/ic-46-143.PMC4189143.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.143  •  Infect Chemother 2014;46(3) :143-148 www.icjournal.org 145 One of the injection rabies vaccines used domestically now - adays is a live vaccine produced with attenuated live vaccine  strain Evelyn-Rokitnicki-Abelseth, and is used only on live - stock such as dogs, cattle, sheep and horse [15].",Non-OADS,/arxiv_data1/oa_pdf/6d/10/ic-46-143.PMC4189143.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.143  •  Infect Chemother 2014;46(3) :143-148 www.icjournal.org 147 day for twice without immunoglobulin is sufficient.,Non-OADS,/arxiv_data1/oa_pdf/6d/10/ic-46-143.PMC4189143.pdf
Available  at: http://is.cdc.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/6d/10/ic-46-143.PMC4189143.pdf
Available at: http://www.who.int/rabies/WHO_ Guide_Rabies_Pre_Post_Exposure_Prophylaxis_Hu - mans_2013.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/6d/10/ic-46-143.PMC4189143.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2014.46.3.165 Infect Chemother 2014;46(3):165-171 pISSN 2093-2340 · eISSN 2092-6448 Received: December 30, 2013   Revised:  August 18, 2014  Accepted: August 18, 2014 Corresponding Author : Seung Soon Lee, MD Division of Infectious Diseases, Department of Internal Medicine, Hallym University  Sacred Heart Hospital, 22 Gwanpyeong-ro, 170 bean-gil, Dongan-gu, Anyang  431-070, Korea Tel: +82-31-380-3724, Fax: +82-31-381-3724 E-mail: hushh93@hallym.or.kr, hushh93@gmail.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/a9/ic-46-165.PMC4189144.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.165  •  Infect Chemother 2014;46(3) :165-171 www.icjournal.org 167 ratory, or wound care; after contact with biological body flu - id); and low risk (other conditions, such as after contact with  patient surroundings) [4, 6].",Non-OADS,/arxiv_data1/oa_pdf/b2/a9/ic-46-165.PMC4189144.pdf
  http://dx.doi.org/10.3947/ic.2014.46.3.165  •  Infect Chemother 2014;46(3) :165-171 www.icjournal.org 169 hand hygiene compliance were performed quarterly.,Non-OADS,/arxiv_data1/oa_pdf/b2/a9/ic-46-165.PMC4189144.pdf
"  http://dx.doi.org/10.3947/ic.2014.46.3.165  •  Infect Chemother 2014;46(3) :165-171 www.icjournal.org 171 Fourth, awareness of being observed increased from 30.2% to  46.7% among doctors, and from 73.5% to 81.3% among nurses  between the two periods.",Non-OADS,/arxiv_data1/oa_pdf/b2/a9/ic-46-165.PMC4189144.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/b2/a9/ic-46-165.PMC4189144.pdf
Two policy developments which occurred 5 years  after the start of the study are of particular importance:  the publication by the Inter-Agency Standing Committee  of its guidelines Mental Health and Psychosocial Support  in Emergency Settings (see http://www.humanitarianinfo.,Non-OADS,/arxiv_data1/oa_pdf/fd/91/IP-7-60.PMC4189185.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/92/62/openhrt-2013-000011.PMC4189220.pdf
"Public Health Resources Unit, October 2009. http://heartuk.org.uk/FHToolkit/downloads/3.3/3C%20South%20Central%20Cardiac%20Network%20example.pdf Last viewed 27 Jan 2014.",Non-OADS,/arxiv_data1/oa_pdf/0e/ec/openhrt-2013-000015.PMC4189221.pdf
"NICE, 2013. http://publications.nice.org.uk/familial-hypercholesterolaemia-qs41 last viewed 27 Jan 2014.",Non-OADS,/arxiv_data1/oa_pdf/0e/ec/openhrt-2013-000015.PMC4189221.pdf
"NICE, 2009. http://guidance.nice.org.uk/CG71/CostingTemplate/xls/Englishlast viewed 27 Jan 2014.",Non-OADS,/arxiv_data1/oa_pdf/0e/ec/openhrt-2013-000015.PMC4189221.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/8b/openhrt-2014-000134.PMC4189222.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/openhrt-2014- 000124).,Non-OADS,/arxiv_data1/oa_pdf/a6/8b/openhrt-2014-000124.PMC4189224.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/openhrt- 2014-000068).,Non-OADS,/arxiv_data1/oa_pdf/32/af/openhrt-2014-000068.PMC4189225.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/32/af/openhrt-2014-000068.PMC4189225.pdf
"Worktable 23R Death rates by 10-year age groups: United States and each state, 2007. http://www.cdc.gov/nchs/data/dvs/MortFinal2007_Worktable23r.pdf (accessedApr 2014).",OADS,/arxiv_data1/oa_pdf/6f/de/openhrt-2014-000150.PMC4189226.pdf
To view please visit the journal (http://dx.doi.org/10.1136/ openhrt-2014-000127) Received 25 March 2014 Revised 3 June 2014Accepted 15 July 2014 For numbered affiliations seeend of article.,Non-OADS,/arxiv_data1/oa_pdf/54/dc/openhrt-2014-000127.PMC4189228.pdf
37The phase I KAT301 study is an ongoing trial designed to evaluate the safety and ef ﬁ- cacy of intramyocardial injection of AdVEGF-D in patientswith chronic ischaemia and no option of revasvularisation (http://clinicaltrials.gov/show/NCT01002430).,Non-OADS,/arxiv_data1/oa_pdf/37/4f/openhrt-2013-000016.PMC4189230.pdf
"The primary outcomes to be measured are long-term all-cause mortality, cardiac death, major asso- ciated cardiac events (MACE) and rehospitalisationbetween the cell therapy group and the placebo group (http://clinicaltrials.gov/show/NCT01569178).",Non-OADS,/arxiv_data1/oa_pdf/37/4f/openhrt-2013-000016.PMC4189230.pdf
"The images of the tricuspid valve used in Figures 2,3,7  (second image), and 9, were generously provided by Paul A. Iaizzo from the University of Minnesota and are available at the website: http://www.vhlab.umn.edu/atlas/right-atrium/tricuspid-valve/index.shtml.",Non-OADS,/arxiv_data1/oa_pdf/a5/a3/APC-7-193.PMC4189236.pdf
http://www.qiagen.com/ knowledge-and-support/resource-center/resource-download.aspx?id=402bb209-4104-4956-a005-6226ff0b67d5&lang=en (accessed2013).,OADS,/arxiv_data1/oa_pdf/ba/15/openhrt-2014-000138.PMC4189251.pdf
"doi:10.1136/openhrt-2013- 000009 Accepted 17 January 2014 ▸http://dx.doi.org/10.1136/ openhrt-2013-000001 ▸http://dx.doi.org/10.1136/ openhrt-2013-000002 1The Heart Hospital, University College London Hospitals UCLH, London, UK 2Yale Medical School, New Haven, Connecticut, USA Correspondence to Dr Rodney de Palma; rodney_de_palma@icloud.",Non-OADS,/arxiv_data1/oa_pdf/7b/7f/openhrt-2013-000009.PMC4189252.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/7f/openhrt-2013-000009.PMC4189252.pdf
"Conium extract Ethanolic extract of  C. maculatum  was procured as  homeopathic mother tincture from Boiron Laboratory®,  Lyon, France, which was prepared by using 65%  ethanol as solvent, adopting the guidelines of  European  Pharmacopeia 7thedition (http://www.pharmabooks.com.",Non-OADS,/arxiv_data1/oa_pdf/93/c2/PM-10-524.PMC4189268.pdf
(http://emedicine.medscape.com/article/821362-overview) 12.,Non-OADS,/arxiv_data1/oa_pdf/93/c2/PM-10-524.PMC4189268.pdf
"The Cochrane Collaboration, 2008. http://www.cochrane-handbook.org 25.",OADS,/arxiv_data1/oa_pdf/98/42/openhrt-2014-000079.PMC4189291.pdf
http://www.casp-uk.net/#!,Non-OADS,/arxiv_data1/oa_pdf/98/42/openhrt-2014-000079.PMC4189291.pdf
Participant organisations in ALICE RAP can be seen at http://www.alicerap.eu/about-alice-rap/partner-institutions.html.,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/openhrt-2014-000135.PMC4189294.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/01/0d/openhrt-2013-000004.PMC4189296.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/67/23/openhrt-2013-000012.PMC4189298.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f0/d8/openhrt-2013-000005.PMC4189300.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/96/d4/openhrt-2014-000113.PMC4189301.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/openhrt- 2013-000013).,Non-OADS,/arxiv_data1/oa_pdf/fd/e0/openhrt-2013-000013.PMC4189306.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fd/e0/openhrt-2013-000013.PMC4189306.pdf
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 15.,Non-OADS,/arxiv_data1/oa_pdf/fd/e0/openhrt-2013-000013.PMC4189306.pdf
"10Pflanzenöltechnologie 11Capax Environmental Services 12Green Fuels 13Neutral Consulting Ltd 14Plant Cell Biology Research Centre, School of Botany, University of Melbourne Correspondence to: Staffan Persson at Persson@mpimp-golm.mpg.de URL: http://www.jove.com/video/51393 DOI: doi:10.3791/51393 Keywords: Environmental Sciences, Issue 87, botany, plants, Biorefining, Poplar, Tobacco tree, Arabidopsis, suberin, lignin, cell walls, biomass, long-chain hydrocarbons, isoprenoids, Nicotiana glauca , systems biology Date Published: 5/16/2014 Citation: Ruprecht, C., Tohge, T., Fernie, A., Mortimer, C.L., Kozlo, A., Fraser, P.D., Funke, N., Cesarino, I., Vanholme, R., Boerjan, W., Morreel, K., Burgert, I., Gierlinger, N., Bulone, V., Schneider, V., Stockero, A., Navarro, J.P., Pudel, F., Tambuyser, B., Hygate, J., Bumstead, J., Notley, L., Persson, S. Transcript and Metabolite Profiling for the Evaluation of Tobacco Tree and Poplar as Feedstock for the Bio-based Industry.",Non-OADS,/arxiv_data1/oa_pdf/51/45/jove-87-51393.PMC4189316.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51393/ Introduction Population and economic growth have caused an increasing demand for food, water and fuels.",Non-OADS,/arxiv_data1/oa_pdf/51/45/jove-87-51393.PMC4189316.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/postgradmedj-2013- 000001).,Non-OADS,/arxiv_data1/oa_pdf/b0/02/openhrt-2013-000001.PMC4189317.pdf
To view please visit the journal (http://dx.doi.org/10.1136/openhrt-2014- 000064).,Non-OADS,/arxiv_data1/oa_pdf/a4/06/openhrt-2014-000064.PMC4189321.pdf
"9 Relevant RCTs were searched until September 2013 through MEDLINE, the Cochrane Central Register of Controlled Trials (CENTRAL), Google Scholar andEMBASE databases and through http://www.tctmd.com, http://www.clinicaltrials.gov, h ttp://www.clinicaltrialresults.",OADS,/arxiv_data1/oa_pdf/a4/06/openhrt-2014-000064.PMC4189321.pdf
org and http://www.cardiosource.com websites; documentsaccessible through the FDA website were scrutinised as well.,Non-OADS,/arxiv_data1/oa_pdf/a4/06/openhrt-2014-000064.PMC4189321.pdf
20. http://www.medscape.com/viewarticle/714902 (accessed Jan 2014).21.,Non-OADS,/arxiv_data1/oa_pdf/a4/06/openhrt-2014-000064.PMC4189321.pdf
57. http://www.trialresultscenter.org/study8670-ZEST-AMI-(vs-SES).htm; http://www.trialresultscenter.org/study8670-ZEST-AMI-(vs-PES).htm(accessed Jan 2014).,OADS,/arxiv_data1/oa_pdf/a4/06/openhrt-2014-000064.PMC4189321.pdf
http://www.accessdata.fda.gov/cdrh_docs/pdf6/p060040a.pdf (accessed 1 Oct 2013).,OADS,/arxiv_data1/oa_pdf/ab/7d/openhrt-2014-000109.PMC4189322.pdf
Decision memo for ventricular assist devices as destination therapy (CAG-00119N).http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=79.,Non-OADS,/arxiv_data1/oa_pdf/ab/7d/openhrt-2014-000109.PMC4189322.pdf
http://www.nhlbi.nih.gov/meetings/ workshops/nextgen-vads.htm.,Non-OADS,/arxiv_data1/oa_pdf/ab/7d/openhrt-2014-000109.PMC4189322.pdf
http://www.medicare.gov/ sign-up-change-plans/medicare-health-plans/medicare-advantage-plans/private-fee-for-service-plans.html (accessed 28 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/ab/7d/openhrt-2014-000109.PMC4189322.pdf
http://www.kff.org/medicare/upload/8080.pdf (accessed 12 Jul 2012).,Non-OADS,/arxiv_data1/oa_pdf/ab/7d/openhrt-2014-000109.PMC4189322.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/89/91/openhrt-2014-000097.PMC4189323.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/openhrt-2014- 000133).,Non-OADS,/arxiv_data1/oa_pdf/69/61/openhrt-2014-000133.PMC4189336.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/openhrt-2014-000092).,Non-OADS,/arxiv_data1/oa_pdf/2a/8a/openhrt-2014-000092.PMC4189337.pdf
"Controls aredrawn from a registry that contains drug dispensing records from community pharmacies (PHARMO Institute for Drug Outcomes Research, Utrecht, theNetherlands http://www.pharmo.nl/), 10 25and from a database that contains the complete medical records of >60 000 people from a large group of GPs in the studyarea (HAG-net-AMC).",OADS,/arxiv_data1/oa_pdf/7e/17/openhrt-2014-000112.PMC4189338.pdf
Toview please visit the journal online (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c5/61/openhrt-2013-000002.PMC4189340.pdf
Funding This study has been funded by research grants from the Swedish Foundation of Strategic Research (http://www.stratresearch.com/en/).,Non-OADS,/arxiv_data1/oa_pdf/c5/61/openhrt-2013-000002.PMC4189340.pdf
2008. http://www.who.int/whosis/ whostat/EN_WHS08_Full.pdf 2.,OADS,/arxiv_data1/oa_pdf/c5/61/openhrt-2013-000002.PMC4189340.pdf
http://www.socialstyrelsen.se/register/ halsodataregister/patientregistret/inenglish 25.,Non-OADS,/arxiv_data1/oa_pdf/c5/61/openhrt-2013-000002.PMC4189340.pdf
"There  is a general consensus, promoted by the Eurogentest Network  of Excellence (http://www.eurogentest.org), that genetic coun - seling should be a mandatory accompaniment to all medical  genetics interventions.",Non-OADS,/arxiv_data1/oa_pdf/61/58/41436_2014_Article_BFgim2014103.PMC4189378.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/ Genetics in medicine   |  Volume 16  |  Number 10  |  October 2014",Non-OADS,/arxiv_data1/oa_pdf/61/58/41436_2014_Article_BFgim2014103.PMC4189378.pdf
"SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim ACKNOWLEDGMENTS The authors acknowledge Professor Yoshikatsu Eto, Professor Toya Ohashi, and Dr Masahisa Kobayashi (The Jikei University School of Medicine) for performing gene mutation measurements, and Pro- fessor Fumio Endo and Dr Kimitoshi Nakamura (Kumamoto Uni- versity Hospital) for completing measurements of enzyme activity.",Non-OADS,/arxiv_data1/oa_pdf/28/38/gim201428a.PMC4189383.pdf
http://www.ema.europa.eu/docs/en_GB/ document_library/Other/2010/ 11/WC500099241.pdf Accessed December 2012.,Non-OADS,/arxiv_data1/oa_pdf/28/38/gim201428a.PMC4189383.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-nd/3.0/  Volume 16  |  Number 10  |  October 2014  |  Genetics in Medicine",Non-OADS,/arxiv_data1/oa_pdf/28/38/gim201428a.PMC4189383.pdf
"SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim ACKNOWLEDGMENTS The authors are grateful to Kathleen Melia, PhD, SRSC, LLC, for assistance with medical writing, and to Lisa Underhill, MS, and Iva Ivanovska Holder, PhD, Genzyme Global Medical Affairs, for criti- cal review of the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/a9/ce/gim201425a.PMC4189384.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-nd/3.0/ GeNeTICS in MeDICINe  |   Volume 16  |  Number 10  |  October 2014",Non-OADS,/arxiv_data1/oa_pdf/a9/ce/gim201425a.PMC4189384.pdf
These variants were annotated using the SeattleSeq Web  server (http://snp.gs.washington.edu/SeattleSeqAnnotation/).,OADS,/arxiv_data1/oa_pdf/45/55/gim201439a.PMC4189385.pdf
"SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim ACKNOWLEDGMENTS This work was supported by grants from the Department of Health (DOH100-TD-C-111-008; DOH101-TD-C-111-008; DOH102-TD-C-111-008), Taipei, Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/45/55/gim201439a.PMC4189385.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/   Volume 16  |  Number 10  |  October 2014  |  GENETICS in MEDICINE",Non-OADS,/arxiv_data1/oa_pdf/45/55/gim201439a.PMC4189385.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2014 |  88  | e51671 | Page 1 of 8Video Article An Isolated Working Heart System for Large Animal Models Matthew A. Schechter1, Kevin W. Southerland1, Bryan J. Feger1, Dean Linder Jr.1, Ayyaz A. Ali2, Linda Njoroge1, Carmelo A. Milano1, Dawn E. Bowles1 1Department of Surgery, Duke University Medical Center 2Department of Cardiothoracic Surgery, University Hospital of South Manchester Correspondence to: Dawn E. Bowles at dawn.bowles@dm.duke.edu URL: http://www.jove.com/video/51671 DOI: doi:10.3791/51671 Keywords: Medicine, Issue 88, cardiac physiology, surgery, transplantation, large animal models, isolated working heart, cardiac disease Date Published: 6/11/2014 Citation: Schechter, M.A., Southerland, K.W., Feger, B.J., Linder, D., Ali, A.A., Njoroge, L., Milano, C.A., Bowles, D.E.",Non-OADS,/arxiv_data1/oa_pdf/1f/20/jove-88-51671.PMC4189428.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51671/ Introduction Much of our understanding of basic cardiac biology and physiology has come from experiments that utilized the isolated, retrograde-perfused Langendorff heart and the isolated working heart systems.",Non-OADS,/arxiv_data1/oa_pdf/1f/20/jove-88-51671.PMC4189428.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMay 2014 |  87  | e51455 | Page 1 of 9Video Article Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale Valentina Gandin1, Kristina Sikström2, Tommy Alain3, Masahiro Morita3, Shannon McLaughlan1, Ola Larsson2, Ivan Topisirovic1 1Lady Davis Institute and Department of Oncology, McGill University 2Department of Oncology-Pathology, Karolinska Institutet 3Goodman Cancer Centre and Department of Biochemistry, McGill University Correspondence to: Ola Larsson at ola.larsson@ki.se , Ivan Topisirovic at ivan.topisirovic@mcgill.ca URL: http://www.jove.com/video/51455 DOI: doi:10.3791/51455 Keywords: Biochemistry, Issue 87, Cells, Eukaryota, Nutritional and Metabolic Diseases, Neoplasms, Metabolic Phenomena, Cell Physiological Phenomena, mRNA translation, ribosomes, protein synthesis, genome-wide analysis, translatome, mTOR, eIF4E, 4E-BP1 Date Published: 5/17/2014 Citation: Gandin, V., Sikström, K., Alain, T., Morita, M., McLaughlan, S., Larsson, O., Topisirovic, I. Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale.",Non-OADS,/arxiv_data1/oa_pdf/76/06/jove-87-51455.PMC4189431.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51455/ Introduction The regulatory networks that control gene expression have been extensively studied in the last two decades.,Non-OADS,/arxiv_data1/oa_pdf/76/06/jove-87-51455.PMC4189431.pdf
"Bioconductor is installed by typing (in the R-terminal):    source(""http://bioconductor.org/biocLite.R"")    biocLite()",OADS,/arxiv_data1/oa_pdf/76/06/jove-87-51455.PMC4189431.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMay 2014 |  87  | e51455 | Page 4 of 9  3.Install the anota bioconductor package (and the qvalue package that anota requires) by typing (in the R-terminal):    source(""http://bioconductor.org/biocLite.R"")    biocLite(c(“anota”, “qvalue”)) 4.Test that the package was successfully installed and open the anota manual by typing (in the R-terminal):    library(“anota”)    vignette(“anota”)     5.Note: Additional help for all functions that are used in the anota package can be found either at the anota web-page (http:// www.bioconductor.org/packages/release/bioc/html/anota.html) or by using the help function within R. For example, to get help on the anotaPerformQc function go to the R-terminal and type (note that this only works when the anota package has been loaded):    library(“anota”) #loads the anota package    ?anotaPerformQc #opens help for this function     2.Import data to R: 1.Prepare expression data for analysis.",OADS,/arxiv_data1/oa_pdf/76/06/jove-87-51455.PMC4189431.pdf
" Hee Seung Kim, et al: Cyclooxygenase in Cervical Cancer 127 A u t h o r s  o r  p r o t o c o l  I D S a m p l e  s i z e I n t e r v e n t i o n s T a r g e t e d  d i s e a s e R esponse rate Weppelmann and Monkemeier5276 vs. 84 (control) Oxyphenbutazon e Cervical cancer 5-year surviva l rate    : 70% vs. 55% 10-year survival rate   : 62% vs. 44% Hefler et al.57  8 vs. 8  (control) Rofecoxib CIN* 2-3 25% vs.12.5% Farley et al.5812 vs. 13 (control) Celecoxib CIN* 2-3 75% vs. 31% Herrera et al.59 31 Celecoxib Cervical cancer 81% Gaffney et al.60 84 Celecoxib Cervical cancer Toxicity: 48%  NCT00081263† (GOG-0207) 100 Celecoxib CIN* 2-3 - NCT00152828† 45 Celecoxib Cervical cancer - NCT00072540† (SWOG-S0212) 100 Celecoxib CIN* 2-3 - *Cervical intraepithelial neoplasia; †Active clinical trials (availabl e at http://clinicaltrials.gov) .Table 1.",Non-OADS,/arxiv_data1/oa_pdf/91/74/jcp-18-123.PMC4189449.pdf
http://clinicaltrials.gov/ct2/show/NCT00023660?,Non-OADS,/arxiv_data1/oa_pdf/91/74/jcp-18-123.PMC4189449.pdf
The basic CAGG-PBase (pCyL43) and  piggyBac transposon (pCyL50) vector frames  were donated by the Sanger Institute (http://www.sanger.,Non-OADS,/arxiv_data1/oa_pdf/22/5f/jcp-19-068.PMC4189472.pdf
Website  http://www.promega.com/resources/pubhub/high-concentration-genomic-dna-from-whole-blood-using-the-maxwell-16-low-elution-volume-instrument/    [accessed 10 September   2014].,Non-OADS,/arxiv_data1/oa_pdf/fb/73/apps.1400048.PMC4189495.pdf
Website  http://dna.uga.edu/ wp-content/uploads/2013/12/DNeasy-Plant-Handbook-for-DNA-puriﬁ  cation-Qiagen.pdf    [accessed 10 September 2014].,Non-OADS,/arxiv_data1/oa_pdf/fb/73/apps.1400048.PMC4189495.pdf
Website  http://www.R-project.org/  [accessed 10 September 2014].,Non-OADS,/arxiv_data1/oa_pdf/fb/73/apps.1400048.PMC4189495.pdf
Website  http://www.nanodrop.com/Library/T042-NanoDrop-Spectrophotometers-Nucleic-Acid-Purity-Ratios.pdf  [accessed 10 September 2014].,Non-OADS,/arxiv_data1/oa_pdf/fb/73/apps.1400048.PMC4189495.pdf
Website  http://www.promega.com/resources/pubhub/enotes/wizard-genomic-dna-puriﬁ  cation-kit-and- the-isolation-of-plant-genomic-dna/  [accessed 10 September 2014].,Non-OADS,/arxiv_data1/oa_pdf/fb/73/apps.1400048.PMC4189495.pdf
"Adapt-ers, ribosomal RNA, and low-quality and low-complexity sequences were removed/trimmed using SeqClean (http://sourceforge.net/projects/seqclean/), and each taxon was assembled separately by the TGI Clustering tools (TGICL;  Pertea et al., 2003 ) using default settings.",OADS,/arxiv_data1/oa_pdf/18/ba/apps.1400049.PMC4189496.pdf
Website http://cran.r-project.org/web/packages/dplR/index.html  [accessed 30 August 2014  ].,Non-OADS,/arxiv_data1/oa_pdf/76/d2/apps.1400054.PMC4189497.pdf
Website:  http://www.R-project.org  [accessed 8 September 2014].,Non-OADS,/arxiv_data1/oa_pdf/76/d2/apps.1400054.PMC4189497.pdf
Dendrochronologia    in press  http://dx.doi.org/10.1016/j.dendro.2014 .07.006 .,OADS,/arxiv_data1/oa_pdf/76/d2/apps.1400054.PMC4189497.pdf
"  Applications in Plant Sciences   2014   2 ( 10 ): 1400057   López-Villalobos et al.— Camissoniopsis cheiranthifolia   microsatellites   doi:10.3732/apps.1400057  3 of 6 http://www.bioone.org/loi/apps Untergasser et al., 2012 ) and Ampliﬁ  x 1.5.4 (http://crn2m.univ-mrs.fr/AmplifX)  to design primer pairs optimized to contain 18–22 bases, 40–60% GC content, 50–60 ° C melting temperature, and yield 100–350 bp PCR products.",Non-OADS,/arxiv_data1/oa_pdf/b4/f7/apps.1400057.PMC4189498.pdf
"2 of 3  Applications in Plant Sciences   2014   2 ( 10 ): 1400070   Chatwin et al.—Post oak microsatellites   doi:10.3732/apps.1400070  http://www.bioone.org/loi/appsequilibrium (HWE), observed heterozygosity ( H  o ), expected heterozygosity  ( H  e ), and total number of alleles using the computer program Arlequin version  3.5 ( Excofﬁ  er and Lischer, 2010 ).",OADS,/arxiv_data1/oa_pdf/fa/06/apps.1400070.PMC4189500.pdf
Website  http://www.geneious.com  [accessed 8 September 2014].,Non-OADS,/arxiv_data1/oa_pdf/fa/06/apps.1400070.PMC4189500.pdf
"3, September, 2014http://dx.doi.org/10.15430/JCP.2014.19.3.231 pISSN 2288-3649ㆍeISSN 2288-3657 L1 Cell Adhesion Molecule Expression Is Associated  With Pelvic Lymph Node Metastasis and Advanced  Stage in Diabetic Patient s With Endometrial Cancer:  A Matched Case Control StudyOriginal  Ar ticle Dong Hoon Suh1, Min A Kim2, Hee Seung Kim3, Hyun Hoon Chung3, Noh Hyun Park3, Yong Sang Song3,4,5, Soon-Beom  Kang6 1Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea, 2Department of Pathology, Seoul  National University College of Medicine, Seoul, Korea, 3Department of Obstetrics and Gynecology, Seoul National University College of Medicine,  Seoul, Korea, 4Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea, 5Major in Biomodulation, World Class  University, Seoul National University, Seoul, Korea, 6Women’s Gynecologic Oncology Center, Department of Obstetrics and Gynecology, Konkuk  University School of Medicine, Seoul, Korea Background:  Diabetic patients with endometrial cancer had more lymph node metastasis than non-diabetic patients with endometrial  cancer.",Non-OADS,/arxiv_data1/oa_pdf/ce/ec/jcp-19-231.PMC4189503.pdf
"3, September, 2014http://dx.doi.org/10.15430/JCP.2014.19.3.216 pISSN 2288-3649ㆍeISSN 2288-3657 Supplementation of Seaweeds Extracts Suppresses  Azoxymethane-induced Aber rant DNA Methylation  in Colon and Liver of ICR MiceOriginal  Ar ticle So Young Bu1, Hoonjeong Kwon2, Mi-Kyung Sung3 1Department of Food and Nutrition, Daegu University, Gyeongsan, Korea, 2Department of Food and Nutrition, Seoul National University, Seoul,  Korea, 3Department of Food and Nutrition, Sookmyung Women’s University, Seoul, Korea Background: Seamustard and seatangle are commonly consumed seaweeds in Korea and rich sources of non-digestible polysaccharides  which possess biological activities.",Non-OADS,/arxiv_data1/oa_pdf/87/14/jcp-19-216.PMC4189504.pdf
"3, September, 2014http://dx.doi.org/10.15430/JCP.2014.19.3.187 pISSN 2288-3649ㆍeISSN 2288-3657 The Nuclear Matrix Protei n, NRP/B, Acts as a  Transcriptional Repressor of E2F-mediated  Transcriptional ActivityOriginal  Ar ticle Jina Choi1*, Eun Sung Yang2*, Kiweon Cha3, John Whang2, Woo-Jung Choi1, Shalom Avraham3, Tae-Aug Kim1,2 1CHA Cancer Institute, CHA University, Seoul, Korea, 2Cancer Cell Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda,  MD, USA, 3Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA Background: NRP/B, a family member of the BTB/Kelch repeat proteins, is implicated in neuronal and cancer development, as well as  the regulation of oxidative stress responses in breast and brain cancer.",Non-OADS,/arxiv_data1/oa_pdf/a2/06/jcp-19-187.PMC4189505.pdf
"(J Cancer Prev 2014;19:187-198) Key Words: NRP/B, E2F transcription factor, Transcriptional activity, Breast cancer Received  August 16, 2014, Revised  August 29, 2014, Accepted  August 29, 2014  Correspondence to: Tae-Aug Kim CHA Cancer Institute, CHA University, 605 Ye oksam-dong, Gangnam-gu, Seoul 135-081, Korea Tel: +82-2-3468-2859, Fax: +82-2-3468-2651, E-mail: takim@cha.ac.k r, ORCID: Tae-Aug Kim, http://orcid.org/0000-0002-8886-5134 *Jina Choi and Eun Sung Yang are equally contributed.",Non-OADS,/arxiv_data1/oa_pdf/a2/06/jcp-19-187.PMC4189505.pdf
"3, September, 2014http://dx.doi.org/10.15430/JCP.2014.19.3.199 pISSN 2288-3649ㆍeISSN 2288-3657 Fibroblast and Epidermal Growth Factors Utilize  Different Signaling Pathways to Induce  Anchorage-independent Cell Transformation in JB6  Cl41 Mouse Skin Epidermal CellsOriginal  Ar ticle Cheol-Jung Lee*, Mee-Hyun Lee*, Yong-Yeon Cho College of Pharmacy, The Catholic University of Korea, Bucheon, Korea Background: Extracellular stimulation of cells with growth factors such as epidermal growth factor (EGF) induces cell proliferation and  cell transformation.",Non-OADS,/arxiv_data1/oa_pdf/b9/02/jcp-19-199.PMC4189506.pdf
"(J Cancer Prev 2014;19:199-208) Key Words: Fibroblast growth factor, Fibroblast growth factor rece ptor, Kaempferol, Cell transformation, Signaling pathway Received  August 27, 2014, Revised  September 11, 2014, Accepted  September 12, 2014 Correspondence to: Yong-Yeon Cho College of Pharmacy, The Catholic University of Korea, 43 Jibong-ro, Wonmi-gu, Bucheon 420-743, Korea Tel: +82-2-2164-4092, Fax: +82-2-2164-4092, E-mail: yongyeon@catholi c.ac.kr, ORCID: Yong-Yeon Cho, http://orcid.org/0000-0003-1 107-2651 *Cheol-Jung Lee and Mee-Hyun Lee contributed equally to this work Copyright © 2014 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/b9/02/jcp-19-199.PMC4189506.pdf
"3, September, 2014http://dx.doi.org/10.15430/JCP.2014.19.3.153 pISSN 2288-3649ㆍeISSN 2288-3657 Modulation of Colitis-associated Colon  Tumorigenesis by Baicalein and BetaineReview Dong Hwan Kim, Bokyung Sung, Hae Young Chung, Nam Deuk Kim Department of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, Pusan National University, Busan, Korea In this review, we will summarize the current understanding of modulation of colitis-associated colon tumorigenesis by two natu ral  products, baicalein and betaine, which have anti-inflammatory activities.",Non-OADS,/arxiv_data1/oa_pdf/c7/f8/jcp-19-153.PMC4189507.pdf
"kr, ORCID: Nam Deuk Kim, http://orcid.org/0000-0001-9033-98 65 Copyright © 2014 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/c7/f8/jcp-19-153.PMC4189507.pdf
"3, September, 2014http://dx.doi.org/10.15430/JCP.2014.19.3.240 pISSN 2288-3649ㆍeISSN 2288-3657 Obesity, Body Ima ge, Depression, and  Weight-control Behaviour Among Female University  Students in KoreaOriginal  Ar ticle Eun Mi Jun1, Seung Bae Choi2 1Department of Nursing Science, Dong-eui University, Busan, Korea, 2Department of Data Information Science, Dong-eui University, Busan, Korea Background: Obesity has become epidemic worldwide and 31.0% of Korean adults are obese.",Non-OADS,/arxiv_data1/oa_pdf/37/29/jcp-19-240.PMC4189508.pdf
"3, September, 2014http://dx.doi.org/10.15430/JCP.2014.19.3.209 pISSN 2288-3649ㆍeISSN 2288-3657 Antioxidative Activity of Blueberry Leaf Extract  Prevents High-fat Diet-ind uced Obesity in C57BL/6  MiceOriginal  Ar ticle In-Chul Lee1, Dae Yong Kim2, Bu Young Choi2 1Department of Cosmetic Science and Technology, 2Department of Pharmaceutical Science and Engineering, Seowon University, Chungju, Korea Background: Health beneficial effects of blueberry have been well documented.",Non-OADS,/arxiv_data1/oa_pdf/d4/ce/jcp-19-209.PMC4189509.pdf
"ac.kr, ORCID: Bu Young Choi, http://orcid.org/0000-0001-8698- 5880 Copyright © 2014 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/d4/ce/jcp-19-209.PMC4189509.pdf
"3, September, 2014http://dx.doi.org/10.15430/JCP.2014.19.3.161 pISSN 2288-3649ㆍeISSN 2288-3657 Kaempferol Downregulates Insulin-like Growth  Factor-I Receptor and ErbB3 Signaling in HT-29  Human Colon Cancer CellsOriginal  Ar ticle Hyun Sook Lee1*, Han Jin Cho2,3*, Gyoo Taik Kwon2, Jung Han Yoon Park2,4 1Department of Food Science and Nutrition, Dongseo University, Busan, Korea, 2Department of Food Science and Nutrition, Hallym University,  Chuncheon, Korea, 3WCU Biomodulation Major, Department of Agricultural Biotechnology and Center for Food and Bioconvergence, Seoul National  University, Seoul, Korea, 4Advanced Institutes of Convergence Technology, Seoul National University, Suwon, Korea Background:  Novel dietary agents for colon cancer prevention and therapy are desired.",Non-OADS,/arxiv_data1/oa_pdf/e5/ce/jcp-19-161.PMC4189510.pdf
"(J Cancer Prev 2014;19:161-169) Key Words: Kaempferol, Insulin-like growth factor-I receptor, ErbB3, HT-29 human colon cancer  Received  June 20, 2014, Revised  July 14, 2014, Accepted  July 14, 2014 Correspondence to:  Jung Han Yoon Park Department of Food Science and Nutrition, Hallym Un iversity, 1 Hallymdaehak-gil,  Chuncheon 200-702, Korea Tel: +82-33-248-2134, Fax: +82-33-256-0199, E-mail: jyoon@hallym.ac.kr,  ORCID: Jung Han Yoon Park, http://orcid.org/0000-0002-5 518-4279 *Hyun Sook Lee and Han Jin Cho contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/e5/ce/jcp-19-161.PMC4189510.pdf
"3, September, 2014http://dx.doi.org/10.15430/JCP.2014.19.3.170 pISSN 2288-3649ㆍeISSN 2288-3657 Carnosic Acid Induces Apoptosis Through Reactive  Oxygen Species-mediated Endoplasmic Reticulum  Stress Induction in Human Renal Carcinoma Caki  CellsOriginal  Ar ticle Kyoung-jin Min*, Kyong-Jin Jung*, Taeg Kyu Kwon Department of Immunology, School of Medicine, Keimyung University, Daegu, Korea  Background: Carnosic acid, which is one of extract components of rosemary, has anti-inflammatory, anti-oxidant, and anti-cancer effects.",Non-OADS,/arxiv_data1/oa_pdf/66/ab/jcp-19-170.PMC4189511.pdf
"(J Cancer Prev 2014;19:170-178) Key Words: Carnosic acid, Reactive oxygen species, Activating transcript ion factor 4, CCAAT/enhancer-bin ding protein-homologous protein Received  August 5, 2014, Revised  September 5, 2014, Accepted  September 5, 2014 Correspondence to: Taeg Kyu Kwon Department of Immunology, School of Medicine, Keimyung University, 2800 Dalgubeoldaero, Dalseo-gu, Daegu 704-701, Korea Tel: +82-53-580-3882, Fax: +82-53-580-3795, E-mail: kwontk@dsmc.or .kr, ORCID: Taeg Kyu Kwon, http://orcid.org/0000-0003-1204-20 59 *Kyoung-jin Min and Kyong-Jin Jung contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/66/ab/jcp-19-170.PMC4189511.pdf
"3, September, 2014http://dx.doi.org/10.15430/JCP.2014.19.3.224 pISSN 2288-3649ㆍeISSN 2288-3657 Histologic Findings and Inflammatory Reactions  After Long-term Colonization of Helicobacter felis  in  C57BL/6 MiceOriginal  Ar ticle Ju Yup Lee1, Nayoung Kim1, Yoon Jeong Choi1, Ryoung Hee Nam1, Yoon Jin Choi1, Yong Hwan Kwon1, Kichul Yoon1,  Ji Hyung Suh1, Seon Min Lee1, Hye Seung Lee2, Dong Ho Lee1 Departments of 1Internal Medicine and 2Pathology, Seoul National University Bundang Hospital, Seoungnam, Korea Background:  The Helicobacter felis  (H. felis ) mouse model has been developed for the research regarding pathogenesis of chronic gastritis  and gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/57/01/jcp-19-224.PMC4189513.pdf
"(J Cancer Prev 2014;19:224-230) Key Words: Helicobacter felis , Inflammation, Interleukin-1beta, Tumor necrosis factor-alpha Received  August 1, 2014, Accepted  August 20, 2014 Correspondence to: Nayoung Kim Department of Internal Medicine , Seoul National University Bundang Hospital, 82,  Gumi-ro 173 beon-gil, Bu ndang-gu, Seongnam 463 -707, Korea Tel: +82-31-787-7008, Fax: +82-31-787-4051, E-ma il: nayoungkim49@empas.com, ORCID: Nayoung Kim, http://orcid.org/0000-0002-9397 -0406 Copyright © 2014 Korean Society of Cancer Prevention cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/57/01/jcp-19-224.PMC4189513.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/4d/main.PMC4189531.pdf
"After  10  months  of  Imatinib,  CT  scan  showed  a  2  cm decrease  in  tumor  size  and  diminishment  of  contrast  enhancement http://dx.doi.org/10.1016/j.ijscr.2014.05.009 2210-2612/© 2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/0b/4d/main.PMC4189531.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/4d/main.PMC4189531.pdf
"The questionnaire is available online as an Appendix,at http://links.lww.com/OPX/A158.",Non-OADS,/arxiv_data1/oa_pdf/88/d8/opx-91-452.PMC4189593.pdf
"APPENDIX The appendix, the study participant’s questionnaire, is available online at http://links.lww.com/OPX/A158.",Non-OADS,/arxiv_data1/oa_pdf/88/d8/opx-91-452.PMC4189593.pdf
"Video abstract http://links.lww.com/CONH/A14 Keywords chronic kidney disease, renin–angiotensin–aldosterone system-blockade, sodium restriction, volume status INTRODUCTION Restriction of dietary sodium to a maximum of 5 g of salt (sodium chloride) daily for an adult, correspond- ing to ca.",Non-OADS,/arxiv_data1/oa_pdf/17/7e/conhy-23-533.PMC4189688.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/91/ppa-8-1347.PMC4189699.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1347–1352Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1347Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5735 8Patient preferences and perspectives regarding  reducing alcohol consumption: role of nalmefene Amandine Luquiens Henri-Jean Aubin iNSeRM U669, Université Paris Sud,   Hôpital Paul Brousse, Assistance  Publique – Hôpitaux de Paris (AP-HP),   villejuif, FranceAbstract:  Alcohol use disorder is a major public health issue.",Non-OADS,/arxiv_data1/oa_pdf/66/91/ppa-8-1347.PMC4189699.pdf
"Stigma denigrates  the value of people who have a mental illness, and the social and professional support Correspondence: Amandine Luquiens  Addictologie, Hôpital Paul Brousse,  12 Avenue Paul vaillant-Couturier,  94800 villejuif, France Tel +33 145 594 018 email amandineluquiens@yahoo.f r Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2014 Volume: 8 Running head verso: Luquiens and Aubin Running head recto: Role of nalmefene in reducing alcohol consumption DOI: http://dx.doi.org/10.2147/PPA.S57358",Non-OADS,/arxiv_data1/oa_pdf/66/91/ppa-8-1347.PMC4189699.pdf
Available from: http://www.samhsa.,Non-OADS,/arxiv_data1/oa_pdf/66/91/ppa-8-1347.PMC4189699.pdf
Available from: http://www.dsm5.org/ Documents/Substance%20Use%20Disorder%20Fact%20Sheet.pd f.   Accessed 2013.,OADS,/arxiv_data1/oa_pdf/66/91/ppa-8-1347.PMC4189699.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2010/03/WC500074898.pdf.,Non-OADS,/arxiv_data1/oa_pdf/66/91/ppa-8-1347.PMC4189699.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/66/91/ppa-8-1347.PMC4189699.pdf
Available from: http://ansm.sante.fr/var/ansm_site/ storage/original/application/5478accaf69e1a0f97987c9eeb9b9347.pdf.,OADS,/arxiv_data1/oa_pdf/66/91/ppa-8-1347.PMC4189699.pdf
Available from: http://www.nta.nhs.uk/uploads/ nta_review_of_the_effectiveness_of_treatment_for_alcohol_problems_ fullreport_2006_alcohol2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/66/91/ppa-8-1347.PMC4189699.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/28/c4/dddt-8-1613.PMC4189701.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1613–1619Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1613Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6559 6Pharmacokinetics and tolerability of the new   second-generation nonnucleoside reverse-   transcriptase inhibitor KM-023 in healthy subjects Yu-Jung cha1,* Kyoung soo lim2,* Min-Kyu Park1 stephen schneider3 Brian Bray3 Myung-chol Kang3 Jae-Y ong chung1 seo hyun Y oon1 Joo-Y oun cho1 Kyung-sang Yu1 1Department of clinical   Pharmacology and Therapeutics,    seoul national University college   of Medicine and hospital, seoul,    south Korea; 2Department of clinical   Pharmacology and Therapeutics,    cha University school of Medicine   and cha Bundang Medical center,    seongnam, south Korea;  3Kainos   Medicine Usa inc., Morrisville,    nc, Usa *These authors contributed equally   to this work correspondence: Kyung-sang Yu   Department of clinical Pharmacology   and Therapeutics, seoul national   University college of Medicine and   hospital, 101 Daehak-ro, Jongno-gu,   seoul  110-744, south Korea   Tel +82 2 2072 1920  Fax +82 2 742 9252  email ksyu@snu.ac.k rBackground:  KM-023 is a new second-generation nonnucleoside reverse-transcriptase   inhibitor that is under development for the treatment of human immunodeficiency virus (HIV)  type 1 infection.",Non-OADS,/arxiv_data1/oa_pdf/28/c4/dddt-8-1613.PMC4189701.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/28/c4/dddt-8-1613.PMC4189701.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/c4/dddt-8-1613.PMC4189701.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/97/prbm-7-273.PMC4189702.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2014:7 273–283Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  273Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S5226 8Potential of eye movement desensitization   and reprocessing therapy in the treatment   of post-traumatic stress disorder Tracy M McGuire Christopher w Lee Peter D Drummond School of Psychology, Murdoch  University, Perth, wA, Australia Correspondence: Christopher w Lee   School of Psychology,   Murdoch University, South Street,   Murdoch, Perth, wA, Australia  6150  Tel +61 08 9360 2186  email chris.lee@murdoch.edu.a uAbstract:  Post-traumatic stress disorder (PTSD) continues to attract both empirical and clinical  interest due to its complex symptom profile and the underlying processes involved.",Non-OADS,/arxiv_data1/oa_pdf/57/97/prbm-7-273.PMC4189702.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/57/97/prbm-7-273.PMC4189702.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/57/97/prbm-7-273.PMC4189702.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/bf/ijn-9-4569.PMC4189703.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4569–4580International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4569OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6913 7enhancement of osseointegration of polyethylene  terephthalate artificial ligament by coating  of silk fibroin and depositing of hydroxyapatite Jia Jiang1,2 Fang Wan1 Jianjun Yang1 Wei hao3 Yaxian Wang3 Jinrong Yao3 Zhengzhong shao3 Peng Zhang1 Jun chen1 liang Zhou4 shiyi chen1 1Fudan University sports Medicine  center and Department of sports  Medicine and arthroscopy surgery,  huashan hospital, 2state Key  Laboratory of Molecular Engineering  of Polymers, 3Laboratory of Advanced  Materials, National Key Laboratory  of Molecular engineering of Polymers,  Department of Macromolecular  science, Fudan University, shanghai,  People’s Republic of China;  4Department of Forest Products,  anhui agricultural University, hefei  Anhui Province, People’s Republic  of china correspondence: shiyi chen Fudan University sports Medicine center  and Department of sports Medicine and  arthroscopy surgery, huashan hospital,  12 Middle Wulumuqi road, shanghai,  200040, People’s Republic of China Tel +86 21 5288 8255 Fax +86 21 6249 6020 email cshiyi@163.co m Background:  Application of artificial ligament in anterior cruciate ligament reconstruction  is one of the research focuses of sports medicine but the biological tendon–bone healing still  remains a problem.",Non-OADS,/arxiv_data1/oa_pdf/7f/bf/ijn-9-4569.PMC4189703.pdf
"Keywords:  biomineralization, tendon–bone healing, ligament reconstructionJournal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Jiang et al Running head recto: Osseointegration of polyethylene terephthalate artificial ligament DOI: http://dx.doi.org/10.2147/IJN.S69137",Non-OADS,/arxiv_data1/oa_pdf/7f/bf/ijn-9-4569.PMC4189703.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7f/bf/ijn-9-4569.PMC4189703.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 4580Jiang et al  9.,Non-OADS,/arxiv_data1/oa_pdf/7f/bf/ijn-9-4569.PMC4189703.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/40/opth-8-2001.PMC4189704.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2001–2012Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2001Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6844 6Purpose:  To describe the fundus autofluorescence (FAF) features of the inflammatory   maculopathies and develop a quantification method for FAF analysis.,Non-OADS,/arxiv_data1/oa_pdf/92/40/opth-8-2001.PMC4189704.pdf
"Most patients with an inflammatory maculopathy present with painless loss of  vision with or without a viral prodrome, but differ in their clinical presentation, need Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Lee et al Running head recto: FAF features in the inflammatory maculopathies DOI: http://dx.doi.org/10.2147/OPTH.S68446 Fundus autofluorescence features   in the inflammatory maculopathies Cecilia s lee1 aaron Y lee2 Farzin Forooghian3 Chris s Bergstrom1 Jiong Yan1 steven Yeh1 1Section of Vitreoretinal Disease  and Surgery, Department of  Ophthalmology, emory eye Center,  emory University, atlanta, ga, Usa;  2Department of Ophthalmology  and Visual Sciences, Washington  University in st louis, st louis, MO,  Usa; 3Department of Ophthalmology  and Visual Sciences, University  of British Columbia, Vancouver,  BC, Canada Correspondence: steven Yeh Emory Eye Center, 1365 B Clifton Road,  suite B2400, atlanta, ga 30322, Usa Tel +1 404 778 5073 email steven.yeh@emory.ed u",Non-OADS,/arxiv_data1/oa_pdf/92/40/opth-8-2001.PMC4189704.pdf
"To evaluate the non-normalized FAF signal in the fovea,  a circular area that corresponded to the size of the optic disc  was placed on the center of the foveola using ImageJ soft - ware ( http://rsbweb.nih.gov/ij/index.htm l).",OADS,/arxiv_data1/oa_pdf/92/40/opth-8-2001.PMC4189704.pdf
"The median and standard deviation (SD) of  foveal autofluorescence were measured using ImageJ, and  all statistics were performed with the R statistical language  (http://www.r-project.org /).",OADS,/arxiv_data1/oa_pdf/92/40/opth-8-2001.PMC4189704.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/92/40/opth-8-2001.PMC4189704.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 2012lee et al enlargement of the area of measurement to the entire macula,  could be considered.",Non-OADS,/arxiv_data1/oa_pdf/92/40/opth-8-2001.PMC4189704.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/33/ijn-9-4581.PMC4189705.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4581–4595International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4581OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6911 5a novel hydrolysis-resistant lipophilic folate  derivative enables stable delivery of targeted  liposomes in vivo  Yifei huang1,* Tan Yang2,* Wendian Zhang2 Yao lu2 Peng Ye2 guang Yang2 Bin li2 shibo Qi2 Y ong liu2 Xingxing he3 robert J lee4 chuanrui Xu2 guangya Xiang2 1Department of Pharmacy, Union  hospital, Tongji Medical college,  huazhong University of science  and Technology, Wuhan, hubei,  People’s republic of china; 2school  of Pharmacy, Tongji Medical college,  huazhong University of science and  Technology, Wuhan, hubei, People’s  republic of china; 3Tongji hospital,  Tongji Medical college, huazhong  University of science and Technology,  Wuhan, hubei, People’s republic  of china; 4Division of Pharmaceutics  and Pharmaceutical chemistry,  college of Pharmacy, The Ohio state  University, columbus, Oh, Usa *These authors contributed equally  to this work correspondence: chuanrui Xu;  guangya Xiang  school of Pharmacy, Tongji Medical  college, hangkong road 13, Wuhan,  hubei 430030, People’s republic of china Tel +86 27 8369 2745 email xcr@hust.edu.c n; gyxiang1968@ hotmail.co m Abstract:  Instability of targeting ligand is a roadblock towards successful development of folate  targeted liposomes.",Non-OADS,/arxiv_data1/oa_pdf/fd/33/ijn-9-4581.PMC4189705.pdf
"It is one of the only two families of therapeutic nanocarriers that have  been approved in clinical practice.12 Compared with free molecules, liposomes can  help prolong systemic circulation time, enhance the tumor localization, and overcome  multi-drug resistance.13,14 Liposomes can also reduce the adverse effects of chemothera - peutic drugs, such as the cardiac toxicity of doxorubicin (Dox).15–18 For two decades,  studies have been focused on the development of novel liposomal therapeutic agents Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Huang et al Running head recto: Hydrolysis-resistant folate conjugating liposome DOI: http://dx.doi.org/10.2147/IJN.S69115",Non-OADS,/arxiv_data1/oa_pdf/fd/33/ijn-9-4581.PMC4189705.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fd/33/ijn-9-4581.PMC4189705.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 4595hydrolysis-resistant folate conjugating liposome 3,2000200400600 3,831.142 3,787.014 3,742.999 3,698.872 3,654.890 3,610.9073,963.2044,140.312 4,213.472 4,345.694 4,477.848 4,521.916 4,610.1214,051.298Intens (au) 3,4003 ,600 3,8004 ,000 4,200 4,400 4,600 4,800 5,000 m/z Figure S1 Mass spectrum of F-cONh-Peg-Nh-chol (folate-cONh-Peg-Nh-cholesterol).",Non-OADS,/arxiv_data1/oa_pdf/fd/33/ijn-9-4581.PMC4189705.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/69/dddt-8-1629.PMC4189707.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1629–1647Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1629ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6610 5α-Mangostin from Cratoxylum arborescens   demonstrates apoptogenesis in MCF-7 with  regulation of NF- κB and Hsp70 protein  modulation in vitro, and tumor reduction in vivo Mohamed Y ousif Ibrahim1 Najihah Mohd Hashim1 Syam Mohan2 Mahmood Ameen Abdulla3 Behnam Kamalidehghan1 Mostafa Ghaderian1,4 Firouzeh Dehghan1,5 Landa Zeenelabdin Ali1 Ismail Adam Arbab6 Maizatulakmal Yahayu7 Gwendoline Ee Cheng Lian8 Fatemeh Ahmadipour1 Hapipah Mohd Ali9 1Department of Pharmacy, Faculty of Medicine,   University of Malaya, Kuala Lumpur, Malaysia;   2Medical Research Centre, Jazan University,   Jazan, Saudi Arabia;  3Department of Molecular  Medicine, Faculty of Medicine University of  Malaya, Kuala Lumpur, Malaysia;  4Epigenetics  Lab, Institute of Biological Sciences, Faculty of  Science, University of Malaya, Kuala Lumpur,   Malaysia;  5Department of Physiology, Faculty of  Medicine, University of Malaya, Kuala Lumpur,   Malaysia;  6School of Chemical Sciences and  Food T echnology, Faculty of Science and  T echnology, Universiti Kebangsaan Malaysia,   Selangor, Malaysia;  7Department of Bioproduct  Research and Innovation, Institute of Bioproduct  Development (IBD), Universiti T eknologi  Malaysia, Johor, Malaysia;  8Department of  Chemistry, Faculty of Science, Universiti Putra  Malaysia, Selangor, Malaysia;  9Department of  Chemistry, University of Malaya, Kuala Lumpur,   Malaysia Correspondence: Najihah Mohd Hashim   Department of Pharmacy, Faculty of Medicine,   University of Malaya, 50603 Kuala Lumpur, Malaysia   Tel +60 1 2327 9594   Fax +60 3 7967 4964   Email najihahmh@um.edu.m y    Mohamed Yousif Ibrahim   Department of Pharmacy, Faculty of Medicine,   University of Malaya, 50603 Kuala Lumpur, Malaysia   Tel +60 1 7337 9596   Fax +60 3 7967 4964   Email al_omdah2003@hotmail.co m Abstract:  Cratoxylum arborescens  is an equatorial plant belonging to the family Guttiferae.",Non-OADS,/arxiv_data1/oa_pdf/16/69/dddt-8-1629.PMC4189707.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/16/69/dddt-8-1629.PMC4189707.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/69/dddt-8-1629.PMC4189707.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/37/dddt-8-1659.PMC4189708.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1659–1672Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1659Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S6801 6Anticancer, antioxidant activities, and DNA affinity  of novel monocationic bithiophenes and analogues Mohamed a ismail1,2 reem K arafa3 Magdy M Y oussef1,2 Wael M el-sayed1,4 1Departments of chemistry and  Biological sciences, college of  science, King Faisal University,   hofuf, saudi arabia; 2Department  of chemistry, Faculty of science,   Mansoura University, Mansoura,   egypt; 3Department of Pharmaceutical  chemistry, Faculty of Pharmacy, cairo  University, cairo, egypt; 4Department  of Zoology, Faculty of science,   University of ain shams, abbassia,   cairo, egyptAbstract:  A series of 15 monocationic bithiophenes and isosteres were prepared and subjected  to in vitro antiproliferative screening using the full National Cancer Institute (NCI)-60 cell line  panel, representing nine types of cancer.",Non-OADS,/arxiv_data1/oa_pdf/32/37/dddt-8-1659.PMC4189708.pdf
"For example, diallyldisulfide, found in garlic, appears to be potent in protecting against  skin, colon, and lung cancer.6–8 Also, biotin, known as vitamin B7, contains a tetrahydrothi - azole ring as an integral part of its structure and acts as an essential cofactor in integral bio - logical metabolic pathways, such as gluconeogenesis, fatty acid synthesis, and amino acid  anabolism.9 Bithiophenes and oligothiophenes and their derivatives are  important synthetic correspondence: Mohamed a ismail Department of chemistry, college of  science, King Faisal University, PO Box  380, hofuf 31982, saudi arabia Tel +966 533 543 735 email mabouelenan@kfu.edu.s a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Ismail et al Running head recto: Anticancer properties of novel monocationic bithiophenes DOI: http://dx.doi.org/10.2147/DDDT.S68016",Non-OADS,/arxiv_data1/oa_pdf/32/37/dddt-8-1659.PMC4189708.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/32/37/dddt-8-1659.PMC4189708.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/37/dddt-8-1659.PMC4189708.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/30/13/dddt-8-1673.PMC4189710.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1673–1683Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1673Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S6824 7an optimized probucol microencapsulated  formulation integrating a secondary bile acid  (deoxycholic acid) as a permeation enhancer armin Mooranian1 rebecca negrulj1 nigel chen-Tan2 gerald F Watts3 Frank arfuso4 hani al-salami1 1Biotechnology and Drug  Development research laboratory,   school of Pharmacy, curtin health  innovation research institute,   Biosciences research Precinct, curtin  University, 2Faculty of science and  engineering, curtin University, 3school  of Medicine and Pharmacology, royal  Perth hospital, University of Western  australia, 4school of Biomedical  science, curtin health innovation  research institute, Biosciences  research Precinct, curtin University,   Perth, australiaAbstract:  The authors have previously designed, developed, and characterized a novel  microencapsulated formulation as a platform for the targeted delivery of therapeutics in an  animal model of type 2 diabetes, using the drug probucol (PB).",Non-OADS,/arxiv_data1/oa_pdf/30/13/dddt-8-1673.PMC4189710.pdf
"Keywords:  artificial cell microencapsulation, diabetes, bile acids, probucol, antioxidant, anti- inflammatory, BÜCHI B390 Introduction Diabetes mellitus is a metabolic disorder classified as type 1 diabetes or type 2 diabetes  (T2D).1,2 Type 1 diabetes is an autoimmune disease marked by the destruction of  β-cells of the pancreas, resulting in a partial or complete lack of insulin production and  the inability of the body to control glucose levels.3 T2D develops due to genetic and  environmental factors that lead to tissue desensitization to insulin.4 Current therapies  are aimed at resolving the persistent hyperglycemia by increasing available insulin or  improving tissue sensitivity.5,6 However, damage of pancreatic β-cells and the build-up  of free radicals and toxins, together with persistent inflammation, remain detrimental  in diabetes treatment and long-term prognosis.7 There is growing evidence for the use of antioxidants as adjuncts in the treatment  of T2D.8–10 Probucol (PB) is a drug that was initially developed to treat hyperlipidemia,  but its strong anti-inflammatory and antioxidant properties have made it a potential  therapeutic agent in the treatment of T2D.11,12 In addition, PB has shown a protective  effect on pancreatic β-cells.13,14 It is highly lipophilic and accumulates extensively correspondence: hani al-salami school of Pharmacy, curtin University,  gPO Box U1987, Perth, Wa 6845,  australia Tel +61 8 9266 9816 Fax +61 8 9266 2769 email hani.al-salami@curtin.edu.a u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Mooranian et al Running head recto: Novel DCA–probucol microcapsules for type 2 diabetes treatment DOI: http://dx.doi.org/10.2147/DDDT.S68247",Non-OADS,/arxiv_data1/oa_pdf/30/13/dddt-8-1673.PMC4189710.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/30/13/dddt-8-1673.PMC4189710.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/13/dddt-8-1673.PMC4189710.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/25/dddt-8-1621.PMC4189711.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1621–1627Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1621Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6347 6Buccal acetaminophen provides fast analgesia: two  randomized clinical trials in healthy volunteers gisèle Pickering1–3 nicolas Macian1 Frédéric libert2,4 J Michel cardot1 séverine coissard1 Philippe Perovitch5 Marc Maury5 claude Dubray1–3 1chU clermont-Ferrand, centre de  Pharmacologie clinique, clermont- Ferrand, France; 2inserm, clermont- Ferrand, France; 3clermont Université,   laboratoire de Pharmacologie,   Faculté de Médecine, clermont- Ferrand, France; 4laboratoire de  Pharmacologie, chU clermont- Ferrand, France; 5Unither  Pharamceuticals, Paris, France correspondence: gisèle Pickering   clinical Pharmacology centre, Bâtiment  3c, chU, hopital g Montpied, 63001  clermont-Ferrand cedex, France   Tel +33 4 73 17 84 16   Fax +33 4 73 17 84 12   email gisele.pickering@udamail.f rBackground:  Acetaminophen (APAP) by oral or intravenous (iv) routes is used for mild to  moderate pain but may take time to be effective.",Non-OADS,/arxiv_data1/oa_pdf/a6/25/dddt-8-1621.PMC4189711.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a6/25/dddt-8-1621.PMC4189711.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/25/dddt-8-1621.PMC4189711.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/02/jmdh-7-419.PMC4189712.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2014:7 419–429Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  419Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S4999 4Breast cancer in young women: special  considerations in multidisciplinary care Chantal Reyna Marie Catherine Lee Comprehensive Breast Program,   H Lee Moffitt Cancer Center and  Research institute, Tampa, FL, USA Correspondence: Marie Catherine Lee   Moffitt Cancer Center, Comprehensive  Breast Program,  12902 Magnolia Drive,  Tampa, FL  33612, USA   Tel +1 813 745 8480  Fax +1 813 745 7287  email m.catherine.lee@moffitt.or gAbstract:  Breast cancer is one of the most prevalent cancers in females, and  5%–7% of breast  cancer cases occur in women under  40 years of age.",Non-OADS,/arxiv_data1/oa_pdf/69/02/jmdh-7-419.PMC4189712.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/69/02/jmdh-7-419.PMC4189712.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/02/jmdh-7-419.PMC4189712.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/16/ott-7-1793.PMC4189713.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1793–1800OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1793Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S4918 7An evidence-based review of ixazomib citrate   and its potential in the treatment of newly  diagnosed multiple myeloma Massimo Offidani1 Laura Corvatta2 Patrizia Caraffa1 Silvia Gentili1 Laura Maracci1 Pietro Leoni1 1Hematology Department, Azienda  Ospedaliero Universitaria Ospedali  Riuniti di Ancona, 2Division of  Medicine, Ospedale Stelluti Scala,   Fabriano, italy Correspondence: Massimo Offidani   Clinica di ematologia, Azienda   Ospedaliero–Universitaria,   Ospedali Riuniti di Ancona,   71 via Conca, Ancona 60126, italy   Tel +39 071 596 4735   Fax +39 071 218 3448   email massimo.offidani@ospedaliriuniti.",Non-OADS,/arxiv_data1/oa_pdf/26/16/ott-7-1793.PMC4189713.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/26/16/ott-7-1793.PMC4189713.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/16/ott-7-1793.PMC4189713.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/d1/dddt-8-1595.PMC4189714.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1595–1611Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1595Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6969 0EGFR mutations as a prognostic and predictive  marker in non-small-cell lung cancer Shu Fang1 Zhehai wang2 1School of Medicine and Life Sciences,   University of Jinan-Shandong Academy  of Medical Sciences, Shandong  Cancer Hospital, Jinan, Shandong  Province, People’s Republic of China;   2Department of Oncology, Shandong  Cancer Hospital, Jinan, Shandong  Province, People’s Republic of ChinaAbstract:  Non-small-cell lung cancer (NSCLC) has entered the age of individual treatment,  and increasing point mutations of specific oncogenes and rearrangement of some chromosomes  are biomarkers used to predict the therapeutic effect of targeted therapy.",Non-OADS,/arxiv_data1/oa_pdf/bf/d1/dddt-8-1595.PMC4189714.pdf
"The most common EGFR  mutations reported  are deletions in exon 19 and the p.L858R point mutation in exon 21 (85%–90%).14,15  It has been reported that EGFR  mutations usually occur in a subset of NSCLC  patients with the following features: nonsmoker, female, East Asian, adenocarci - noma with bronchioloalveolar carcinoma, and well- or moderately differentiated   tumor cells.16–18 During the past decade, some research demonstrated that EGFR TK  inhibitor (EGFR-TKI) sensitivity was influenced by the presence of EGFR  mutations  and increased EGFR  copy numbers.19–25 Some Phase III trials also revealed that,  compared with those treated with erlotinib or gefitinib, the EGFR -mutated NSCLC Correspondence: Zhehai wang Department of Oncology, Shandong  Cancer Hospital, No 440 Jiyan Road,  Jinan, Shandong 250117, People’s  Republic of China  Tel/fax +86 531 6762 6331  email wzhai8778@sina.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2014 Volume: 8 Running head verso: Fang and Wang Running head recto: EGFR mutations in non-small-cell lung cancer DOI: http://dx.doi.org/10.2147/DDDT.S69690",Non-OADS,/arxiv_data1/oa_pdf/bf/d1/dddt-8-1595.PMC4189714.pdf
Available from: http://www.clinicaltrials.gov/ show/NCT01526928.,Non-OADS,/arxiv_data1/oa_pdf/bf/d1/dddt-8-1595.PMC4189714.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bf/d1/dddt-8-1595.PMC4189714.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/d1/dddt-8-1595.PMC4189714.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/f3/ott-7-1783.PMC4189715.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1783–1791OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1783Case RepORTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6565 3Capecitabine-induced cardiotoxicity: more  evidence or clinical approaches to protect the  patients’ heart?,Non-OADS,/arxiv_data1/oa_pdf/ab/f3/ott-7-1783.PMC4189715.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ab/f3/ott-7-1783.PMC4189715.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/f3/ott-7-1783.PMC4189715.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/opth-8-2013.PMC4189719.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 2013–2018Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2013Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6475 6survey of Japanese ophthalmic surgeons  regarding perioperative disinfection and antibiotic  prophylaxis in cataract surgery Kazuki Matsuura1 Takafumi Mori2 Takeshi Miyamoto3 Chikako suto4 Yusuke saeki5 shigeto Tanaka6 hajime Kawamura7 shinji Ohkubo8 Masaki Tanito9,10 Y oshitsugu inoue11 1nojima hospital, Kurayoshi,   2Department of Ophthalmology,   school of Medicine, Fukushima  Medical University, Fukushima,   3Department of Ophthalmology,   Wakayama Medical University,   Wakayama, 4Department of  Ophthalmology, T okyo Women’s  Medical University, T okyo,   5Department of Ophthalmology,   school of Medicine, Fukuoka  University, Fukuoka, 6Tonosho  Central hospital, Kagawa, 7shiga  University of Medical science, Otsu,   8Department of Ophthalmology and  Visual science, Kanazawa University  graduate school of Medical  science, Kanazawa, 9Department of  Ophthalmology, shimane University  Faculty of Medicine, izumo, 10Division  of Ophthalmology, Matsue red  Cross hospital, Matsue, 11Division  of Ophthalmology and Visual science,   Faculty of Medicine, T ottori University,   Y onago, Japan Correspondence: Kazuki Matsuura  nojima hospital, 2714-1, sesaki-machi,  Kurayoshi-city, T ottori, 682-0863, Japan   email i-mnys2001@za.ztv.ne.j pPurpose:  To elucidate Japanese trends for perioperative disinfection and antibiotic selection  during cataract surgeries.",Non-OADS,/arxiv_data1/oa_pdf/a2/fe/opth-8-2013.PMC4189719.pdf
"However, there is limited evidence on the efficacy of  prophylactic antibiotic administration, including preoperative topical antibiotics,  subconjunctival antibiotic injections, and antibiotic irrigation.Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Matsuura et al Running head recto: Disinfection and antibiotic prophylaxis in cataract surgery in Japan DOI: http://dx.doi.org/10.2147/OPTH.S64756",Non-OADS,/arxiv_data1/oa_pdf/a2/fe/opth-8-2013.PMC4189719.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a2/fe/opth-8-2013.PMC4189719.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 2018Matsuura et al,Non-OADS,/arxiv_data1/oa_pdf/a2/fe/opth-8-2013.PMC4189719.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3d/ce/cia-9-1645.PMC4189720.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1645–1660Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1645RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5784 9Optimal management of elderly cancer  patients: usefulness of the Comprehensive  Geriatric Assessment Philippe Caillet1,2 Marie Laurent1,2 Sylvie Bastuji-Garin1,3,4 evelyne Liuu2 Stephane Culine5 Jean-Leon Lagrange6 Florence Canoui-Poitrine1,2,3,* elena Paillaud1,2,* 1Laboratoire d’Investigation Clinique  (LIC), Faculté de Medecine, Université  Paris est Créteil (UP eC), Créteil,   Paris, 2Unité de Coordination d’Onco- Gériatrie, Département de Médecine  Interne et Gériatrie, Hôpital Henri- Mondor, Assistance Publique –  Hopitaux de Paris (AP-HP), Créteil,   3Service de Santé Publique, Hôpital  Henri-Mondor, AP-HP , Créteil, 4Unité  de Recherche Clinique, Hôpital Henri- Mondor, AP-HP , Créteil, 5Service  d’Oncologie Médicale, Hôpital  Saint-Louis, AP-HP , Paris, 6Service de  Radiotherapie, Hôpital Henri-Mondor,   AP-HP , Créteil, France *These authors contributed equally  to this work Background:  Cancer is common in older patients, who raise specific treatment challenges due  to aging-related, organ-specific physiologic changes and the presence in most cases of comor - bidities capable of affecting treatment tolerance and outcomes.",Non-OADS,/arxiv_data1/oa_pdf/3d/ce/cia-9-1645.PMC4189720.pdf
"Comorbidities Correspondence:  elena Paillaud Unité de Coordination d’Onco-Gériatrie,  Département de Médecine Interne et  Gériatrie, Hôpital Henri Mondor,   51 rue de Marechal de Lattre de Tassigny,  94010 Créteil Cedex, France Tel +331 4981 3074 email elena.paillaud@hmn.aphp.f r Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2014 Volume: 9 Running head verso: Caillet et al Running head recto: CGA in management of elderly cancer patients DOI: http://dx.doi.org/10.2147/CIA.S57849",Non-OADS,/arxiv_data1/oa_pdf/3d/ce/cia-9-1645.PMC4189720.pdf
The three investigators used the PRISMA® (Preferred  Reporting Items for Systematic Reviews and Meta-analysis)  guidelines ( http://www.prisma-statement.org/statement.htm )  to assess the quality of included studies.,OADS,/arxiv_data1/oa_pdf/3d/ce/cia-9-1645.PMC4189720.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/3d/ce/cia-9-1645.PMC4189720.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3d/ce/cia-9-1645.PMC4189720.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJune 2014 |  88  | e51734 | Page 1 of 9Video Article Evaluation of Integrated Anaerobic Digestion and Hydrothermal Carbonization for Bioenergy Production M. Toufiq Reza1, Maja Werner1, Marcel Pohl1, Jan Mumme1 1APECS Group, Leibniz Institute for Agricultural Engineering Correspondence to: M. Toufiq Reza at TReza@atb-potsdam.de URL: http://www.jove.com/video/51734 DOI: doi:10.3791/51734 Keywords: Environmental Sciences, Issue 88, Biomethane, Hydrothermal Carbonization (HTC), Calorific Value, Lignocellulosic Biomass, UASS, Anaerobic Digestion Date Published: 6/15/2014 Citation: Reza, M.T., Werner, M., Pohl, M., Mumme, J.",Non-OADS,/arxiv_data1/oa_pdf/af/a1/jove-88-51734.PMC4189747.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51734/ Introduction Finding renewable and sustainable energy sources are major concerns in the world’s energy sector.,Non-OADS,/arxiv_data1/oa_pdf/af/a1/jove-88-51734.PMC4189747.pdf
Weblink: http://www.eclac.org/ publicaciones/xml/6/29836/UNEnergybioenergy_english.pdf .,Non-OADS,/arxiv_data1/oa_pdf/af/a1/jove-88-51734.PMC4189747.pdf
"Weblink: http://www.vdi.eu/guidelines/vdi_4630- vergaerung_organischer_stoffe_substratcharakterisierung_probenahme_stoffdatenerhebung_gaerversuche/ 22.Rehl, T., Müller, J.",Non-OADS,/arxiv_data1/oa_pdf/af/a1/jove-88-51734.PMC4189747.pdf
"Human respiratory syncytial virus (hRSV) has developed several  *Correspondence to: J Amaranath Govindan; Email: govindan@molbio.mgh.harvard.edu Submitted: 09/23/2014; Accepted: 09/23/2014; Published Online: 10/07/2014http://dx.doi.org/10.4161/viru.36667Pathogens J Amaranath Govindan1,2,* and Gary r uvkun1,2 1department of Molecular Biology; Massachusetts General Hospital; Boston, MA U sA; 2department of Genetics; Harvard Medical s chool; Boston, MA U sA",Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Immunity 2009; 30:766-75; PMID:19538928 ;  http://dx.doi.org/10.1016/j.immuni.2009.06.004 2.,OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Cold Spring Harb  Symp Quant Biol 1989; 54:1-13; PMID:2700931 ;  http://dx.doi.org/10.1101/SQB.1989.054.01.003 3.,OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Science 2002; 296:301-5; PMID:11951032 ;  http://dx.doi.org/10.1126/science.1071059 4.,OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Cell Host Microbe 2009; 6:10-21; PMID:19616762 ;  http://dx.doi.org/10.1016/j.chom.2009.06.007 5.,OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Nat Rev Immunol 2008; 8:279-89;  PMID:18340345 ; http://dx.doi.org/10.1038/nri2215 6.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Nature 2002; 418:191-5; PMID:12110890 ;  http://dx.doi.org/10.1038/nature00858 7.,OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
J Leukoc Biol 2007;  81:1-5;  PMID:17032697; http://dx.doi.org/10.1189/ jlb.0306164 8.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
J  Am Soc Nephrol 2011; 22:416-25; PMID:21335516 ;  http://dx.doi.org/10.1681/ASN.2010040430 9.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Nat Rev Immunol 2013; 13:199- 206; PMID:23411798 ; http://dx.doi.org/10.1038/ nri3398 11.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Cell 2006; 124:803- 14; PMID:16497589 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Annu Rev Phytopathol 2008; 46:189-215;  PMID:18422429 ; http://dx.doi.org/10.1146/ annurev.phyto.46.120407.110050 13.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Cell Host Microbe 2012; 11:375-86;  PMID:22520465 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Cell Host Microbe  2012; 11:364-74;  PMID:22520464 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Immunity 2011; 35:536-49; PMID:22018470 ;  http://dx.doi.org/10.1016/j.immuni.2011.08.015 18.,OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
PLoS Pathog 2011; 7:e1001289;  PMID:21390206 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Infect Immun 2012; 80:3570-5; PMID:22851749 ; http://dx.doi.org/10.1128/ IAI.00557-1220.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
PLoS Pathog 2014; 10:e1004229;  PMID:25058342 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Virulence 2014; 5:697- 702; PMID: 24802615; http://dx.doi.org/10.4161/ viru.29091 22.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Virulence  2014; 5:733-739; PMID: 25090027; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Virulence 2014; 5:710- 721; PMID: 25101626; http://dx.doi.org/10.4161/ viru.29755 24.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Virulence 2014; 5:752-760; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Virulence 2014; 5:703-709; PMID: 24972269;  http://dx.doi.org/10.4161/viru.29652 26.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Virulence 2014; 5:722-732; http://dx.doi.org/10.4161/viru.29798 27.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Virulence 2014; 5:761-771; PMID:  24799669; http://dx.doi.org/10.4161/viru.29062 28.,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
Virulence 2014; 5:740-751; http://dx.doi.org/10.4161/viru.32225,Non-OADS,/arxiv_data1/oa_pdf/d2/d2/viru-5-695.PMC4189874.pdf
"PRRs can also recognize cellular damage by binding with products of cel - lular and tissue degradation, or damage-associated molecular *Correspondence to: Rajmohan Rajamuthiah;   Email: Rrajamuthiah@molbio.mgh.harvard.eduSubmitted: 03/17/2014; Revised: 04/30/2014; Accepted: 05/01/2014;  Published Online: 05/06/2014; http://dx.doi.org/10.4161/viru.29091Effector triggered immunity Activation of innate immunity in metazoans   by bacterial effectors Rajmohan Rajamuthiah1,2,* and e leftherios Mylonakis1,2 1Division of i nfectious Diseases; Rhode i sland Hospital; Alpert Medical School of Brown University; Providence, R i USA; 2Massachusetts General Hospital;   Harvard Medical School; Boston, MA USA Keywords:  innate immunity, metazoans, animal cells, PAMP, MAMP, DAMP, PRR, translation inhibition, actin cytoskeleton,  pore forming toxin Pathogenic bacteria produce virulence factors called  effectors, which are important components of the infection  process.",Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat Immunol  2004; 5:971-4;  PMID:15454919 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat Immunol  2006; 7:1237-42;  PMID:17110939 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Curr Opin  Immunol 2007; 19:392-401; PMID:17662586 ;  http://dx.doi.org/10.1016/j.coi.2007.06.005 4.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell 2010; 143:694-702;  PMID:21111231 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
PLoS Pathog 2011; 7:e1001289;  PMID:21390206 ; http://dx.doi.org/10.1371/jour - nal.ppat.1001289 6.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Immunol Rev 2011;  243:26-39;  PMID:21884165 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell 2006; 124:783- 801; PMID:16497588 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell 2010; 140:805-20;  PMID:20303872 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell 2007; 130:1071-82; PMID:17889651 ;  http://dx.doi.org/10.1016/j.cell.2007.09.008 10.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat Immunol 2009; 10:1200-7;  PMID:19801985 ; http://dx.doi.org/10.1038/ni.1792 11.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Science 2002; 296:301-5; PMID:11951032 ;  http://dx.doi.org/10.1126/science.1071059 12.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Am J Physiol Cell Physiol 2006; 290:C917- 24; PMID:16267105 ; http://dx.doi.org/10.1152/ ajpcell.00401.2005 13.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat Med 2007; 13:1042-9; PMID:17767165 ; http://dx.doi.org/10.1038/ nm1638 14.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Blood 2009; 113:429-37;  PMID:18952897 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat Rev Immunol 2013; 13:397-411;  PMID:23702978 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Immunity 2009; 30:766-75; PMID:19538928 ;  http://dx.doi.org/10.1016/j.immuni.2009.06.00417.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat Rev Immunol 2010; 10:131- 44; PMID:20098461 ; http://dx.doi.org/10.1038/ nri2707 19.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat Immunol  2007; 8:1179-87;  PMID:17952043 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat  Rev Immunol 2012; 12:89-100; PMID:22273771 ;  http://dx.doi.org/10.1038/nri3141 21.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Trends Microbiol 2009; 17:139-45; PMID:19299134 ;  http://dx.doi.org/10.1016/j.tim.2009.01.004 23.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat Rev Immunol 2013; 13:199- 206; PMID:23411798 ; http://dx.doi.org/10.1038/ nri3398 25.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Proc Natl Acad Sci U S A 2004; 101:10995-1000;  PMID:15256590 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell 2006; 126:1135- 45; PMID:16990137 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
PLoS Pathog 2012; 8:e1002812;  PMID:22829768 ; http://dx.doi.org/10.1371/jour - nal.ppat.1002812 28.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell Host Microbe  2012; 11:337-51;  PMID:22520462 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
PLoS Pathog 2009; 5:e1000538;  PMID:19662166 ;  http://dx.doi.org/10.1371/journal.ppat.1000538 30.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell Host Microbe  2012; 11:364-74;  PMID:22520464 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell Host Microbe 2012; 11:375-86;  PMID:22520465 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Infect Immun 2012; 80:3570- 5; PMID:22851749 ; http://dx.doi.org/10.1128/ IAI.00557-12 33.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell Microbiol 2011;  13:1881-93;  PMID:21848814 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Immunity 2011; 35:536-49; PMID:22018470 ;  http://dx.doi.org/10.1016/j.immuni.2011.08.015 35.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat Rev Immunol 2013; 13:679- 92; PMID:23954936 ; http://dx.doi.org/10.1038/ nri3495 36.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Oncogene 2006; 25:6758- 80; PMID:17072327; http://dx.doi.org/10.1038/ sj.onc.1209943 37.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Annu Rev Immunol 2009; 27:693- 733; PMID:19302050 ; http://dx.doi.org/10.1146/ annurev.immunol.021908.132641 38.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Genes Dev 2009; 23:2333- 44; PMID:19797770 ; http://dx.doi.org/10.1101/ gad.1827009 39.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
J Cell Physiol 2009; 220:664-71;  PMID:19452446 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell Host Microbe 2012; 12:60- 70; PMID:22817988 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
PLoS One  2011; 6:e17638;  PMID:21408005 ;  http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat Rev Microbiol 2009; 7:13-24;  PMID:19011659 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Expert Opin Drug Discov 2011; 6:645-52;  PMID:21686092 ; http://dx.doi.org/10.1517/174604 41.2011.573781,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell 2012; 149:452-66;  PMID:22500807 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Annu Rev Cell Dev Biol 2010; 26:261-83;  PMID:20929312 ; http://dx.doi.org/10.1146/ annurev-cellbio-100109-104034 48.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell Host Microbe 2012; 11:563- 75; PMID:22704617 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Curr  Opin Cell Biol 2010; 22:124-31; PMID:20034776 ;  http://dx.doi.org/10.1016/j.ceb.2009.11.014 51.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Trends Cell Biol 2005; 15:163-71;  PMID:15752980 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Nat Rev Immunol 2010; 10:182- 92; PMID:20182458 ; http://dx.doi.org/10.1038/ nri2724 53.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Int J Biochem Cell Biol  2012; 44:928-41;  PMID:22465711 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Exp Cell Res 2010; 316:2810- 24; PMID:20678498 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
J Immunol  2001; 166:4831-4;  PMID:11290758 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
FEMS Yeast Res 2009; 9:1226-35; PMID:19817875 ;  http://dx.doi.org/10.1111/j.1567-1364.2009.00581.x58.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Biochem Biophys Res Commun 2006; 342:529- 36; PMID:16488394 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Exp Cell Res 2013; 319:2329-36;  PMID:23648569 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
J Cell Physiol  2004; 200:71-81;  PMID :15137059 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
J Biol Chem 2005; 280:1499-505; PMID :15531589 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Cell 1998; 93:815- 26; PMID:9630225 ; http://dx.doi.org/10.1016/ S0092-8674(00)81442-7 66.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
FEMS  Microbiol Rev 2007; 31:515-34; PMID:17680807 ;  http://dx.doi.org/10.1111/j.1574-6976.2007.00078.x 68.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Prog Biophys Mol Biol  2005; 88:91-142;  PMID :15561302 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Semin Immunopathol 2007; 29:249-60; PMID:17805541 ; http://dx.doi.org/10.1007/ s00281-007-0085-0 72.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Biochem Biophys Res Commun 2009; 385:503-6; PMID:19497299 ;  http://dx.doi.org/10.1016/j.bbrc.2009.05.121 74.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Annu Rev Cell Dev Biol 2003; 19:697-731; PMID:14570587 ; http://dx.doi.org/10.1146/ annurev.cellbio.19.111301.140101 75.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
J Cell Biol  2008; 180:905-14;  PMID:18316410 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
J Exp Med 2004; 200:1647-55;  PMID :15611291 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
J Bacteriol 2008; 190:3896- 903; PMID:18390664 ; http://dx.doi.org/10.1128/ JB.01965-07 79.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
J Microbiol 2013; 51:194-9; PMID:23625220 ; http://dx.doi.org/10.1007/ s12275-013-2579-x 80.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
Infect Immun  2003; 71:6171-7;  PMID:14573633 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/e1/viru-5-697.PMC4189875.pdf
"15-17 On the other side, cyto - plasmic and nuclear effectors affect host defense mechanisms by *Correspondence to: Hugo Germain; Email: hugo.germain@uqtr.ca Submitted: 03/11/2014; Revised: 06/11/2014; Accepted: 06/19/2014; Published Online: 06/27/2014; http://dx.doi.org/10.4161/viru.29652Effector biology during biotrophic invasion   of plant cells Prateek Chaudhari1, Bulbul Ahmed1, David L Joly2, and Hugo Germain1,* 1Groupe de Recherche en Biologie v égétale; Département de Chimie, Biochimie et Physique; Université du Québec à Trois-Rivières; Trois-Rivières, QC Canada;   2Département de Biologie; Université de Moncton; Moncton, NB Canada Keywords:  biotrophic pathogen, haustoria, nucleolus, effector target, rust, vesicle Several obligate biotrophic phytopathogens, namely  oomycetes and fungi, invade and feed on living plant cells  through specialized structures known as haustoria.",Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Annu Rev Plant Biol 2009; 60:379-406;  PMID:19400727 ; http://dx.doi.org/10.1146/ annurev.arplant.57.032905.105346 4.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Bioessays  2006; 28:880-9;  PMID:16837346 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Curr  Opin Plant Biol 2012; 15:349-57; PMID:22705024 ;  http://dx.doi.org/10.1016/j.pbi.2012.05.006 6.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Plant Cell 2006; 18:465-76; PMID:16377758 ;  http://dx.doi.org/10.1105/tpc.105.036574,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Mol Cell  2000; 5:1003-11;  PMID:10911994 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Nat Immunol 2005; 6:973-9;  PMID:16177805 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Microbiol Mol Biol Rev  2004; 68:771-95;  PMID :15590783 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Can J Bot 1972; 50:231-40; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Nat Rev Microbiol 2013; 11:800- 14; PMID:24129511 ; http://dx.doi.org/10.1038/ nrmicro3119 14.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
PLoS Biol  2014; 12:e1001801;  PMID:24586116 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Plant Cell 2008; 20:1948-63;  PMID:18660430 ; http://dx.doi.org/10.1105/ tpc.108.059394 16.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Plant Cell 2008; 20:1169-83;  PMID:18451324 ;  http://dx.doi.org/10.1105/tpc.107.056325 17.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Proc Natl Acad Sci U S A 2009; 106:1654- 9; PMID:19171904 ; http://dx.doi.org/10.1073/ pnas.0809201106 18.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Plant J  2007; 49:1030-40;  PMID:17319846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Nature 2007; 449:827-34;  PMID:17943119 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Cold Spring Harb Symp Quant Biol 2012; 77:235- 47; PMID:23223409 ; http://dx.doi.org/10.1101/ sqb.2012.77.015933 21.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Proc Natl Acad Sci U S A  2006; 103:8888-93;  PMID:16731621 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
PLoS Pathog  2012; 8:e1003004;  PMID:23209402 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Proc Natl Acad Sci U S A 2013; 110:17594- 9; PMID:24101475 ; http://dx.doi.org/10.1073/ pnas.1307614110 26.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Mol Plant Pathol  2013; 14:96-107;  PMID:22998218 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Mol Plant Microbe Interact  2005; 18:1130-9;  PMID:16353548 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Trends Microbiol 2012; 20:199-208; PMID:22341410 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Plant J  2012; 69:252-65;  PMID:21914011 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Curr Opin Plant  Biol 2011; 14:512-8; PMID:21723182 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
PLoS Biol 2007; 5:e68; PMID:17298188 ;  http://dx.doi.org/10.1371/journal.pbio.0050068 33.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Plant Cell 2009; 21:2503- 16; PMID:19700630 ; http://dx.doi.org/10.1105/ tpc.108.064519 34.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Curr Biol 2007; 17:2023-9;   PMID:17997306 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Nat Commun 2013; 4:2530;  PMID:24067909 ; http://dx.doi.org/10.1038/ ncomms3530 37.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
"Arch Microbiol 2001; 176:393-9; PMID:11734881 ; http://dx.doi.org/10.1007/ s002030100344 38. van Dijk K, Fouts DE, Rehm AH, Hill AR, Collmer A, Alfano JR.",OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Mol Plant Microbe Interact 1994; 7:223-39;  http://dx.doi.org/10.1094/MPMI-7-0223 40.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
J Mol Biol 2005; 348:85-100;  PMID :15808855 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Cell 2006; 125:187-99; PMID :16615899 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Nucleic Acids Res  2007; 35:W585-7;  PMID:17517783 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Proteomics 2010; 10:3045- 50; PMID:20564263 ; http://dx.doi.org/10.1002/ pmic.201000162 46.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Virus Res  2005; 114:23-34;  PMID :15992957 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
J Gen Virol  2003; 84:1951-60;  PMID:12867625 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
J Gen Virol 2005; 86:2891-6;  PMID:16186245 ; http://dx.doi.org/10.1099/ vir.0.81101-0 49.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Nat Rev Microbiol 2007; 5:119-27;  PMID:17224921 ; http://dx.doi.org/10.1038/ nrmicro1597,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Science  1987; 235:1659-62;  PMID:17795599 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
PLoS Pathog 2012; 8:e1002643; PMID:22496661 ;  http://dx.doi.org/10.1371/journal.ppat.1002643 53.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Mol Plant Microbe Interact 2011; 24:808-18; PMID:21644839 ; http://dx.doi.org/10.1094/ MPMI-01-11-0006 54.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Plant J  2005; 44:516-29;  PMID:16236160 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Physiol  Mol Plant Pathol 1993; 43:135-46; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Physiol Mol Plant Pathol 1993; 143:147-60; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Cell  Microbiol 2012; 14:682-97; PMID:22233428 ;  http://dx.doi.org/10.1111/j.1462-5822.2012.01751.x 61.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Plant Cell  2002; 14:2941-55;  PMID:12417712 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Plant Physiol  2010; 152:1309-19;  PMID:20107027 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
PLoS Pathog 2013; 9:e1003670;  PMID:24130484 ; http://dx.doi.org/10.1371/jour - nal.ppat.1003670 64.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Plant Cell 2010; 22:1826- 37; PMID:20543027 ; http://dx.doi.org/10.1105/ tpc.110.075952 66.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Plant Signal Behav  2010; 5:1 568-70;  PMID :21512325 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Science 2004; 305:855-8;  PMID :15297671 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Genes Dev 2009; 23:2496-506;  PMID:19833761 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Curr Opin Cell Biol 1997; 9:496- 504; PMID:9261061 ; http://dx.doi.org/10.1016/ S0955-0674(97)80025-7 71.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
EMBO J 1999; 18:1071- 80; PMID:10022848 ; http://dx.doi.org/10.1093/ emboj/18.4.1071 73.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Curr Biol 1994; 4:220- 33; PMID:7922327 ; http://dx.doi.org/10.1016/ S0960-9822(00)00051-8 75.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Cell  1994; 78:937-48;  PMID:7923363 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
J Biol Chem 2008; 283:26974-84; PMID:18678865 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Mol Plant Pathol 2009; 10:815-28; PMID:19849787 ;  http://dx.doi.org/10.1111/j.1364-3703.2009.00585.x 79.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
PLoS Pathog 2010; 6:e1000961;  PMID:20585567 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Mol Plant Microbe Interact 2012; 25:279- 93; PMID:22046958 ; http://dx.doi.org/10.1094/ MPMI-09-11-0238 81.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
Proc Natl Acad Sci U S A 2011; 108:9166- 71; PMID :21536894 ; http://dx.doi.org/10.1073/ pnas.1019315108 82.,OADS,/arxiv_data1/oa_pdf/68/a4/viru-5-703.PMC4189876.pdf
"Here we describe in detail the recent exciting developments on how plants deploy ETI to  *Correspondence to: Zheng Qing Fu; Email: zfu@mailbox.sc.edu Submitted: 03/15/2014; Revised: 06/05/2014; Accepted: 06/26/2014; Published Online: 07/10/2014; http://dx.doi.org/10.4161/viru.29755Go in for the kill How plants deploy effector-triggered immunity   to combat pathogens Liang wu†, Huan Chen†, Chad Curtis, and Zheng Qing Fu* Department of Biological Sciences; University of South Carolina; Columbia, SC USA †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Front Plant Sci 2012; 3:77;  PMID:22629279 ; http://dx.doi.org/10.3389/ fpls.2012.00077 2.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Front Plant Sci  2012 ;  3:85; PMID:22639669 ; http://dx.doi.org/10.3389/ fpls.2012.00085 3.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Proc Natl Acad Sci U S A 2007 ; 104:19613 -8;  PMID:18042724 ; http://dx.doi.org/10.1073/ pnas.07051471045.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell   2008 ; 20:471-81; PMID:18263776 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Annu Rev Plant Biol 2009 ; 60:379- 406; PMID:19400727 ; http://dx.doi.org/10.1146/ annurev.arplant.57.032905.105346 7.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell  1996 ; 8:1793 - 807; PMID:12239362 ; http://dx.doi.org/10.1105/ tpc.8.10.17939.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Cell Host Microbe  2008 ; 3:126-35; PMID:18329612 ;  http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Front Plant Sci  2013 ;  4:364; PMID:24062762 ; http://dx.doi.org/10.3389/ fpls.2013.00364 11.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Annu Rev Phytopathol 2004 ; 42:185- 209; PMID:15283665 ; http://dx.doi.org/10.1146/ annurev.phyto.42.040803.140421 12.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Curr  Opin Plant Biol 2006 ; 9:383-90; PMID:16713729 ;  http://dx.doi.org/10.1016/j.pbi.2006.05.009,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Proc Natl Acad Sci U S A 1998 ; 95:10306 -11;  PMID:9707643 ; http://dx.doi.org/10.1073/ pnas.95.17.10306 16.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Tobacco mosaic virus  regulates the expression of its own resistance gene N.  Plant Physiol  2004 ; 135:2392 -7; PMID :15299123 ;  http://dx.doi.org/10.1104/pp.104.044859 17.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
J Exp Bot 2005 ; 56:567-75;  PMID :15545294 ; http://dx.doi.org/10.1093/jxb/ eri030 18.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Nature  2005 ; 435:1122 - 5; PMID :15973413 ; http://dx.doi.org/10.1038/ nature03630 20.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Mol Plant Microbe Interact 2004 ; 17:1192 -200;  PMID:15553245 ; http://dx.doi.org/10.1094/ MPMI.2004.17.11.1192 21.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Nat Rev Microbiol  2013 ; 11:745-60; PMID:24129510 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell  2012 ; 24:859-74;  PMID:22408077 ; http://dx.doi.org/10.1105/ tpc.111.095380 24.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
PLoS Pathog  2014 ; 10:e1003883 ; PMID:24453975 ;  http://dx.doi.org/10.1371/journal.ppat.1003883 25.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Annu Rev Plant Biol  2009 ; 60:139-64; PMID:19014346 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Science  2005 ; 309:929- 32; PMID:15976272 ; http://dx.doi.org/10.1126/ science.1109977 27.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
PLoS Pathog   2010 ; 6:e1001111 ; PMID:20862316 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant J   2012 ; 69:411-20; PMID:21967323 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant J   2002 ; 31:87-95; PMID:12100485 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Physiol   2008 ; 147:790-801; PMID:18434604 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Proc Natl Acad Sci U S A 2010 ;  107 :13538 -43; PMID:20624951 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Proc Natl Acad Sci U S A 2003 ; 100:8024 - 9; PMID:12788974 ; http://dx.doi.org/10.1073/ pnas.1230660100 36.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
EMBO J  2000 ; 19:4004 -14; PMID:10921881 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell   2013 ; 25:1463 -81; PMID:23548743 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Proc Natl Acad Sci U S A  2006 ; 103:8888 -93; PMID:16731621 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Cell 2003 ; 112:379- 89; PMID :12581527 ; http://dx.doi.org/10.1016/ S0092-8674(03)00040-041.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Cell 2002 ; 108:743- 54; PMID:11955429 ; http://dx.doi.org/10.1016/ S0092-8674(02)00661-X 42.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Cell Host Microbe 2011 ; 9:137- 46; PMID:21320696 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Cell Host Microbe 2011 ; 9:125- 36; PMID:21320695 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Cell  2003 ; 112:369-77; PMID :12581526 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Cell 2005 ; 121:749- 59; PMID :15935761 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Mol Microbiol   2003 ; 49:1537-46; PMID:12950919 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Signal Behav   2009 ; 4:1107 -10; PMID:20514222 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
PLoS Biol  2009 ;  7:e1000139 ; PMID:19564897 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Science  2011 ; 333:596- 601; PMID:21798943 ; http://dx.doi.org/10.1126/ science.1203659 50.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Nat Rev  Immunol  2012 ; 12:89-100; PMID:22273771 ;  http://dx.doi.org/10.1038/nri3141 51.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Curr Opin Plant Biol  2005 ; 8:383-9; PMID :15939664 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Science  2011 ; 334:1401 - 4; PMID :22158818 ; http://dx.doi.org/10.1126/ science.1211641 53.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Science   2011 ; 334:1405 -8; PMID :22158819 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
"Proc Natl Acad Sci U S A 2013 ; 110:18722 - 7; PMID:24170858 ; http://dx.doi.org/10.1073/ pnas.1315520110 55. van der Hoorn RA, Kamoun  S. From Guard  to Decoy: a new model for perception of plant pathogen effectors.",OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell  2008 ; 20:2009 - 17; PMID:18723576 ; http://dx.doi.org/10.1105/ tpc.108.060194 56.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Science  1996 ;  274:2063 -5; PMID:8953034 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell  1997 ; 9:61-73; PMID:9014365 ;  http://dx.doi.org/10.1105/tpc.9.1.61 59.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Mol Cell   1998 ; 2:241-5; PMID:9734361 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Curr Opin Microbiol  2008 ; 11:179-85; PMID:18372208 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Curr Biol  2008 ; 18:R218 - 20; PMID:18334200 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Curr Biol  2008 ; 18:74- 80; PMID :18158241 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Science  2007 ;  318:648-51; PMID:17962565 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant  Physiol  2009 ; 150:1697 -712; PMID:19448036 ;  http://dx.doi.org/10.1104/pp.109.139931 67.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Annu Rev Phytopathol 2010 ; 48:419-36;  PMID:19400638 ; http://dx.doi.org/10.1146/ annurev-phyto-080508-08193668.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Science  2007 ; 315:1098 -103; PMID:17185563 ;  http://dx.doi.org/10.1126/science.1136372 70.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
PLoS Pathog  2010 ; 6:e1000970 ;  PMID:20617163 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Front Plant Sci  2013 ; 4:403; PMID:24146667 ;  http://dx.doi.org/10.3389/fpls.2013.00403 72.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant  J 2009 ; 57:1079 -91; PMID:19054367 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
EMBO J  2007 ; 26:4293 -301; PMID:17853890 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Signal Behav  2011 ; 6:42-8; PMID:21258210 ;  http://dx.doi.org/10.4161/psb.6.1.13978 75.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Physiol  2010 ;  153:1425 -34; PMID:20439546 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell  2005 ; 17:1306 - 16; PMID:15772285 ; http://dx.doi.org/10.1105/ tpc.104.029926 77.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Curr Biol  2005 ; 15:1129 -35;  PMID :15964279 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell  2009 ; 21:2503 -16;  PMID:19700630 ; http://dx.doi.org/10.1105/ tpc.108.064519 79. van Doorn  WG.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
J Exp Bot  2011 ; 62:4749 -61; PMID:21778180 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Genes Dev 2009 ;  23:2496 -506; PMID:19833761 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
J Biosci   2013 ; 38:433-49; PMID:23660678 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Proc Natl Acad Sci U S A  1992 ; 89:2480 -4; PMID :1549613 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell   2013 ; 25:4616 -26; PMID:24285797 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell  2009 ; 21:2914 - 27; PMID:19773385 ; http://dx.doi.org/10.1105/ tpc.109.068635 90.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Signal Behav   2013 ; 8:e23182 ; PMID:23299323 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Physiol  2012 ; 158:87-94;  PMID:21951465 ; http://dx.doi.org/10.1104/ pp.111.186163 93.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Front Plant  Sci 2013 ; 4:481; PMID:24319451 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Curr Opin  Plant Biol  2007 ; 10:366-71; PMID:17644023 ;  http://dx.doi.org/10.1016/j.pbi.2007.04.020 95.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Physiol   2009 ; 150:1648 -55; PMID:19420325 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Trends Plant Sci 2004 ; 9:1-4; PMID:14729210 ;  http://dx.doi.org/10.1016/j.tplants.2003.11.002,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant J  2005 ; 43:873-88; PMID:16146526 ;  http://dx.doi.org/10.1111/j.1365-313X.2005.02500.x 99.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant J   2010 ; 64:912-23; PMID:21143673 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell   2013 ; 25:1158 -73; PMID:23532068 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Proc Natl Acad Sci U S A 2013 ; 110:9577 -82;  PMID:23696671 ; http://dx.doi.org/10.1073/ pnas.1222155110 102.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant J  2010 ; 63:229-40; PMID:20409007 ;  http://dx.doi.org/10.1111/j.1365-313X.2010.04232.x 104.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
PLoS Pathog  2013 ; 9:e1003235 ;  PMID:23516366 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Physiol  2011 ;  157:1609 -27; PMID:22021418 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell  2013 ; 25:762- 76; PMID:23435660 ; http://dx.doi.org/10.1105/ tpc.113.109116 108.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant J  2010 ; 64:511-23; PMID:20807211 ;  http://dx.doi.org/10.1111/j.1365-313X.2010.04345.x 111.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Epigenetics  2007 ; 2:106-13; PMID:17965588 ;  http://dx.doi.org/10.4161/epi.2.2.4404 112.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
PLoS Pathog  2010 ; 6:e1001137 ;  PMID:20949080 ; http://dx.doi.org/10.1371/ journal.ppat.1001137 113.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Signal Behav  2009 ; 4:149- 50; PMID:19649196 ; http://dx.doi.org/10.4161/ psb.4.2.7682 114.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Dev Cell  2002 ; 2:807- 17; PMID:12062092 ; http://dx.doi.org/10.1016/ S1534-5807(02)00174-0 115.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Oncogene  2013 ; 32:4683 -93; PMID:23108410 ;  http://dx.doi.org/10.1038/onc.2012.484 116.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Science  2012 ; 336:1448 -51; PMID:22555433 ;  http://dx.doi.org/10.1126/science.1221472 119.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Cell Host Microbe 2008 ; 3:48- 57; PMID:18191794 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Plant Cell  2010 ; 22:918- 36; PMID:20332379 ; http://dx.doi.org/10.1105/ tpc.109.071662 121.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Nature  2007 ; 449:243- 7; PMID:17694048 ; http://dx.doi.org/10.1038/ nature06109 122.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Biochem  Biophys Res Commun 2006 ; 339:459-62;  PMID:16271351 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Nature  2005 ; 434:926- 33; PMID :15829969 ; http://dx.doi.org/10.1038/ nature03465 125.,Non-OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
Proc Natl Acad Sci U S A  2010 ; 107:13544 -9; PMID:20624958 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/8a/viru-5-710.PMC4189877.pdf
"In the case of necrotrophs, plant immune systems are very  *Correspondence to: Guo-Liang Wang; Email: wang.620@osu.edu Submitted: 05/15/2014; Revised: 06/24/2014; Accepted: 07/01/2014; Published Online: 07/17/2014: http://dx.doi.org/10.4161/viru.29798The role of effectors and host immunity   in plant–necrotrophic fungal interactions Xuli w ang1, Nan Jiang1,2, Jinling Liu2, wende Liu1, and Guo-Liang w ang1,3,* 1State Key Laboratory for Biology of Plant Diseases and i nsect Pests; i nstitute of Plant Protection; Chinese Academy of Agricultural Sciences; Beijing, PR China;   2Hunan Provincial Key Laboratory of Crop Germplasm i nnovation and Utilization and College of Agronomy; Hunan Agricultural University; Changsha, Hunan, PR China;  3Department of Plant Pathology; Ohio State University; Columbus, OH USA Keywords:  effectors, necrotrophic fungi, innate immunity, defense response, PRR and epigenetic modification Fungal diseases pose constant threats to the global econ - omy and food safety.",Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol  Plant Pathol 2012; 13:414-30; PMID:22471698 ;  http://dx.doi.org/10.1111/j.1364-3703.2011.00783.x 2.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Annu Rev Phytopathol 2009; 47:233-63;  PMID:19400631 ; http://dx.doi.org/10.1146/ annurev.phyto.112408.132637 3.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Stud Mycol 2013; 75:307- 90; PMID:24014902 ; http://dx.doi.org/10.3114/ sim0017 5.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Australas Plant  Pathol 2009; 38:558-70; http://dx.doi.org/10.1071/ AP09053 6.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Nature 2001;  411:826-33;  PMID:11459065 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Nat Immunol  2005; 6:973-9;  PMID:16177805 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Cell 2006; 124:803- 14; PMID:16497589 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant J  2006; 46:218-30;  PMID:16623885 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant J 2008;  55:188-200;  PMID:18397376 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Genome 2006; 49:1265-73;  PMID:17213908 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Plant Microbe Interact 2007; 20:168-77; PMID:17313168 ; http://dx.doi.org/10.1094/ MPMI-20-2-0168 14.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
FEMS Microbiol Rev  2013; 37:67-93;  PMID:22931103 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Phytopathology 2004; 94:1056-60;   PMID:18943793 ; http://dx.doi.org/10.1094/ PHYTO.2004.94.10.1056 16.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant J 2007; 51:681-92;  PMID:17573802 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Physiol 2008; 146:682-93;  PMID:18065563 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Theor Appl Genet 2009; 120:117- 26; PMID:19816671 ; http://dx.doi.org/10.1007/ s00122-009-1163-6 19.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Plant Pathol  2012; 13:1101-9;  PMID:22830423 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Plant  Microbe Interact 1995; 8:41-8; PMID:7772802 ;  http://dx.doi.org/10.1094/MPMI-8-0041 21.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Genome 2006; 49:1265-73;  PMID:17213908 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Theor Appl Genet 2004; 109:464-71;  PMID:15292990 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Can J Bot 1981;  59:301-10; http://dx.doi.org/10.1139/b81-043 24.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
J Plant Physiol 2001; 158:391-400; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Proc Natl Acad Sci U S A 2000; 97:4961-6;  PMID:10781105 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Agric Biol Chem 1985; 49:807-15; http://dx.doi.org/10.1271/bbb1961.49.80728.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Ann Phytopathological Soc Jpn  1984; http://dx.doi.org/10.3186/jjphytopath.50.600 .,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Tetrahedron  Lett 1986; 27:2753-6; http://dx.doi.org/10.1016/S0040-4039(00)84635-3 31.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Phytopathology 1993; 83:495-502; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
"Proc Jpn Acad, Ser B, Phys Biol Sci 1985;  61:269-72; http://dx.doi.org/10.2183/pjab.61.269 34.",OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Plant Microbe Interact  2012; 25:1419-29;  PMID:22835272 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Mol Biol 1987; 9:121-6; PMID:24276901 ; http://dx.doi.org/10.1007/ BF00015644 37.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Cell  1996; 8:2139-50;  PMID:8953776 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Phytochemistry 2006; 67:1406-13;  PMID:16839576 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Cell 1995; 7:463- 71; PMID:7773018 ; http://dx.doi.org/10.1105/ tpc.7.4.463 41.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Physiol Mol  Plant Pathol 1991; 39:471-82; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Plant  Microbe Interact 1993; 6:745-54; PMID:8118056 ;  http://dx.doi.org/10.1094/MPMI-6-745 44.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Physiol Mol Plant Pathol 1998; 52:53-66;  http://dx.doi.org/10.1006/pmpp.1997.0134 46.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Theor Appl Genet 2007; 114:961-70;  PMID:17356869 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
PLoS One 2013; 8:e53901; PMID:23342034 ; http://dx.doi.org/10.1371/jour - nal.pone.0053901 48.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Plant Microbe Interact 2014; 27:40- 55; PMID:24299212 ; http://dx.doi.org/10.1094/ MPMI-05-13-0145-R 49.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Can J Plant Pathol  2013; 35:46-55; http://dx.doi.org/10.1080/0706066 1.2012.745904 50.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Plant Microbe Interact 2005; 18:849- 55; PMID:16134897 ; http://dx.doi.org/10.1094/ MPMI-18-0849 51.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
J Exp Bot 2009; 60:2613- 20; PMID:19407339 ; http://dx.doi.org/10.1093/ jxb/erp104 52.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Nat Commun 2013; 4:1424; PMID:23361014 ;  http://dx.doi.org/10.1038/ncomms2427 53.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Annu Rev Phytopathol 2002; 40:251-85; PMID:12147761 ; http://dx.doi.org/10.1146/ annurev.phyto.40.011402.114210 54.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Appl Biochem Microbiol  2008; 44:453-65; http://dx.doi.org/10.1134/ S0003683808050013 55.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Physiol Mol Plant Pathol 1995; 46:263-74; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Theor Appl Genet 1985; 71:16-21;  PMID:24247332 ; http://dx.doi.org/10.1007/ BF00278247 64.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Can  J Bot 1954; 32:55-68; http://dx.doi.org/10.1139/b54-008 65.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Science 2012; 338:659-62; PMID:23087001 ;  http://dx.doi.org/10.1126/science.1226743 66.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Nat Commun 2014; 5:3064;  PMID:24451981 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Plant Microbe Interact 2013; 26:903-17; PMID:23634836 ;  http://dx.doi.org/10.1094/MPMI-01-13-0014-R 68.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Phytopathology 1997; 87:154-60;  PMID:18945135 ;  http://dx.doi.org/10.1094/PHYTO.1997.87.2.154 69.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Nat Genet 2006; 38:953-6; PMID:16832356 ;  http://dx.doi.org/10.1038/ng1839 70.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
New Phytol 2013; 199:241- 51; PMID:23550706 ; http://dx.doi.org/10.1111/ nph.1225771.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Cell  2005; 17:3203-12;  PMID:16199615 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Plant 2009; 2:1067-83; PMID:19825681 ;  http://dx.doi.org/10.1093/mp/ssp045 74.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
PLoS One 2012; 7:e40240; PMID:22792250 ;  http://dx.doi.org/10.1371/journal.pone.0040240 75.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
New Phytol 2013; 200:185-200; PMID:23782173 ; http://dx.doi.org/10.1111/ nph.12356 76.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Microbiol 2006; 61:1365-71; PMID:16899081 ;  http://dx.doi.org/10.1111/j.1365-2958.2006.05311.x 78.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Annu Rev Plant Biol 2009; 60:379-406; PMID:19400727 ; http://dx.doi.org/10.1146/ annurev.arplant.57.032905.105346 79.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Proc Natl Acad Sci U S A 2007; 104:19613-8;  PMID:18042724 ; http://dx.doi.org/10.1073/ pnas.0705147104 80.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Cell  2008; 20:471-81;  PMID:18263776 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Physiol 2012; 160:396-406; PMID:22744984 ;  http://dx.doi.org/10.1104/pp.112.201699 82.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Cell  2013; 25:4227-41;  PMID:24104566 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
J Biol Chem 2010; 285:13471-9;  PMID:20200150 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Cell 2010; 22:508- 22; PMID:20179141 ; http://dx.doi.org/10.1105/ tpc.109.068874 86.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Proc Natl Acad Sci U S A 2010; 107:9452-7;  PMID:20439716 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Science 2012; 336:1160-4;  PMID:22654057 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Physiol 2004; 136:2621-32; PMID :15375207 ;  http://dx.doi.org/10.1104/pp.104.046367 91.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Physiol 2014; 165:262- 76; PMID:24639336 ; http://dx.doi.org/10.1104/ pp.113.233759 92.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Physiol 1989; 90:542-8; PMID:16666805 ;  http://dx.doi.org/10.1104/pp.90.2.542 93.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Physiol 2008; 148:1695-706; PMID:18790995 ;  http://dx.doi.org/10.1104/pp.108.127845 95.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Physiol 1986; 80:568- 77; PMID:16664663 ; http://dx.doi.org/10.1104/ pp.80.2.56896.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Physiol 1987; 84:1286-90;  PMID:16665599 ; http://dx.doi.org/10.1104/ pp.84.4.1286 97.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Physiol Plant 1988; 74:740-4; http://dx.doi.org/10.1111/j.1399-3054.1988.tb02046.x 98.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Physiol 2000; 122:1379- 85; PMID:10759534 ; http://dx.doi.org/10.1104/ pp.122.4.1379 99.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Phytochemistry 2006; 67:1068-79;  PMID:16631829 ;  http://dx.doi.org/10.1016/j.phytochem.2006.03.009 100.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Cell  2006; 125:749-60;  PMID:16713565 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Mol Biol 2009; 69:337- 46; PMID:19039666 ; http://dx.doi.org/10.1007/ s11103-008-9430-5 102.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
New Phytol 2013; 198:1165-77; PMID:23496690 ;  http://dx.doi.org/10.1111/nph.12233 105.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Eur J Cell Biol 2010; 89:169-74; PMID:20018402 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
EMBO J 2014; 33:62-75; PMID:24357608 ;  http://dx.doi.org/10.1002/embj.201284303109.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Science  2002; 296:1470-2;  PMID:12029134 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant J 2013; 73:469- 82; PMID:23062058 ; http://dx.doi.org/10.1111/ tpj.12050  112.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant J 2012; 71:194-204;  PMID:22353039 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Annu Rev Phytopathol  2010; 48:225-46;  PMID:20687832 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Plant Microbe Interact 2013; 26:617- 25; PMID:23489060 ; http://dx.doi.org/10.1094/ MPMI-10-12-0255-IA 115.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Science 2013; 342:118- 23; PMID:24092744 ; http://dx.doi.org/10.1126/ science.1239705 116.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Proc Natl Acad Sci U S A 2010; 107:496-501; PMID:20018686 ; http://dx.doi.org/10.1073/ pnas.0909705107 118.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Cell Host Microbe  2010; 7:290-301;  PMID:20413097 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Mol Cell 2014; 54:43-55; PMID:24630626 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Proc Natl Acad Sci U S A 2014; 111:3632-7; PMID:24532660 ; http://dx.doi.org/10.1073/ pnas.1318817111,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Curr Opin Cell Biol 2009; 21:367-76; PMID:19243928 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
PLoS Genet 2011; 7:e1002434;  PMID:22242006 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Cell 2005; 17:1196- 204; PMID :15749761 ; http://dx.doi.org/10.1105/ tpc.104.028514 125.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Cell 2009; 21:1000- 19; PMID:19286969 ; http://dx.doi.org/10.1105/ tpc.108.062364126.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Physiol  2010; 154:1403-14;  PMID:20810545 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Biochim Biophys Acta 2011; 1809:567-76; PMID:21777708 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
PLoS Pathog 2010; 6:e1001137; PMID:20949080 ;  http://dx.doi.org/10.1371/journal.ppat.1001137 132.,Non-OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Cell 2009; 21:2237-52;  PMID:19671879 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant Cell 2012; 24:4220-35; PMID:23064321 ;  http://dx.doi.org/10.1105/tpc.112.103028 134.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
Plant J 2003;  34:395-406;  PMID:12753580 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3b/69/viru-5-722.PMC4189878.pdf
"1,25 HRSV replication  requires the synthesis of a complementary, polycistronics ssRNA (+) antigenome, which is used as a template for the synthesis of *Correspondence to: Alexis M Kalergis; Email: akalergis@bio.puc.cl Submitted: 03/16/2014; Revised: 07/05/2014; Accepted: 07/31/2014; Published Online: 08/05/2014; http://dx.doi.org/10.4161/viru.32225Modulation of host adaptive immunity   by hRSV proteins Janyra A e spinoza1, Karen Bohmwald1, Pablo F Céspedes1, Claudia A Riedel2, Susan M Bueno1,3, and Alexis M Kalergis1,3,4,* 1Millennium i nstitute on i mmunology and i mmunotherapy; Departamento de Genética Molecular y Microbiología; Facultad de Ciencias Biológicas;   Pontificia Universidad Católica de Chile; Santiago, Chile; 2Millennium i nstitute on i mmunology and i mmunotherapy; Departamento de Ciencias Biológicas;   Facultad de Ciencias Biológicas y Facultad de Medicina; Universidad Andrés Bello; Santiago, Chile; 3iNSeRM UMR1064; Nantes, France;   4Departamento i nmunología Clínica y Reumatologia; Facultad de Medicina; Pontificia Universidad Católica de Chile; Santiago, Chile Keywords:  respiratory syncytial virus, virulence proteins, innate immune response, adaptive immune response Globally, the human respiratory syncytial virus (hRSV) is  the major cause of lower respiratory tract infections (LRT is) in  infants and children younger than 2 years old.",Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Int Immunopharmacol 2008; 8:1320- 9; PMID:18687294 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Infect 2002; 45:18-24; PMID:12217726 ; http://dx.doi.org/10.1053/ jinf.2002.1015 4.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Infect Dis 2011;  204:996-1002;  PMID:21881113 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Lancet 2011;  378:1917-30;  PMID:22078723 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Pediatr 1981; 99:100- 3; PMID:7252646 ; http://dx.doi.org/10.1016/ S0022-3476(81)80969-9 13.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Infect Dis 1985; 152:895-902;  PMID:2931491 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Virus Res 2011; 162:80-99; PMID:21963675 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
EMBO  J 2000; 19:2681-9; PMID:10835365 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Proc Natl Acad Sci U S A 1999; 96:11259-64;  PMID:10500164 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2005; 79:13943- 52; PMID:16254330 ; http://dx.doi.org/10.1128/ JVI.79.22.13943-13952.2005 20.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Innate Immun  2012; 18:856-65;  PMID:22535679 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2000; 74:10508-13;  PMID:11044095 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Nat Med 2011; 17:1132-5; PMID:21841784 ;  http://dx.doi.org/10.1038/nm.2444 25.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Curr Mol Med 2013; 13:1122-39; PMID :23157678 ;  http://dx.doi.org/10.2174/1566524011313070007 26.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Proc Am Thorac Soc 2005; 2:166-73; PMID:16113487 ; http://dx.doi.org/10.1513/ pats.200501-011AW 28.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Proc Natl Acad Sci U S A  2013; 110:11133-8;  PMID:23776214 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Infect 2014;  68(Suppl 1):S115-8;  PMID:24171820 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2012; 86:4432-43; PMID:22318136 ;  http://dx.doi.org/10.1128/JVI.06744-11,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Adv  Virol 2011; 2011;  PMID :21931576 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2000; 74:6442- 7; PMID:10864656 ; http://dx.doi.org/10.1128/ JVI.74.14.6442-6447.2000 33.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2009; 83:12424-31; PMID:19759128 ; http://dx.doi.org/10.1128/ JVI.00806-09 34.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Biol Chem  2007; 282:15315-8 ;  PMID:17395582 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
PLoS One 2012; 7:e43031;  PMID:22912779 ; http://dx.doi.org/10.1371/jour - nal.pone.0043031 37.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Virology  2011; 413:103-10;  PMID:21377708 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol  2013; 87:6314-25;  PMID:23536668 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
PLoS One 2012; 7:e30030; PMID:22272270 ;  http://dx.doi.org/10.1371/journal.pone.0030030 40.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Expert Rev Clin Immunol 2014;  10:963-71;  PMID:24784476 ; http://dx.doi.org/10.1 586/1744666X.2014.913482 41.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Immunol Rev 2013; 253:112-28;  PMID:23550642 ; http://dx.doi.org/10.1111/ imr.12060 42.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Gen Virol  2012; 93:2346-56;  PMID:22894925 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
PLoS One 2011; 6:e27113;  PMID:22216085 ; http://dx.doi.org/10.1371/jour - nal.pone.0027113 44.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Immune Netw 2013; 13:163-7; PMID:24198740 ;  http://dx.doi.org/10.4110/in.2013.13.5.163 45.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
BMB Rep  2014; 47:184-91;  PMID:24568879 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Virus Res 2012; 167:138- 45; PMID:22698878 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2009; 83:1492- 500; PMID:19019963 ; http://dx.doi.org/10.1128/ JVI.00671-08 48.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Nat Immunol 2000;  1:398-401;  PMID:11062499 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Immunol 2006; 176:1733-40;  PMID:16424203 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Immunol 2010; 185:2231-9; PMID:20624950 ; http://dx.doi.org/10.4049/ jimmunol.1000733 51.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Nat Immunol 2005; 6:981-8;  PMID:16127453 ; http://dx.doi.org/10.1038/ni1243 52.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Eur Respir J 2004; 23:327-33; PMID:14979512 ; http://dx.doi.org/10.1183/090319 36.03.00098803 54.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Immunol 2001; 167:5868-73; PMID:11698462 ;  http://dx.doi.org/10.4049/jimmunol.167.10.5868 55.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Annu Rev Physiol  2001; 63:521-54;  PMID:11181966 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Am J Respir Cell Mol Biol 2000; 23:586-92;  PMID:11062136 ; http://dx.doi.org/10.1165/ ajrcmb.23.5.3771 58.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Eur J Immunol 1999; 29:3478- 84; PMID:10556802 ; http://dx.doi.org/10.1002/ (SICI)1521-4141(199911)29:11<3478::AID-IMMU3478>3.0.CO;2-W 59.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Immunol  2002; 168:5989-92;  PMID:12055204 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Biol Chem 2000;  275:22442-51;  PMID:10801802 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Biol Chem 2002; 277:6830-7;  PMID:11724772 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
"J Allergy Clin Immunol 2012; 130:1175-86, e9;  PMID:23036746 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Immunol Cell Biol 2011; 89:231-8;  PMID:20603637 ; http://dx.doi.org/10.1038/ icb.2010.85 65.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Microbes Infect 2013; 15:230-42; PMID:23246463 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Exp Med 1974;  139:380-97;  PMID:4589990 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Immunity 2005; 22:561- 70; PMID :15894274 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Immunol 2007;  179:1648-58;  PMID:17641031 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Leukoc Biol 2006; 79:16-35; PMID:16204622 ;  http://dx.doi.org/10.1189/jlb.0705397 70.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
PLoS One 2013; 8:e74338;  PMID:24058549 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2009; 83:3734-42; PMID:19193793 ; http://dx.doi.org/10.1128/ JVI.02434-08 72.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol  2005; 79:5353-62;  PMID :15827150 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2008; 82:8780-96; PMID:18562519 ; http://dx.doi.org/10.1128/ JVI.00630-08 74.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2007; 81:1786-95; PMID:17151097 ;  http://dx.doi.org/10.1128/JVI.01420-06 76.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2007; 81:3428-36; PMID:17251292 ;  http://dx.doi.org/10.1128/JVI.02303-06 77.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Infect Dis  2006; 193:573-81;  PMID:16425137 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2012; 86:7777-89;  PMID:22593156 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Virology 2007; 369:309- 23; PMID:17825340 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Immunol 2007; 179:2741-7; PMID:17709487 ;  http://dx.doi.org/10.4049/jimmunol.179.5.2741 81.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Immunol 2006; 176:5529- 37; PMID:16622022 ; http://dx.doi.org/10.4049/ jimmunol.176.9.5529 82.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Gen Virol 2004; 85:1153-65; PMID :15105532 ;  http://dx.doi.org/10.1099/vir.0.19769-0 85.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2007; 81:8361-6;  PMID:17494063 ; http://dx.doi.org/10.1128/ JVI.02717-0686.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Protein Sci 2008; 17:813- 20; PMID:18369195 ; http://dx.doi.org/10.1110/ ps.073366208 87.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Thorax  2013; 68:66-75;  PMID :23229815 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Biol Chem 2012; 287:24671-89;  PMID:22621926 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Virology  1998; 243:293-302;  PMID:9568029 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol  2013; 87:13466-79;  PMID:24089561; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Infect Dis 2004; 190:1936-40;  PMID :15529257 ; http://dx.doi.org/10.1086/425516 94.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Immunol  2006; 176:1600-8;  PMID:16424189 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
The G glycoprotein of respiratory  syncytial virus depresses respiratory rates through the CX3C motif and substance P. J Virol 2003; 77:6580- 4; PMID:12743318 ; http://dx.doi.org/10.1128/ JVI.77.11.6580-6584.2003 97.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Gen Virol 2009; 90:1119- 23; PMID:19264600 ; http://dx.doi.org/10.1099/ vir.0.009308-098.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Viral  Immunol 2009; 22:243-51; PMID:19594395 ;  http://dx.doi.org/10.1089/vim.2009.0016 102.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Immunol 2004; 172:503-8;  PMID:14688360 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Viruses 2013; 5:873-85; PMID:23518574 ;  http://dx.doi.org/10.3390/v5030873 104.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Vaccine 2007; 25:7271-9; PMID:17825960 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Clin Microbiol Rev 2005; 18:541- 55; PMID:16020689 ; http://dx.doi.org/10.1128/ CMR.18.3.541-555.2005 107.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2001; 75:10730-7; PMID:11602714 ; http://dx.doi.org/10.1128/ JVI.75.22.10730-10737.2001 109.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2014; 88:3135- 43; PMID:24371055 ; http://dx.doi.org/10.1128/ JVI.02139-13 110.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Immunology 2003;  108:474-80;  PMID:12667209 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Biochem Biophys Res Commun  2009; 381:528-32;  PMID:19233131 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2013; 87:3314-23; PMID:23302879 ;  http://dx.doi.org/10.1128/JVI.03019-12 113.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Biochem Biophys Res Commun 2001; 280:188-95; PMID:11162498 ;  http://dx.doi.org/10.1006/bbrc.2000.4093114.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Viruses 2010; 2:27-32;  PMID:21994598 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Science 2009;  326:1279-83;  PMID:19965480 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
Proc Natl Acad Sci U S A 2009; 106:4441-6; PMID:19251668 ; http://dx.doi.org/10.1073/ pnas.0805740106 119.,OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
J Virol 2012; 86:8375- 87; PMID:22623798 ; http://dx.doi.org/10.1128/ JVI.00058-12 120.,Non-OADS,/arxiv_data1/oa_pdf/f0/5e/viru-5-740.PMC4189880.pdf
"Further, the predominance of ribu - lose-1,5-bisphosphate carboxylase/oxygenase (rubisco), which catalyzes the first major step of carbon fixation and is gener - ally considered the most abundant protein on earth, makes it difficult to concentrate plant protein extracts, and necessitates *Correspondence to: David S. Guttman; Email: david.guttman@utoronto.ca;  Darrell Desveaux; Email: darrell.desveaux@utoronto.caSubmitted: 04/16/2014; Revised: 08/08/2014; Accepted: 09/02/2014;  Published Online: 09/23/2014; http://dx.doi.org/10.4161/viru.36329Proteomics of effector-triggered immunity (ETI)   in plants Brenden Hurley1, Rajagopal Subramaniam2, David S Guttman1,3,†,*, and Darrell Desveaux1,3,†,* 1Department of Cell & Systems Biology; University of Toronto; Toronto, ON Canada; 2ea stern Cereal and Oilseed Research Centre; Agriculture and Agri-Food Canada; Ottawa,  ON Canada; 3Centre for the Analysis of Genome ev olution & Function; University of Toronto; Toronto, ON Canada; †These authors contributed equally.",Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Curr Biol 1998; 8:R226-7; PMID:9545207 ;  http://dx.doi.org/10.1016/S0960-9822(98)70145-9 2.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Nature 2001; 411:826-33;  PMID:11459065 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Curr Opin Plant Biol 2010; 13:394-401; PMID:20570209 ;  http://dx.doi.org/10.1016/j.pbi.2010.04.010 4.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Mass Spectrom Rev 2013; 32:335-65; PMID:23315723 ;  http://dx.doi.org/10.1002/mas.21365 5.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Nat Rev Mol Cell Biol 2004; 5:699-711; PMID:15340378 ; http://dx.doi.org/10.1038/ nrm1468 6.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Annu Rev Biomed Eng 2009; 11:49-79; PMID:19400705 ; http://dx.doi.org/10.1146/ annurev-bioeng-061008-124934 7.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Phytochemistry 2010; 71:351-62; PMID:20005547 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Mol Cell Proteomics 2007; 6:1198-214; PMID:17317660 ; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Mol Cell Proteomics 2003; 2:1234-43; PMID:14506206 ;  http://dx.doi.org/10.1074/mcp.T300006-MCP20010.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant J 2007; 51:931-40; PMID:17651370 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Science 2009; 324:744-6; PMID:19423813 ; http://dx.doi.org/10.1126/ science.1171666 15.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Science 2002; 295:1722-6; PMID:11872842 ; http://dx.doi.org/10.1126/ science.295.5560.1722 16.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Phytochemistry 2004; 65:1805-16; PMID :15276439 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant Physiol 2006; 142:1603-20; PMID :17028151 ; http://dx.doi.org/10.1104/ pp.106.086231 19.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Mol Cell Proteomics 2009; 8:145-56; PMID:18716313 ;  http://dx.doi.org/10.1074/mcp.M800043-MCP200 20.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Proteomics 2013; 13:1934-46;  PMID:23533086 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant J 1998; 14:247-57; PMID:9628020 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
PLoS Genet 2010; 6:e1000894;  PMID:20368970 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Proc Natl Acad Sci U S A 2008; 105:6475-80;  PMID:18424557 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Science 1995; 269:843-6; PMID:7638602 ; http://dx.doi.org/10.1126/ science.7638602 27.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Mol Plant Microbe Interact 2009; 22:857-67; PMID:19522568 ;  http://dx.doi.org/10.1094/MPMI-22-7-0857 30.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant J 2003; 34:205-16; PMID:12694595 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
New Phytol 2010; 188:161-74;  PMID:20704660 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
J Exp Bot 2014; 65:1297-312; PMID:24420567 ; http://dx.doi.org/10.1093/jxb/ ert441 33.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant Cell 2013; 25:4616-26;  PMID:24285797 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
PLoS One 2013; 8:e73091;  PMID:24023671 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant Cell 1994; 6:511-20;  PMID:7911348 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Cell 2002; 109:589-98;  PMID:12062102 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
J Biol Chem 2011; 286:14129-36;  PMID:21378171 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
New Phytol 2014; 202:259-69; PMID:24372399 ;  http://dx.doi.org/10.1111/nph.12651 40.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
PLoS Pathog 2012; 8:e1002768;  PMID:22719257 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant J 2014; 77:297-309; PMID:24279912 ;  http://dx.doi.org/10.1111/tpj.12391 42.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant J 2002; 32:299-315; PMID:12410809 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant J 2006; 46:14-33; PMID:16553893 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Proteomics 2009; 9:138-47;  PMID:19053141 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant J 2010; 61:249-58;  PMID:19843314 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Cell 2002; 108:743-54; PMID:11955429 ; http://dx.doi.org/10.1016/ S0092-8674(02)00661-X 47.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Cell 2003; 112:379-89; PMID :12581527 ;  http://dx.doi.org/10.1016/S0092-8674(03)00040-0 48.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Cell 2003; 112:369-77;  PMID :12581526 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Mol Cell Proteomics 2012; 11:014555; PMID:22215637 ; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Cell Host Microbe 2011; 9:137-46; PMID:21320696 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Proc Natl Acad Sci U S A 2006; 103:10104-9;  PMID:16785433 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Proc Natl Acad Sci U S A 2010; 107:9452-7;  PMID:20439716 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Genes Dev 2009; 23:2496-506;  PMID:19833761 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Biochem J 2011; 436:15-34; PMID :21524275 ; http://dx.doi.org/10.1042/ BJ20110078 56.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant Cell 2012; 24:2200-12;  PMID:22589465 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Proc Natl Acad Sci U S A 2009; 106:20532-7; PMID:19918071 ; http://dx.doi.org/10.1073/ pnas.0903859106 59.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant Physiol 2010; 154:444-8;  PMID:20921160 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Proteomics 2006; 6:4155-65; PMID:16850419 ;  http://dx.doi.org/10.1002/pmic.200500172 61.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant Cell 2007; 19:4120-30; PMID:18165327 ; http://dx.doi.org/10.1105/ tpc.107.055061 62.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
J Biol Chem 2007; 282:1352-8; PMID:17110382 ;  http://dx.doi.org/10.1074/jbc.M608931200 63.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Proc Natl Acad Sci U S A 2005; 102:8054-9;  PMID:15911759 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Science 2008; 321:952-6;  PMID:18635760 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Proteomics 2008; 8:1459-69; PMID:18297659 ; http://dx.doi.org/10.1002/ pmic.200700536 66.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Electrophoresis 2009; 30:2460-8;  PMID :19598157 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
FEBS J 2008; 275:2862-72;  PMID:18445036 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Proteomics 2009; 9:4368-80;  PMID:19655309 ;  http://dx.doi.org/10.1002/pmic.200800985 69.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Front Plant Sci 2013; 4:450; PMID:24282406 ;  http://dx.doi.org/10.3389/fpls.2013.00450 70.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Proteomics 2012; 12:1576-90; PMID:22611051 ; http://dx.doi.org/10.1002/ pmic.201100523 71.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Mol Microbiol 2004; 54:353-65;  PMID:15469508 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Cell Microbiol 2012; 14:669-81;  PMID:22233353 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant J 2009; 57:932-44;  PMID:19000159 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Mol Cell Proteomics 2010; 9:1650-65; PMID:20445003 ; http://dx.doi.org/10.1074/mcp.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant Cell 2009; 21:3170-84; PMID:19855047 ; http://dx.doi.org/10.1105/ tpc.109.069179 76.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
PLoS Biol 2009; 7:e1000139;  PMID:19564897 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
J Biol Chem 2011; 286:31297-307; PMID:21757708 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant Cell 2013; 25:1143-57; PMID:23532072 ;  http://dx.doi.org/10.1105/tpc.112.107904 79.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Mol Plant Pathol 2011; 12:702-8;  PMID:21726371 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant J 2010; 61:507-18;  PMID:19919571 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
PLoS Pathog 2013; 9:e1003123;  PMID:23382672 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Mol Plant Microbe Interact 2002; 15:281-91; PMID:11952131 ; http://dx.doi.org/10.1094/ MPMI.2002.15.3.28183.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Cell Host Microbe 2011; 9:125-36; PMID:21320695 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Plant Cell 2003; 15:2636-46; PMID:14576290 ; http://dx.doi.org/10.1105/ tpc.015842 85.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Genes Dev 2007; 21:1484-93;  PMID:17575050 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
PLoS Pathog 2009; 5:e1000526;  PMID:19629177 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
Nat Methods 2013; 10:730-6; PMID:23921808 ;  http://dx.doi.org/10.1038/nmeth.2557,OADS,/arxiv_data1/oa_pdf/82/16/viru-5-752.PMC4189881.pdf
"(In a third, most limiting sense, prions are only infectious pathogenic agents, and only PrP prions  Classifying prion and prion-like phenomena Djamel Harbi and Paul M Harrison* Department of Biology; McGill University; Montreal, QC Canada Keywords:  bioinformatics, database,  classification, prion-like, prionoid,  quasi-prion Submitted: 08/09/2013 Revised: 01/15/2014Accepted: 01/22/2014Published Online: 02/18/2014http://dx.doi.org/10.4161/pri.27960*Correspondence to: Paul M Harrison; Email: paul.",Non-OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Science 1982; 216:136- 44; PMID:6801762 ; http://dx.doi.org/10.1126/ science.6801762 2.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Proc Natl Acad Sci U S A  1998 ; 95:13363 -83; PMID:9811807 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
J Mol Biol  2007 ;  368:273-82; PMID:17320905 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Proc Natl Acad Sci U S A 2012 ; 109:11025 - 30; PMID:22711819 ; http://dx.doi.org/10.1073/ pnas.1206555109 8.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Science  2000 ; 289:595-9; PMID:10915616 ;  http://dx.doi.org/10.1126/science.289.5479.595 9.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Science  2004 ; 305:673-6;  PMID :15286374 ; http://dx.doi.org/10.1126/ science.110019510.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
J Virol  2012 ; 86:1874 -6; PMID:22090130 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Cold Spring Harb Symp Quant Biol 2004 ; 69:489- 96; PMID:16117685 ; http://dx.doi.org/10.1101/ sqb.2004.69.489 12.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Biophys J  2012 ; 102:2339 -44; PMID:22677387 ;  http://dx.doi.org/10.1016/j.bpj.2012.04.011 13.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Cell  2001 ; 106:171-82; PMID:11511345 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Cell 2010 ; 140:421-35;  PMID:20144764 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Cell  2003 ; 115:879-91; PMID:14697205 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Cell 2001 ; 106:183- 94; PMID:11511346 ; http://dx.doi.org/10.1016/ S0092-8674(01)00440-819.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Neuron   2009 ; 64:783-90; PMID:20064386 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Neurodegener Dis   2010 ; 7:28-31; PMID:20160454 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Nat Cell Biol  2009 ; 11:909-13; PMID:19503072 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
J Biol Chem 2011 ; 286:15317 - 31; PMID:21372138 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Cell 2011 ; 146:448-61; PMID:21782231 ;  http://dx.doi.org/10.1016/j.cell.2011.06.041 25.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Nucleic Acids Res 2004 ; 32:D258 -61;  PMID:14681407 ; http://dx.doi.org/10.1093/nar/ gkh036 26.,OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
Biochemistry  2011 ; 50:10567 - 9; PMID:22092386 ; http://dx.doi.org/10.1021/ bi201578h  II to the Quasi-Prion category ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/5b/9a/prio-8-161.PMC4189883.pdf
"12 For the purpose of detecting  *Correspondence to: Vladka Čurin Šerbec; Email address: vladka.curin@ztm.si Submitted: 12/19/2013; Revised: 02/07/2014; Accepted: 02/27/2014; Published Online: 02/28/2014http://dx.doi.org/10.4161/pri.28388Regional distribution of anchorless prion   protein, PrP226*, in the human brain Anja Lukan1,†, Maja Černilec1,†, tanja Vranac1, Mara Popović2, and Vladka Čurin Šerbec1,* 1Department for the Production of Diagnostic r eagents and r esearch; Blood t ransfusion Centre of Slovenia; Ljubljana, Slovenia;   2institute for Pathology; Medical Faculty; u niversity of Ljubljana; Ljubljana; Slovenia †these authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
Cell 1985;  40:735-46;  PMID:2859120 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
Proc Natl Acad Sci U S A 1993; 90:10962- 6; PMID:7902575 ; http://dx.doi.org/10.1073/ pnas.90.23.10962 3.,OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
Br Med Bull 2003; 66:213-39; PMID:14522861 ; http://dx.doi.org/10.1093/ bmb/66.1.2135.,Non-OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
J Biol Chem 2008; 283:30557-65;  PMID:18753138 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
J Biol Chem 2003; 278:40429-36;  PMID:12917418 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
J Biol Chem  2004; 279:3694-8;  PMID:14593100 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
Mol Immunol 2011; 48:746-50; PMID:21176851 ;  http://dx.doi.org/10.1016/j.molimm.2010.11.012 10.,Non-OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
BMC Neurol 2013; 13:126; PMID:24063733 ;  http://dx.doi.org/10.1186/1471-2377-13-126 11.,Non-OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
Neurology 1990; 40:110- 7; PMID:1967489 ; http://dx.doi.org/10.1212/ WNL.40.1.110,Non-OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
Eur J Neurosci 2007; 25:2649-55; PMID:17466020 ;  http://dx.doi.org/10.1111/j.1460-9568.2007.05518.x 15.,Non-OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
Microsc Res Tech  2000; 50:58-65;  PMID:10871549 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
PLoS Med 2006; 3:e14;  PMID:16354106 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
Proc Natl Acad Sci U S A 1992; 89:7620-4;  PMID:1354357 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
PLoS Pathog 2010; 6:e1000800;  PMID:20221436 ;  http://dx.doi.org/10.1371/journal.ppat.1000800 21.,Non-OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
Acta Neuropathol  2010; 119:189-97;  PMID:19911184 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
Immunol Lett 2007; 113:29-39;  PMID:17884181 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/aa/45/prio-8-203.PMC4189891.pdf
"An infectious prion with a 17 kDa PK-resistant core was generated de novo during this attempt, which was named as rPrP-res 17kDa.11 Both rPrP-resOSU and rPrP-res17kDa have the charac - teristic self-perpetuating C-terminal PK-resistant conformation  *Correspondence to: Jiyan Ma; Email: Jiyan.Ma@vai.org Submitted: 11/29/2013; Revised: 03/18/2014; Accepted: 03/26/2014; Published Online: 04/10/2014http://dx.doi.org/10.4161/pri.28669Comparison of 2 synthetically generated  recombinant prions Yi Zhang1,2, Fei Wang2,†, Xinhe Wang2,†, Zhihong Zhang1, Yuanyuan Xu1, Guohua Yu1, chonggang Yuan1, and Jiyan Ma1,2,†,* 1Key Laboratory of Brain Functional Genomics; Ministry of e ducation; s hanghai Key Laboratory of Brain Functional Genomics; s chool of Life s ciences;   east c hina Normal University; s hanghai, PR c hina; 2Department of Molecular and c ellular Biochemistry; Ohio s tate University; c olumbus, O h UsA †current affiliation: c enter for Neurodegenerative s cience; Van Andel Research Institute; Grand Rapids, MI U sA Keywords:  prion, sPMCA, recombinant PrP, recombinant prion, bioassay, histopathology, GuHCl denaturation assay Abbreviations:  TSEs, transmissible spongiform encephalopathies; PrP, prion protein; PrPSc, the pathogenic conformational isoform  of prion protein; PrPC, the normal host prion protein; PK, proteinase K; sPMCA, serial protein misfolding cyclic amplification;  rPrP, bacterially-expressed recombinant prion protein;POPG, 1-palmitoyl-2-oleoylphosphatidylglycerol; rPrP-res, proteinase K  resistant recombinant PrP conformer; dpi, days post inoculation; FC, frontal cortex;CN, caudate nucleus;CWM, cerebellum white  matter; PET blot, paraffin-embedded tissue blot; IHC, immunohistochemical; GuHCl, guanidine hydrochloride; TBST, tris- buffered saline buffer with 0.1% Tween-20; BSA, bovine serum albumin; PBS, phosphate buffered saline Prion is a protein-conformation-based infectious agent causing fatal neurodegenerative diseases in humans and  animals.",Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Proc Natl Acad Sci U S A  1998; 95:13363-83;  PMID:9811807 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Annu Rev Pathol  2008; 3:11-40;  PMID:18233951 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Science 1982; 216:136-44;  PMID:6801762 ; http://dx.doi.org/10.1126/ science.6801762 4.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Trends Cell Biol 1997; 7:56-62; PMID:17708907 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Proc Natl Acad Sci U S A 2000; 97:10168- 72; PMID:10963679 ; http://dx.doi.org/10.1073/ pnas.97.18.10168 6.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Nature 2001; 411:810-3;  PMID:11459061 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Cell 2005; 121:195- 206; PMID :15851027 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
J Virol  2012; 86:1874-6;  PMID:22090130 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
FASEB J 2013; 27:4768-75; PMID:23970796 ; http://dx.doi.org/10.1096/ fj.13-233965 12.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
J Biol Chem 2010; 285:14083-7;  PMID:20304915 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Proc Natl Acad Sci U S A 2007; 104:9741- 6; PMID:17535913 ; http://dx.doi.org/10.1073/ pnas.0702662104 16.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
PLoS Pathog 2009; 5:e1000535; PMID:19649330 ; http://dx.doi.org/10.1371/jour - nal.ppat.1000535 17.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
PLoS Pathog 2011; 7:e1001277;  PMID:21347353 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
J Virol 2011; 85:2582-8; PMID:21228241 ;  http://dx.doi.org/10.1128/JVI.02098-10 19.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
PLoS Pathog 2009; 5:e1000421;  PMID :19436715 ;  http://dx.doi.org/10.1371/journal.ppat.1000421 20.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
PLoS One  2008; 3:e3872;  PMID:19060956 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Acta Crystallogr D Biol  Crystallogr 2012; 68:1501-12;  PMID:23090399 ;  http://dx.doi.org/10.1107/S0907444912037328 22.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
J Biol Chem 2005; 280:11247-58;  PMID :15618225 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
PLoS Pathog 2012; 8:e1002589; PMID:22511864 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Acta Biochim Biophys Sin (Shanghai) 2013; 45:485-93;  PMID:23583976 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Biochemistry 2007; 46:7045-53; PMID:17503780 ; http://dx.doi.org/10.1021/ bi700299h26.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Biochemistry 2010; 49:8169-76;  PMID:20718504 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Biochemistry 2003; 42:3295- 304; PMID:12641461 ; http://dx.doi.org/10.1021/ bi026872q 29.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
J Biol Chem 1999; 274:36859-65; PMID:10601237 ;  http://dx.doi.org/10.1074/jbc.274.52.36859 30.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
J Mol Biol 2003; 332:47-57;  PMID:12946346 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
J Biol Chem 2008;  283:19616-25;  PMID:18456654 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Science 2010; 327:869-72; PMID:20044542 ;  http://dx.doi.org/10.1126/science.1183218 33.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
PLoS One 2013; 8:e71081;  http://dx.doi.org/10.1371/journal.pone.0071081 ;  PMID:23936256 34.,Non-OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Science 2007;  318:930-6;  PMID:17991853 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Am J Pathol 2000; 156:51- 6; PMID:10623653 ; http://dx.doi.org/10.1016/ S0002-9440(10)64705-0 36.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Biochim Biophys Acta 2009; 1792:555- 63; PMID:19281844 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
Methods 2011; 53:208-13;  PMID:21176786 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/05/prio-8-215.PMC4189893.pdf
"Submit your next manuscript and get advantages of OMICS Group submissions Unique features •User friendly/feasible website-translation of your paper to 50 world’s leading languages •Audio Version of published paper •Digital articles to share and explore Special features •300 Open Access Journals •25,000 editorial team •21 days rapid review process •Quality and quick editorial, review and publication processing •Indexing at PubMed (partial), Scopus, EBSCO, Index Copernicus and Google Scholar etc •Sharing Option: Social Networking Enabled •Authors, Reviewers and Editors rewarded with online Scientific Credits •Better discount for your subsequent articles Submit your manuscript at: http://www.editorialmanager.com/omicsgroup/Braverman et al.",Non-OADS,/arxiv_data1/oa_pdf/be/01/nihms-565020.PMC4190039.pdf
e-mail: kah3@cornell.edu ©2014 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/f0/a1/jes-25-057.PMC4190064.pdf
e-mail: Fumio_Sato@jra.go.jp ©2014 Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/c0/1a/jes-25-061.PMC4190065.pdf
"Cell Host & Microbe Article Epithelial IL-22RA1-Mediated Fucosylation Promotes Intestinal Colonization Resistanceto an Opportunistic Pathogen Tu Anh N. Pham,1Simon Clare,1David Goulding,1Julia M. Arasteh,1Mark D. Stares,1Hilary P. Browne,1 Jacqueline A. Keane,1Andrew J. Page,1Natsuhiko Kumasaka,1Leanne Kane,1Lynda Mottram,1Katherine Harcourt,1 Christine Hale,1Mark J. Arends,2Daniel J. Gaffney,1The Sanger Mouse Genetics Project,1Gordon Dougan,1 and Trevor D. Lawley1,* 1Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, CB10 1SA, UK 2Department of Pathology, University of Cambridge, Addenbrooke’s Hospital, Cambridge, CB2 0QQ, UK *Correspondence: tl2@sanger.ac.uk http://dx.doi.org/10.1016/j.chom.2014.08.017 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/7b/e6/main.PMC4190086.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition Leukemia (2014) 28,2112–2115; doi:10.1038/leu.2014.193 We propose that measurements of naturally occurring calcium (Ca) isotopes can serve as an accurate near-real-time detector ofbone metabolism for patients with multiple myeloma (MM), aneoplasm characterized by clonal proliferation of plasma cells and their production of a monoclonal immunoglobulin.",Non-OADS,/arxiv_data1/oa_pdf/1c/0c/leu2014192a.PMC4190403.pdf
Available at: http://www.esmo.org/conferences/past - conferences/european -cancer -congress -2013/news/ecc -2013 - press -release -longest -follow -up-of-largest -number -of-melanoma - patients -treated -with-ipilimumab -shows -some -survive -up-to-ten- years.,Non-OADS,/arxiv_data1/oa_pdf/b9/70/cjc-33-09-413.PMC4190430.pdf
Available at: http://jco.ascopubs.org/content/31/28/3501.full.pdf+html.,Non-OADS,/arxiv_data1/oa_pdf/b9/70/cjc-33-09-413.PMC4190430.pdf
"Source:  http://www.clinicaltrials.gov; Accessed on July 26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/28/90/cjc-33-09-445.PMC4190434.pdf
"Summary of major ongoing clinical trials evaluating the role of PD -1/PD-L1 blockade in various tumor types  (continued ) Source: http://www.clinicaltrials.gov; Accessed on July 26, 2014.Cancer type Trial identifier Study title Melanoma NCT01656642 A Phase 1b Study of MPDL3280A (an Engineered Anti -PDL1 Antibody) in Combination with  Vemurafinib (Zelboraf®) in Patients with Previously Untreated BRAFV600-Mutation Positive  Metastatic Melanoma NCT02027961 Phase 1 Safety and Tolerability of MEDI4736 in Combination with Dabrafenib and Trametinib or  with Trametinib Alone NCT01721746 A Study to Compare BMS -936558 to the Physician's Choice of Either Dacarbazine or Carboplatin  and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti -CTLA -4  Therapy (CheckMate 037) NCT01721772 Study of BMS -936558 vs. Dacarbazine in Untreated, Unresectable or Metastatic Melanoma  (CheckMate066) Merkel cell carcinoma NCT02155647 MSB0010718C in Subjects with Merkel Cell Carcinoma Pancreatic cancer NCT01313416 Gemcitabine and CT -011 for Resected Pancreatic Cancer Prostate cancer NCT01420965 Sipuleucel -T, CT -011, and Cyclophosphamide for Advanced Prostate Cancer Renal cell carcinoma NCT01358721 Phase I Biomarker Study (BMS -936558) NCT01441765 PD-1 Alone or with Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine NCT01668784 Study of Nivolumab (BMS -936558) Vs. Everolimus in Pre -treated Advanced or Metastatic Clear - cell Renal Cell Carcinoma (CheckMate025) Solid tumors NCT01629758 Safety Study of IL -21/Anti -PD-1 Combination in the Treatment of Solid Tumors NCT01714739 A Phase I Study of an Anti -KIR Antibody in Combination with an Anti -PD1 Antibody in Patients  with Advanced Solid Tumors NCT01968109 Safety Study of Anti -LAG-3 with and without Anti -PD-1 in the Treatment of Solid Tumors NCT02179918 A Study of 4 -1BB Agonist PF -05082566 Plus PD -1 Inhibitor MK -3475 in Patients with Solid  Tumors (B1641003/KEYNOTE-0036) NCT02013804 A Phase 1 Study to Evaluate AMP -514 NCT01295827 Study of Pembrolizumab (MK -3475) in Participants with Progressive Locally Advanced or  Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE -001) NCT00836888 ONO -4538 Phase I Study in Patients with Advanced Malignant Solid Tumors in Japan NCT01352884 Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP -224 in Patients with  Advanced Cancer NCT01375842 A Phase 1 Study of MPDL3280A (an Engineered Anti -PDL1 Antibody) in Patients with Locally  Advanced or Metastatic Solid Tumors NCT01633970 A Phase 1b Study of MPDL3280A (an Engineered Anti-PDL1 Antibody) in Combination with Avastin (Bevacizumab) and/or with Chemotherapy in Patients with Locally Advanced or Metastatic Solid Tumors NCT01772004 MSB0010718C in Solid Tumors NCT01943461 MSB0010718C in Metastatic or Locally Advanced Solid Tumors NCT01938612 A Phase I, Open -label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics  of MEDI4736 in Japanese Patients with Advanced Solid Tumors NCT01848834 Study of Pembrolizumab (MK -3475) in Participants with Advanced Solid Tumors (MK -3475 -012/ KEYNOTE -012) NCT00729664 Multiple Ascending Dose (MDX1105 -01) (Anti -PDL1) Urothelial bladder cancer NCT02108652 A Study of MPDL3280A in Patients with Locally Advanced or Metastatic Urothelial Bladder Cancer",Non-OADS,/arxiv_data1/oa_pdf/28/90/cjc-33-09-445.PMC4190434.pdf
Available at: http://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/9080?sid=55766fbf-0d39-4eda-8665-85ff1fac2f85.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available  at: http://meeting.ascopubs.org/cgi/content/abstract/32/15_ suppl/9066?sid=d88fee02-9cc2-48d6-b947-1a12933b8ea1.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available at: http://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/e20034?sid=a4a9adcb-36ee-43db-8df6-66972e5e1156.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available at: http://meeting.ascopubs.org/cgi/content/ abstract/32/18_suppl/LBA9008?sid=e65ba47c-6221-43c7-ae65-f680998d22bd.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available at: http://meeting.ascopubs.org/cgi/content/ abstract/32/15_suppl/9002?sid=5fe47f07-074b-4963-b8c8- 2bdfb7c44af7.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Avalialbe at: http://meeting.ascopubs.org/cgi/content/abstract/32/15_ suppl/3009?sid=79ccfaca-ae72-4c86-a796-a9d47d32505a.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available at: http://meeting.ascopubs.org/cgi/content/abstract/32/18_suppl/LBA9000?sid=53482d36-be89- 408e-a182-31dc8af59124.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available at: http://meeting.ascopubs.org/cgi/content/abstract/32/15_ suppl/3000?sid=a0af207c-9694-4432-96ee-405a3816376e.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available at: http://meeting.ascopubs.org/cgi/content/abstract/32/18_suppl/LBA9003?sid=96f27b34-e1a8-4ea7-8851-21476aa16fcf.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Aviable at:  http://www.reuters.com/article/2013/09/05/,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available at: http://meeting.ascopubs.org/cgi/content/abstract/32/15_ suppl/9008a?sid=8e6e0101-4d63-4680-a3f3-b910f424c05c.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Aviable at: http://www.reuters.com/article/2014/04/04/amgen -melanoma -idCNL4N0MW3AL20140404.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available  at: http://meeting.ascopubs.org/cgi/content/abstract/32/15_ suppl/9029?sid=6eb4029c-0ebb-49ef-b2bd-a1d959f2d484.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available at: http://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/TPS9107?sid=c346407f-74a5-4150-9274- ebf40a25dd45.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available  at: http://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/e20002?sid=bec1137b-9959-407b-a9ec-b0e4ca0951e5.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available at: http://meeting.ascopubs.org/cgi/content/ abstract/32/15_suppl/9025?sid=784dd2db-982d-4632-9123-67e81b7a2e55.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available  at: http://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/9067?sid=07e3681f-40a6-4e23-94c7-cf78f2135b96.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available at: http://meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/9071?sid=c3ac38d9-0279- 4d16-98f8-66fc1f410135.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
Available at: http://meeting.ascopubs.org/ cgi/content/abstract/32/15_suppl/9098?sid=386f4af7-be4d-4279-930c-ec01070b1e78.,Non-OADS,/arxiv_data1/oa_pdf/4c/80/cjc-33-09-458.PMC4190435.pdf
The geographical patterns of the species richness of each FC were analysed with the use of QGIS (http://www.qgis.org/en/site/).,OADS,/arxiv_data1/oa_pdf/e8/20/srep06557.PMC4190504.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e8/20/srep06557.PMC4190504.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6557 | DOI: 10.1038/srep06557 8",Non-OADS,/arxiv_data1/oa_pdf/e8/20/srep06557.PMC4190504.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/37/0d/srep06565.PMC4190505.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6565 | DOI: 10.1038/srep06565 10",Non-OADS,/arxiv_data1/oa_pdf/37/0d/srep06565.PMC4190505.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e5/89/srep06550.PMC4190506.pdf
Maps were created using Mapinfo software; data are from the National Fundamental Geographic Information System (NFGIS) website (http://ngcc.sbsm.gov.,OADS,/arxiv_data1/oa_pdf/ed/d8/srep06564.PMC4190507.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6564 | DOI: 10.1038/srep06564 6",Non-OADS,/arxiv_data1/oa_pdf/ed/d8/srep06564.PMC4190507.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6568 | DOI: 10.1038/srep06568 8",Non-OADS,/arxiv_data1/oa_pdf/69/75/srep06568.PMC4190508.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/96/d0/srep06562.PMC4190509.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6562 | DOI: 10.1038/srep06562 8",Non-OADS,/arxiv_data1/oa_pdf/96/d0/srep06562.PMC4190509.pdf
QTL analyses were performed using the QTLCartographer 2.5 software (http://statgen.ncsu.edu/qtlcart/WQTLCart.htm) 30.,OADS,/arxiv_data1/oa_pdf/1a/f5/srep06567.PMC4190510.pdf
wrote the paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1a/f5/srep06567.PMC4190510.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6567 | DOI: 10.1038/srep06567 9",Non-OADS,/arxiv_data1/oa_pdf/1a/f5/srep06567.PMC4190510.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 1542 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/e0/dyu094.PMC4190515.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 1438 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/f5/dyu190.PMC4190523.pdf
"•More information about the PATHS Data Resource, including how external investigators can apply for access, can be found at [http://www.umanitoba.ca/faculties/medicine/units/community_health_sciences/departmental_units/mchp/ protocol/media/PATHS_Resource_Website.pdf].International Journal of Epidemiology , 2014, Vol.",Non-OADS,/arxiv_data1/oa_pdf/03/f5/dyu190.PMC4190523.pdf
Provisional guidance for quantitative risk assessment of polycyclic aromatic hydrocarbons http://cfpub.epa.,Non-OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
"Agents classified by the IARC monographs, volumes 1–109 http://monographs.iarc.fr/ENG/Classification/index.",Non-OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
Theme 2: source apportionment and source/receptor analysis http://www.htap.org/ (accessed 6 April 2014).,OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
ESRI Inc. ArcGIS for Desktop http://www.esri.com (accessed 6 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
All Office products http://office.microsoft.com (accessed 6 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
Ambient air quality standards (GB 3095–2012) http://www.zhb.gov.cn/ (accessed 6 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
"Technical support document for cancer potency factors: methodologies for derivation, listing of available values, and adjustments to allow for early life stage exposures http://oehha.ca.gov/air/hot_ spots/2009/TSDCancerPotency.pdf (accessed 6 April 2014).",Non-OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
"Federal contaminated site risk assessment in Canada, part I: guidance on human health preliminary quantitative risk assessment (PQRA), Version 2.0 http://www.healthcanada.gc.ca/ (accessed 6 April 2014).",Non-OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
"Carcinogen Assessment of Coke Oven Emissions, Final Report http://cfpub.epa.gov/ncea/cfm/recordisplay.",OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
LandScan Global Population 2007 Database http://www.ornl.gov/sci/landscan/ (accessed 6 April 2014).,OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
(1999) Choice of a marker compound for polycyclic aromatic hydrocarbon http://webarchive.nationalarchives.gov.uk/ 20060715141954/http://www.defra.gov.uk/environment/airquality/aqs/poly/6.htm (accessed 6 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
United States Cancer Statistics (USCS) http://www.cdc.gov/cancer/npcr/uscs/download_data.htm (accessed 6 April 2014).,OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6561 | DOI: 10.1038/srep06561 8",Non-OADS,/arxiv_data1/oa_pdf/74/fb/srep06561.PMC4190535.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6551 | DOI: 10.1038/srep06551 5",Non-OADS,/arxiv_data1/oa_pdf/05/34/srep06551.PMC4190537.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6555 | DOI: 10.1038/srep06555 9",Non-OADS,/arxiv_data1/oa_pdf/d5/93/srep06555.PMC4190569.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/18/51/srep06559.PMC4190570.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6559 | DOI: 10.1038/srep06559 6",Non-OADS,/arxiv_data1/oa_pdf/18/51/srep06559.PMC4190570.pdf
"The lab strains equipped with many genetic markers for phenotype selections are convenient, how- ever, such strains often have mutated gene copies and allelic varia- tions (http://www.yeastgenome.org/) that may not necessarily reflect response or performance of an industrial yeast10.",Non-OADS,/arxiv_data1/oa_pdf/38/76/srep06556.PMC4190571.pdf
"Through protein sequence alignment analysis, we found 98.6% and 98.3% of these ORFs showing high degrees of homology to entries in non-redundant protein (NR, http://www.ncbi.nlm.nih.gov/) database and Kyoto Encyclopedia of Genes and Genomes (KEGG, http://www.kegg.jp/) database, respectively.",OADS,/arxiv_data1/oa_pdf/38/76/srep06556.PMC4190571.pdf
"Based on the genome sequences (SGD, http://www.yeastgenome.org/) of eight yeaststrains from a variety of sources and application scopes, includinglaboratory, bakery, wine, industrial bioethanol, sake and natural isolates, as well as that of Y-12632, 942 single-copy orthologous gene-sets were identified and a phylogenetic tree was generatedaccordingly (Fig.",OADS,/arxiv_data1/oa_pdf/38/76/srep06556.PMC4190571.pdf
"Orthology and sequence identity of each predicted protein was evaluated by searching against Saccharomyces GenomeDatabase (SGD; http://www.yeastgenome.org/), NCBI-NR (http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/38/76/srep06556.PMC4190571.pdf
"nih.gov/) and KEGG database (http://www.kegg.jp/) using BlastP (E-value ,1e-5) and the best-hit was used for the final annotation.",OADS,/arxiv_data1/oa_pdf/38/76/srep06556.PMC4190571.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/38/76/srep06556.PMC4190571.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6556 | DOI: 10.1038/srep06556 9",Non-OADS,/arxiv_data1/oa_pdf/38/76/srep06556.PMC4190571.pdf
Editor: Tobias Baumgart./C2112014 The Authors 0006-3495/14/10/1591/10 $2.00 http://dx.doi.org/10.1016/j.bpj.2014.07.072 Biophysical Journal Volume 107 October 2014 1591–1600 1591,Non-OADS,/arxiv_data1/oa_pdf/53/c5/main.PMC4190607.pdf
Editor: Tobias Baumgart./C2112014 The Authors 0006-3495/14/10/1582/9 $2.00 http://dx.doi.org/10.1016/j.bpj.2014.07.067 1582 Biophysical Journal Volume 107 October 2014 1582–1590,Non-OADS,/arxiv_data1/oa_pdf/f8/41/main.PMC4190651.pdf
The MIDUS website provides details regarding the data set and data collection procedures (http://midmac.med.harvard.edu/research.html).,OADS,/arxiv_data1/oa_pdf/c0/1e/10.1177_2050312113520152.PMC4190673.pdf
"Midlife in the U.S. (MIDUS), http://midmac.med.harvard.edu/ research.html  49.",Non-OADS,/arxiv_data1/oa_pdf/c0/1e/10.1177_2050312113520152.PMC4190673.pdf
"Univariate fMRI Data Analysis The software package XBAM was used for univariate analysis (http://www.brainmap.co.uk) [Brammer et al.,1997].",OADS,/arxiv_data1/oa_pdf/7d/12/HBM-35-3083.PMC4190683.pdf
The GPC classiﬁer wastrained with leave-one-out cross-validation using the PRO-BID software package (http://www.brainmap.co.uk/PRO-BID).,Non-OADS,/arxiv_data1/oa_pdf/7d/12/HBM-35-3083.PMC4190683.pdf
DOI: http://dx.doi.org/10.1017/S0033291713000676.,Non-OADS,/arxiv_data1/oa_pdf/7d/12/HBM-35-3083.PMC4190683.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.001   [http://www.crter.org/nrr-2012-qkquanwen.html]  Wang WT, Zhou MW, Zhu GY, Li T, Liu N.  Selective control by posterior spinal nerve r oots of micturition and erection in rats.",Non-OADS,/arxiv_data1/oa_pdf/fe/7d/NRR-7-2749.PMC4190855.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.002   [http://www.crter.org/nrr-2012-qkquanwen.html]  Xu WL, Xilinbaoleri, Liu H, Wang RZ, Bai JP.",OADS,/arxiv_data1/oa_pdf/55/60/NRR-7-2755.PMC4190856.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.003   [http://www.crter.org/nrr-2012-qkquanwen.html]  Li LX, Jin DL, Gao JS, Wang LG, Liu XJ, W ang JZ, Xu ZX.",Non-OADS,/arxiv_data1/oa_pdf/5e/7d/NRR-7-2761.PMC4190857.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.004   [http://www.crter.org/nrr-2012-qkquanwen.html]  Liu SM, Liu W, Ma YL, Liu KG, Wang MZ.",OADS,/arxiv_data1/oa_pdf/d0/48/NRR-7-2770.PMC4190858.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.005   [http://www.crter.org/nrr-2012-qkquanwen.html]  Liu TT, Bi HS, Wang XR, Wang GM, Li HY, Wu H, Qu Y, Wen Y, Cong CY, Wang DG.",Non-OADS,/arxiv_data1/oa_pdf/7a/2c/NRR-7-2778.PMC4190859.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.006   [http://www.crter.org/nrr-2012-qkquanwen.html]  Zhou XH, Wang CY, Feng SQ, Chang J, Kong XH, Liu Y, Gao SJ.",OADS,/arxiv_data1/oa_pdf/41/e9/NRR-7-2784.PMC4190860.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.007   [http://www.crter.org/nrr-2012-qkquanwen.html]  Wang AM, Hou N, Bao DY, Liu SY, Xu T. Mechanism of alpha-lipoi c acid in attenuating kanamycin-induced ototoxicity.",OADS,/arxiv_data1/oa_pdf/61/95/NRR-7-2793.PMC4190861.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.008   [http://www.crter.org/nrr-2012-qkquanwen.html]  Jielile J, Aibai M, Sabirhazi G, Shawutali N, Tangkejie W, Badelhan A, Nuerduola Y, Satewalede T, Buranbai D, Hunapia B, Jialih asi A, Ba i JP, Kizaibek M. Active Achilles tendon kinesitherapy accelerate s Ac hilles tendon repair by promoting neurite regeneration.",Non-OADS,/arxiv_data1/oa_pdf/ee/88/NRR-7-2801.PMC4190862.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.009   [http://www.crter.org/nrr-2012-qkquanwen.html]  Yang XH, Xia H, Chen Y, Liu XF, Zhou C, Gao Q, Li ZH.",Non-OADS,/arxiv_data1/oa_pdf/06/cd/NRR-7-2811.PMC4190863.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.010   [http://www.crter.org/nrr-2012-qkquanwen.html]  Zhang X, Yin F, Guo L, Zha DX, Gong G, Gao L, Zhu QS.",Non-OADS,/arxiv_data1/oa_pdf/20/a8/NRR-7-2818.PMC4190864.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.011   [http://www.crter.org/nrr-2012-qkquanwen.html]  Nan JN, Hu XG, Li HX, Zhang XN, Piao RJ.",Non-OADS,/arxiv_data1/oa_pdf/82/85/NRR-7-2826.PMC4190865.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.012   [http://www.crter.org/nrr-2012-qkquanwen.html]  Liu Q, Chen DM, Wang YG, Zhao X, Zheng Y. Cardiac autonom ic nerve distribution and arrhythmia.",OADS,/arxiv_data1/oa_pdf/bd/ff/NRR-7-2834.PMC4190866.pdf
http://ip-science.thomsonreuters.com/mjl  [27] China National Knowledge Infrastructure.,Non-OADS,/arxiv_data1/oa_pdf/bd/ff/NRR-7-2834.PMC4190866.pdf
"http://www.cnki.net  [28] Armour JA, Murphy DA, Yuan BX, et al.",OADS,/arxiv_data1/oa_pdf/bd/ff/NRR-7-2834.PMC4190866.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 35, December 2012    doi:10.3969/j.issn.1673-5374.2012.35.013   [http://www.crter.org/nrr-2012-qkquanwen.html]  Zhang B, Li LR, Chen LX, Huang J.",Non-OADS,/arxiv_data1/oa_pdf/31/c4/NRR-7-2842.PMC4190867.pdf
"The data were analysed in R 2.15.2 (R Foundation for StatisticalComputing, 2012, http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/55/59/UPS-118-240.PMC4190885.pdf
Available from http://www.who.int/immunization_ delivery/systems_policy/HPV_ vaccination_in_Europe.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/02/UPS-118-263.PMC4190886.pdf
Available from http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/8868/ 2008-132-2_20081322.pdf.accessed 14 August 2012.,Non-OADS,/arxiv_data1/oa_pdf/6b/02/UPS-118-263.PMC4190886.pdf
Available fromhttp://www.eurosurveillance.org/ViewArticle.aspx?ArticleId = 19873.,Non-OADS,/arxiv_data1/oa_pdf/6b/02/UPS-118-263.PMC4190886.pdf
Available from http://www.skl.se/vi_arbetar _med/halsaochvard/lakemedel/ vacciner/samtyckesblankett.accessed 28 March 2013.,OADS,/arxiv_data1/oa_pdf/6b/02/UPS-118-263.PMC4190886.pdf
Available from http://www.lakemedels-verket.se/Alla-nyheter/NYHETER-2012/Lakemedelsverket-samordnar-forskning-kring-vaccinsakerhet-och-narkolepsi-/.,OADS,/arxiv_data1/oa_pdf/6b/02/UPS-118-263.PMC4190886.pdf
Available from http://www.smittskyddsinstitutet.se/nyhetsarkiv/2013/stor-andel- ﬂickor-vaccinerade-sig-mot- hpv/.cited 8 February 2013.,OADS,/arxiv_data1/oa_pdf/6b/02/UPS-118-263.PMC4190886.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.001   [http://www.crter.org/nrr-2012-qkquanwen.html]  Yan C, Zhu JQ, Jia XX, Wang C, Wang SX, Kang LY.",Non-OADS,/arxiv_data1/oa_pdf/4f/1d/NRR-7-2853.PMC4190942.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.002   [http://www.crter.org/nrr-2012-qkquanwen.html]  Li X, Li M, Li Y, Quan QK, Wang J.",OADS,/arxiv_data1/oa_pdf/8d/09/NRR-7-2860.PMC4190943.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.003   [http://www.crter.org/nrr-2012-qkquanwen.html]  Xi FF, Sang F, Zhou CX, Ling Y.",Non-OADS,/arxiv_data1/oa_pdf/34/6f/NRR-7-2867.PMC4190944.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.004   [http://www.crter.org/nrr-2012-qkquanwen.html]  Peng Y, Jiang B, Wu HL, Dai RC, Tan LM.",Non-OADS,/arxiv_data1/oa_pdf/6d/92/NRR-7-2874.PMC4190945.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.005   [http://www.crter.org/nrr-2012-qkquanwen.html]  Zhang L, Gan WD, An GY.",Non-OADS,/arxiv_data1/oa_pdf/fa/2c/NRR-7-2882.PMC4190946.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.006   [http://www.crter.org/nrr-2012-qkquanwen.html]  Jiang YY, Xu HT, Liu JX, Li P, Wu YZ.",Non-OADS,/arxiv_data1/oa_pdf/e5/a6/NRR-7-2889.PMC4190947.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.007   [http://www.crter.org/nrr-2012-qkquanwen.html]  Peng YJ, Wang HS, Sun JH, Chen L, Xu MJ, Chu JH.",OADS,/arxiv_data1/oa_pdf/a5/72/NRR-7-2901.PMC4190948.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.008   [http://www.crter.org/nrr-2012-qkquanwen.html]  Feng SJ, Zhuang MH, Wu R. Secretion of nerve growth factor , brain-derived neurotrophic factor, and glial cell-line derived neur otrophi c  factor in co-cultur e  of four cell types in cerebrospinal fluid-c ontaining medium.",OADS,/arxiv_data1/oa_pdf/16/68/NRR-7-2907.PMC4190949.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.009   [http://www.crter.org/nrr-2012-qkquanwen.html]  Jiao L, Jiang M, Fang JH, Deng YS, Chen ZJ, Wu M. Basic fibroblast growth factor gene transfection in repair of internal caroti d arter y  aneurysm   wall.",OADS,/arxiv_data1/oa_pdf/c7/e2/NRR-7-2915.PMC4190950.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.010   [http://www.crter.org/nrr-2012-qkquanwen.html]  Xie R, Xu W, Bao WM, Liu H, Chen LP, Shen YW, Zhu JH.",Non-OADS,/arxiv_data1/oa_pdf/14/d1/NRR-7-2922.PMC4190951.pdf
"After the amino acid compositions of all proteins had been confirmed, a protein database was downloaded from the European Bioinformatics Institute website (ftp://ftp.ebi.ac.uk/goa) to compare with the results obtained in this study.",OADS,/arxiv_data1/oa_pdf/14/d1/NRR-7-2922.PMC4190951.pdf
"Bioinformatics and proteins database search   After LTQ-Orbitrap MS, the sequences of the amino acids from peptides fragments were used to identify the parent protein by searching NCBI databases for human (RefSEQ version, Dec 2006, downloaded from ftp://ftp.ncbi.nih.gov/ refseq/release/) using BioWorks 3.2 software (Thermo Fisher Corporation) and the TurboSequest search engine v2.7 with the following crit eria: two possible missed  cleavage sites, peptide mass tolerance of 10 ppm,  fragment mass tolerance of 1 Da shift, +57 Da shift for carboxyamidomethylated cysteine considered as a fixed modification and +16 Da shift for oxidized methione as variable modifications.",OADS,/arxiv_data1/oa_pdf/14/d1/NRR-7-2922.PMC4190951.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.011   [http://www.crter.org/nrr-2012-qkquanwen.html]  Özdel O, Kalaycı  D, Sözeri-Varma G, K ıroğlu Y, Tümkaya S, Toker-Uğurlu T. Neurochemical metabolites in the medial prefrontal cortex in  bipolar disorder: a proton magnetic  resonance spectroscopy study.",Non-OADS,/arxiv_data1/oa_pdf/c8/f1/NRR-7-2929.PMC4190952.pdf
"Ethical  Principles for Medical Research Involving Human Subjects, DoH/Oct 2008.  http://www.wma.net/en/20activi ties/10ethics/10helsinki/  [45] Hamilton M. A rating sca le for depression.",Non-OADS,/arxiv_data1/oa_pdf/c8/f1/NRR-7-2929.PMC4190952.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.012   [http://www.crter.org/nrr-2012-qkquanwen.html]  Bai X, Wang XM, Wang HW, Zhao SG, Han XD, Hao LJ, Wang XC.",OADS,/arxiv_data1/oa_pdf/71/e5/NRR-7-2937.PMC4190953.pdf
"NEURAL REGENERATION RESEARCH   Volume 7, Issue 36, December 2012    doi:10.3969/j.issn.1673-5374.2012.36.013   [http://www.crter.org/nrr-2012-qkquanwen.html]  Chen JJ, Yao M, Zhao YH, Jin XY, Li YB, Huang LH.",OADS,/arxiv_data1/oa_pdf/fd/cf/NRR-7-2944.PMC4190954.pdf
"Future therapy of portal hypertension in liver cirrhosis –a guess Tilman Sauerbruch* and Jonel Trebicka Address: Department of Internal Medicine I, University of Bonn, Sigmund-Freud-Strasse 25, 53125 Bonn, Germany * Corresponding author: Tilman Sauerbruch (tilman.sauerbruch@ukb.uni-bonn.de) F1000Prime Reports 2014, 6:95 (doi:10.12703/P6-95) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/95 Abstract In patients with chronic liver disease, portal hypertension is driven by progressive fibrosis and intrahepatic vasoconstriction.",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Of the patients Page 2 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Interestingly, macrophage activation within the liver persists after reduction of intrahepatic resistance by usingtransjugular intrahepatic porto-systemic shunt (TIPS) Page 3 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Blockade of the AT1 receptor leads to a rebound increase of renin [100] and angiotensin II, which is not only thesubstrate for cleavage to angiotensin I via angiotensin- converting enzyme (ACE) but also the precursor for Page 4 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"In regard to primary prophylaxis of complications due to portal hypertension, more information is required on Page 5 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Portal hypertension together with liver inflammation induces angiogenesis [155,156], which supports Page 6 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Large studies of Page 7 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Page 8 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S: Long-term follow-up of patients with Page 9 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Li T, Eheim AL, Klein S, Uschner FE, Smith AC, Smith AC, Brandon- Warner E, Ghosh S, Bonkovsky HL, Trebicka J, Schrum LW: Novel role of nuclear receptor Rev-erbalpha in hepatic stellate cell Page 10 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Page 11 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Brensing KA, Textor J, Perz J, Schiedermaier P, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T: Long term outcome after transjugular intrahepatic Page 12 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S: CB1 Page 13 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Page 14 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:95 http://f1000.com/prime/reports/m/6/95",Non-OADS,/arxiv_data1/oa_pdf/c1/65/medrep-06-95.tif.PMC4191223.pdf
"Advances in treating acute myeloid leukemia Margaret M. Showel and Mark Levis* Address: J Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, 401 N. Broadway, Baltimore, MD 21231, USA * Corresponding author: Mark Levis (levisma@jhmi.edu) F1000Prime Reports 2014, 6:96 (doi:10.12703/P6-96) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/23/medrep-06-96.PMC4191225.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/96 Abstract Acute myeloid leukemia (AML) arises within the bone marrow from a malignant hematopoietic progenitor cell.,Non-OADS,/arxiv_data1/oa_pdf/61/23/medrep-06-96.PMC4191225.pdf
"If a remission is achieved after induction therapy, the decision Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:96 http://f1000.com/prime/reports/m/6/96",Non-OADS,/arxiv_data1/oa_pdf/61/23/medrep-06-96.PMC4191225.pdf
"Acute myeloid leukemia with favorable-risk karyotype These cases are composed of acute promyelocytic leuke- mia (APL) and the so-called core-binding factor (CBF) Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:96 http://f1000.com/prime/reports/m/6/96",Non-OADS,/arxiv_data1/oa_pdf/61/23/medrep-06-96.PMC4191225.pdf
"+8 Overexpression of MYC Inhibition of apoptosis; permissive cell growth and proliferation t(11q23) Mixed lineage leukemia gene Histone methyltransferase; promiscuous transcription of the partner geneAssociated with t-MN due to previous topoisomerase inhibitor agents +13 FLT3 Increased expression via gene-dosage effectAssociated with AML1 ( RUNX1 ) mutations t(9;22) BCR-ABL Constitutively activated tyrosine kinase affecting proliferation, apoptosis, and differentiationAlso associated with kinase-independent activity Complex 3 or more chromosomal abnormalities Monosomal Karyotype 2 or more monosomies or 1 paired with a structural abnormalityOften associated with mutated p53 TSG AML, acute myeloid leukemia; t-MN, therapy related myeloid neoplasms; TSG, tumor suppressor gene Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:96 http://f1000.com/prime/reports/m/6/96",Non-OADS,/arxiv_data1/oa_pdf/61/23/medrep-06-96.PMC4191225.pdf
"Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:96 http://f1000.com/prime/reports/m/6/96",Non-OADS,/arxiv_data1/oa_pdf/61/23/medrep-06-96.PMC4191225.pdf
"Cortes J, Moore JO, Maziarz RT, Wetzler M, Craig M, Matous J, Luger S, Dey BR, Schiller GJ, Pham D, Abboud CN, Krishnamurthy M, Brown A Jr, Laadem A, Seiter K: Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:96 http://f1000.com/prime/reports/m/6/96",Non-OADS,/arxiv_data1/oa_pdf/61/23/medrep-06-96.PMC4191225.pdf
"Greif PA, Dufour A, Konstandin NP, Ksienzyk B, Zellmeier E, Tizazu B, Sturm J, Benthaus T, Herold T, Yaghmaie M, Dörge P, Hopfner KP, Hauser A, Graf A, Krebs S, Blum H, Kakadia PM, Schneider S, Hoster E, Schneider F, Stanulla M, Braess J, Sauerland MC,Berdel WE, Büchner T, Woermann BJ, Hiddemann W, Spiekermann K, Bohlander SK: GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:96 http://f1000.com/prime/reports/m/6/96",Non-OADS,/arxiv_data1/oa_pdf/61/23/medrep-06-96.PMC4191225.pdf
"Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:96 http://f1000.com/prime/reports/m/6/96",Non-OADS,/arxiv_data1/oa_pdf/61/23/medrep-06-96.PMC4191225.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:96 http://f1000.com/prime/reports/m/6/96",Non-OADS,/arxiv_data1/oa_pdf/61/23/medrep-06-96.PMC4191225.pdf
"Regulating dynamin dynamics during endocytosis Anna C. Sundborger and Jenny E. Hinshaw* Address: Laboratory of Cell and Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD, 20892, USA * Corresponding author: Jenny E. Hinshaw (jennyh@helix.nih.gov) F1000Prime Reports 2014, 6:85 (doi:10.12703/P6-85) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/e2/biolrep-06-85.PMC4191240.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/6/85 Abstract Dynamin is a large GTPase that mediates plasma membrane fission during clathrin-mediated endocytosis.,Non-OADS,/arxiv_data1/oa_pdf/04/e2/biolrep-06-85.PMC4191240.pdf
"Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:85 http://f1000.com/prime/reports/b/6/85",Non-OADS,/arxiv_data1/oa_pdf/04/e2/biolrep-06-85.PMC4191240.pdf
"In yeast, variation inthe local concentration of PIP 2along the length of the CCP necks has been implicated in facilitating the actualfission reaction [43], but yeast lacks dynamin and, as of yet, local variation in the concentration of PIP 2has not Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:85 http://f1000.com/prime/reports/b/6/85",Non-OADS,/arxiv_data1/oa_pdf/04/e2/biolrep-06-85.PMC4191240.pdf
"Secondly, the GTP-driven constriction of dynamin scaffolds generates Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:85 http://f1000.com/prime/reports/b/6/85",Non-OADS,/arxiv_data1/oa_pdf/04/e2/biolrep-06-85.PMC4191240.pdf
"Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:85 http://f1000.com/prime/reports/b/6/85",Non-OADS,/arxiv_data1/oa_pdf/04/e2/biolrep-06-85.PMC4191240.pdf
"Koh T, Korolchuk VI, Wairkar YP, Jiao W, Evergren E, Pan H, Zhou Y, Venken, Koen J T, Shupliakov O, Robinson IM, O ’Kane CJ, Bellen HJ: Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:85 http://f1000.com/prime/reports/b/6/85",Non-OADS,/arxiv_data1/oa_pdf/04/e2/biolrep-06-85.PMC4191240.pdf
"Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:85 http://f1000.com/prime/reports/b/6/85",Non-OADS,/arxiv_data1/oa_pdf/04/e2/biolrep-06-85.PMC4191240.pdf
"Liu Y, Neumann S, Ramachandran R, Ferguson SM, Pucadyil TJ, Schmid SL: Differential curvature sensing and generating Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:85 http://f1000.com/prime/reports/b/6/85",Non-OADS,/arxiv_data1/oa_pdf/04/e2/biolrep-06-85.PMC4191240.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:85 http://f1000.com/prime/reports/b/6/85",Non-OADS,/arxiv_data1/oa_pdf/04/e2/biolrep-06-85.PMC4191240.pdf
"Transcatheter aortic valve implantation Ahmed Oliemy and Nawwar Al-Attar* Address: Department of Cardiac Surgery, Golden Jubilee National Hospital, Agamemnon Street, Clydebank, G81 4DY, Glasgow, UK * Corresponding author: Nawwar Al-Attar (nawwar.alattar@gjnh.scot.nhs.uk) F1000Prime Reports 2014, 6:92 (doi:10.12703/P6-92) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/medrep-06-92.PMC4191242.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/92 Abstract Transcatheter aortic valve implantation was developed to offer a therapeutic solution to patients with severe symptomatic aortic stenosis who are not candidates for conventional aortic valve replacement.,Non-OADS,/arxiv_data1/oa_pdf/4d/88/medrep-06-92.PMC4191242.pdf
"New designs are available that are intended to avoid some of the complications reported with the previous Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:92 http://f1000.com/prime/reports/m/6/92",Non-OADS,/arxiv_data1/oa_pdf/4d/88/medrep-06-92.PMC4191242.pdf
"Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:92 http://f1000.com/prime/reports/m/6/92",Non-OADS,/arxiv_data1/oa_pdf/4d/88/medrep-06-92.PMC4191242.pdf
"Page 4of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:92 http://f1000.com/prime/reports/m/6/92",Non-OADS,/arxiv_data1/oa_pdf/4d/88/medrep-06-92.PMC4191242.pdf
"Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:92 http://f1000.com/prime/reports/m/6/92",Non-OADS,/arxiv_data1/oa_pdf/4d/88/medrep-06-92.PMC4191242.pdf
"Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:92 http://f1000.com/prime/reports/m/6/92",Non-OADS,/arxiv_data1/oa_pdf/4d/88/medrep-06-92.PMC4191242.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:92 http://f1000.com/prime/reports/m/6/92",Non-OADS,/arxiv_data1/oa_pdf/4d/88/medrep-06-92.PMC4191242.pdf
"Aurélien Roux Address: Biochemistry Department, University ofGeneva , CH-1211 Geneva, Switzerland andSwiss National Centre forCompetence in Research Programme Chemical Biology, CH-1211 Geneva, Switzerland Email: aurelien.roux@unige.ch F1000Prime Reports 2014, 6:86(doi:10.12703/P6-86) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/86 Abstract Among theproteins involved inlipid membrane remodeling inintracellular traffic, dynamin hasbeen thefocus ofmany studies, asitwas thefirst protein shown tobemechanistically involved in membrane fission: thereaction bywhich avesicle neck canbesevered torelease afreevesicle.",OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
"The kinetics were predicted Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:86 http://f1000.com/prime/reports/b/6/86",OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
"The model usedto calculate the radius by conductance relies on themeasurement of tube length (very precise in this case, asmeasured by a micromanipulator with a few nm precision) and the assumption that the tube is perfectly cylindrical Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:86 http://f1000.com/prime/reports/b/6/86",Non-OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
"Elastic stress inthe Page 4of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:86 http://f1000.com/prime/reports/b/6/86",Non-OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
"Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:86 http://f1000.com/prime/reports/b/6/86",Non-OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
"Wenow have a better understanding of how it constricts,and what the sequence of events leading to fission couldbe, if fission is mediated by constriction (see Figure 1 andthe youtube video: https://www.youtube.com/watch?v=q-Er5sEaj2U [Accessed 19 September 2014]).",Non-OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
See the animated version at: https://www.youtube.com/watch?v=q-Er5sEaj2U (Accessed 19 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
"Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:86 http://f1000.com/prime/reports/b/6/86",Non-OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
"Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:86 http://f1000.com/prime/reports/b/6/86",Non-OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
"Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:86 http://f1000.com/prime/reports/b/6/86",Non-OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:86 http://f1000.com/prime/reports/b/6/86",Non-OADS,/arxiv_data1/oa_pdf/75/6b/biolrep-06-86.PMC4191246.pdf
"Mechanical circulatory support in acute cardiogenic shock Mubashar H Khan, Brian J Corbett and Steven M Hollenberg* Address: Cooper University Hospital, One Cooper Plaza, Camden, NJ 08103, USA * Corresponding author: Steven M Hollenberg (hollenberg-steven@cooperhealth.edu) F1000Prime Reports 2014, 6:91 (doi:10.12703/P6-91) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/91 Abstract Cardiogenic shock complicates about 5% to 8% of all admissions for acute myocardial infarction, and despite advancement in treatment over the past 50 years, mortality remains unacceptably high.",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"Comparable results were found in an analysis of 23,000 patients in the Page 2 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:91 http://f1000.com/prime/reports/m/6/91",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"Page 3 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:91 http://f1000.com/prime/reports/m/6/91",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"Page 4 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:91 http://f1000.com/prime/reports/m/6/91",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"Page 5 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:91 http://f1000.com/prime/reports/m/6/91",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"Page 6 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:91 http://f1000.com/prime/reports/m/6/91",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"Page 7 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:91 http://f1000.com/prime/reports/m/6/91",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"Page 8 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:91 http://f1000.com/prime/reports/m/6/91",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
[http://www.nytimes.com/2008/11/19/us/19kantrowiztz.,Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Page 9 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:91 http://f1000.com/prime/reports/m/6/91",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"Page 10 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:91 http://f1000.com/prime/reports/m/6/91",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"[http://www.acoi.org/2013Convention/ Sandeep2.pdf] Page 11 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:91 http://f1000.com/prime/reports/m/6/91",Non-OADS,/arxiv_data1/oa_pdf/10/02/medrep-06-91.PMC4191250.pdf
"Rethinking cardiac metabolism: metabolic cycles torefuel and rebuild thefailing heart Heinrich Taegtmeyer* andGenna Lubrano Address: TheUniversity ofTexas Medical School atHouston, Department ofInternal Medicine, Division ofCardiology, 6431 Fannin, MSB 1.246, Houston, TX77030, USA *Corresponding author: Heinrich Taegtmeyer (Heinrich.Taegtmeyer@uth.tmc.edu) F1000Prime Reports 2014, 6:90(doi:10.12703/P6-90) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/d9/medrep-06-90.PMC4191265.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/90 Abstract The heart isaself-renewing biological pump that converts chemical energy into mechanical energy.,Non-OADS,/arxiv_data1/oa_pdf/ab/d9/medrep-06-90.PMC4191265.pdf
"Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:90 http://f1000.com/prime/reports/m/6/90",Non-OADS,/arxiv_data1/oa_pdf/ab/d9/medrep-06-90.PMC4191265.pdf
"Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:90 http://f1000.com/prime/reports/m/6/90",Non-OADS,/arxiv_data1/oa_pdf/ab/d9/medrep-06-90.PMC4191265.pdf
"Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:90 http://f1000.com/prime/reports/m/6/90",Non-OADS,/arxiv_data1/oa_pdf/ab/d9/medrep-06-90.PMC4191265.pdf
"AMPK Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:90 http://f1000.com/prime/reports/m/6/90",Non-OADS,/arxiv_data1/oa_pdf/ab/d9/medrep-06-90.PMC4191265.pdf
"Inthebiology oftheheart, it seems that interest inallforms ofmetabolism begins to Page 6of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:90 http://f1000.com/prime/reports/m/6/90",Non-OADS,/arxiv_data1/oa_pdf/ab/d9/medrep-06-90.PMC4191265.pdf
"Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:90 http://f1000.com/prime/reports/m/6/90",Non-OADS,/arxiv_data1/oa_pdf/ab/d9/medrep-06-90.PMC4191265.pdf
"Bungard D, Fuerth BJ, Zeng P, Faubert B, Maas NL, Viollet B, Carling D, Thompson CB, Jones RG, Berger SL: Signaling kinase Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:90 http://f1000.com/prime/reports/m/6/90",Non-OADS,/arxiv_data1/oa_pdf/ab/d9/medrep-06-90.PMC4191265.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:90 http://f1000.com/prime/reports/m/6/90",Non-OADS,/arxiv_data1/oa_pdf/ab/d9/medrep-06-90.PMC4191265.pdf
"Expanding use of new oral anticoagulants Jeffrey I. Weitz Address: Departments of Medicine and Biochemistry and Biomedical Sciences, McMaster University and the Thrombosis and Atherosclerosis Research Institute, 237 Barton Street East, Hamilton, ON, L8L 2X2, Canada Email: weitzj@taari.ca F1000Prime Reports 2014, 6:93 (doi:10.12703/P6-93) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/e2/medrep-06-93.PMC4191267.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/93 Abstract New, non-vitamin K antagonist oral anticoagulants (NOACs) have been developed to overcome the limitations of warfarin.",Non-OADS,/arxiv_data1/oa_pdf/5a/e2/medrep-06-93.PMC4191267.pdf
"Page 2 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:93 http://f1000.com/prime/reports/m/6/93",Non-OADS,/arxiv_data1/oa_pdf/5a/e2/medrep-06-93.PMC4191267.pdf
"Page 3 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:93 http://f1000.com/prime/reports/m/6/93",Non-OADS,/arxiv_data1/oa_pdf/5a/e2/medrep-06-93.PMC4191267.pdf
"In a recent meta-analysis of the five phase III trials comparing NOACs with warfarin [26], which included24,455 patients with acute VTE, rates of recurrent VTE,fatal PE, and all-cause mortality were not significantlylower with the NOACs (RR 0.88, 95% CI 0.74 to 1.05; RR 1.02, 95% CI 0.39 to 5.96; and RR 0.97, 95% CI 0.83 to Page 4 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:93 http://f1000.com/prime/reports/m/6/93",Non-OADS,/arxiv_data1/oa_pdf/5a/e2/medrep-06-93.PMC4191267.pdf
"Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:93 http://f1000.com/prime/reports/m/6/93",Non-OADS,/arxiv_data1/oa_pdf/5a/e2/medrep-06-93.PMC4191267.pdf
"Page 6 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:93 http://f1000.com/prime/reports/m/6/93",Non-OADS,/arxiv_data1/oa_pdf/5a/e2/medrep-06-93.PMC4191267.pdf
"Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:93 http://f1000.com/prime/reports/m/6/93",Non-OADS,/arxiv_data1/oa_pdf/5a/e2/medrep-06-93.PMC4191267.pdf
"Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:93 http://f1000.com/prime/reports/m/6/93",Non-OADS,/arxiv_data1/oa_pdf/5a/e2/medrep-06-93.PMC4191267.pdf
"Lu G, Deguzman FR, Hollenbach SJ, Karbarz MJ, Abe K, Lee G, Luan P, Hutchaleelaha A, Inagaki M, Conley PB, Phillips DR, Sinha U: A specific antidote for reversal of anticoagulation by direct and Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:93 http://f1000.com/prime/reports/m/6/93",Non-OADS,/arxiv_data1/oa_pdf/5a/e2/medrep-06-93.PMC4191267.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:93 http://f1000.com/prime/reports/m/6/93",Non-OADS,/arxiv_data1/oa_pdf/5a/e2/medrep-06-93.PMC4191267.pdf
"* Corresponding author: Alberto Luini (a.luini@ibp.cnr.it) F1000Prime Reports 2014, 6:88 (doi:10.12703/P6-88) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/dc/biolrep-06-88.PMC4191269.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/6/88 Abstract Like other cellular modules, the secretory pathway and the Golgi complex are likely to be supervised by control systems that support homeostasis and optimal functionality under all conditions, includingexternal and internal perturbations.",Non-OADS,/arxiv_data1/oa_pdf/4f/dc/biolrep-06-88.PMC4191269.pdf
"PKA then phosphorylates a large number of Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:88 http://f1000.com/prime/reports/b/6/88",Non-OADS,/arxiv_data1/oa_pdf/4f/dc/biolrep-06-88.PMC4191269.pdf
"Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:88 http://f1000.com/prime/reports/b/6/88",Non-OADS,/arxiv_data1/oa_pdf/4f/dc/biolrep-06-88.PMC4191269.pdf
"Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:88 http://f1000.com/prime/reports/b/6/88",Non-OADS,/arxiv_data1/oa_pdf/4f/dc/biolrep-06-88.PMC4191269.pdf
"Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:88 http://f1000.com/prime/reports/b/6/88",Non-OADS,/arxiv_data1/oa_pdf/4f/dc/biolrep-06-88.PMC4191269.pdf
Control system [http://en.wikipedia.org/wiki/Control_system].,OADS,/arxiv_data1/oa_pdf/4f/dc/biolrep-06-88.PMC4191269.pdf
"Page 6of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:88 http://f1000.com/prime/reports/b/6/88",Non-OADS,/arxiv_data1/oa_pdf/4f/dc/biolrep-06-88.PMC4191269.pdf
"Page 7of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:88 http://f1000.com/prime/reports/b/6/88",Non-OADS,/arxiv_data1/oa_pdf/4f/dc/biolrep-06-88.PMC4191269.pdf
"Advances in the diagnosis and treatment of sarcoidosis Marc A. Judson Address: Division of Pulmonary and Critical Care Medicine MC-91, Albany Medical College, Albany, New York 12208, USA Email: judsonm@mail.amc.edu F1000Prime Reports 2014, 6:89 (doi:10.12703/P6-89) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/85/medrep-06-89.PMC4191271.pdf
The electronic version of this article is the complete one and can be found at:http://f1000.com/prime/reports/m/6/89 Abstract This manuscript outlines recent advances in the diagnosis and treatment of sarcoidosis.,Non-OADS,/arxiv_data1/oa_pdf/8e/85/medrep-06-89.PMC4191271.pdf
"Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:89 http://f1000.com/prime/reports/m/6/89",Non-OADS,/arxiv_data1/oa_pdf/8e/85/medrep-06-89.PMC4191271.pdf
"Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:89 http://f1000.com/prime/reports/m/6/89",Non-OADS,/arxiv_data1/oa_pdf/8e/85/medrep-06-89.PMC4191271.pdf
"One example ofsuch care istheobservation that thepresence oftheTNF-a G-308A polymorphism inrheumatoid arthritis patients Page 4of8 (page number notforcitation purposes)F1000Prime Reports 2014, 6:89 http://f1000.com/prime/reports/m/6/89",Non-OADS,/arxiv_data1/oa_pdf/8e/85/medrep-06-89.PMC4191271.pdf
"Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:89 http://f1000.com/prime/reports/m/6/89",Non-OADS,/arxiv_data1/oa_pdf/8e/85/medrep-06-89.PMC4191271.pdf
"Page 6 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:89 http://f1000.com/prime/reports/m/6/89",Non-OADS,/arxiv_data1/oa_pdf/8e/85/medrep-06-89.PMC4191271.pdf
"Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, Du Bois R, Albera C, Brutsche M, Davis G, Donohue JF, Müller-Quernheim J, Schlenker-Herceg R, Flavin S, Lo KH, Oemar B, Barnathan ES: Infliximab Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:89 http://f1000.com/prime/reports/m/6/89",Non-OADS,/arxiv_data1/oa_pdf/8e/85/medrep-06-89.PMC4191271.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:89 http://f1000.com/prime/reports/m/6/89",Non-OADS,/arxiv_data1/oa_pdf/8e/85/medrep-06-89.PMC4191271.pdf
"Management of allergic rhinitis Geoffroy Solelhac and Denis Charpin* Address: Department of Pneumonology and Allergy, North Hospital, Marseille University Hospitals, Chemin des Bourrely, 13915, Marseille, France * Corresponding author: Denis Charpin (denis-andre.charpin@ap-hm.fr) F1000Prime Reports 2014, 6:94 (doi:10.12703/P6-94) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/47/medrep-06-94.PMC4191273.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/94 Abstract In this paper, we review the current management of allergic rhinitis and new directions for future treatment.",Non-OADS,/arxiv_data1/oa_pdf/04/47/medrep-06-94.PMC4191273.pdf
"[19] showed that they had significant efficacy on allergic symptoms, and demonstrated an increase in specificIgG, and a decrease in mean wheal diameter to mite-extracts, while there was no si gnificant difference, com- pared to the placebo group, on use of rescue medication, Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:94 http://f1000.com/prime/reports/m/6/94",Non-OADS,/arxiv_data1/oa_pdf/04/47/medrep-06-94.PMC4191273.pdf
"Page 3 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:94 http://f1000.com/prime/reports/m/6/94",Non-OADS,/arxiv_data1/oa_pdf/04/47/medrep-06-94.PMC4191273.pdf
"Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:94 http://f1000.com/prime/reports/m/6/94",Non-OADS,/arxiv_data1/oa_pdf/04/47/medrep-06-94.PMC4191273.pdf
"Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:94 http://f1000.com/prime/reports/m/6/94",Non-OADS,/arxiv_data1/oa_pdf/04/47/medrep-06-94.PMC4191273.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:94 http://f1000.com/prime/reports/m/6/94",Non-OADS,/arxiv_data1/oa_pdf/04/47/medrep-06-94.PMC4191273.pdf
"Natural killer cellregulation -beyond thereceptors Carsten Watzl*, Doris Urlaub, Frank  Fasbender  andMaren  Claus Address: IfADo -Leibniz Research Centre forWorking Environment andHuman Factors, Ardeystrasse 67,44139 Dortmund, Germany *Corresponding author: Carsten Watzl (watzl@ifado.de) F1000Prime Reports 2014, 6:87(doi:10.12703/P6-87) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/b8/biolrep-06-87.PMC4191275.pdf
The electronic version ofthisarticle isthecomplete one andcanbefound at:http://f1000.com/prime/reports/b/6/87 Abstract Natural killer (NK) cells arelymphocytes thatareimportant forearly andeffective immune responses against infections andcancer.,Non-OADS,/arxiv_data1/oa_pdf/86/b8/biolrep-06-87.PMC4191275.pdf
"Page 2 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:87 http://f1000.com/prime/reports/b/6/87",Non-OADS,/arxiv_data1/oa_pdf/86/b8/biolrep-06-87.PMC4191275.pdf
"Additionally, there is a develop- mental relationship between the different subpopu- lations, suggesting a differentiation of mature NK cells Page 3 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:87 http://f1000.com/prime/reports/b/6/87",Non-OADS,/arxiv_data1/oa_pdf/86/b8/biolrep-06-87.PMC4191275.pdf
"Page 4 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:87 http://f1000.com/prime/reports/b/6/87",Non-OADS,/arxiv_data1/oa_pdf/86/b8/biolrep-06-87.PMC4191275.pdf
"Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:87 http://f1000.com/prime/reports/b/6/87",Non-OADS,/arxiv_data1/oa_pdf/86/b8/biolrep-06-87.PMC4191275.pdf
"Page 6 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:87 http://f1000.com/prime/reports/b/6/87",Non-OADS,/arxiv_data1/oa_pdf/86/b8/biolrep-06-87.PMC4191275.pdf
"Anfossi N, André P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagné F, Ugolini S, Vivier E: Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:87 http://f1000.com/prime/reports/b/6/87",Non-OADS,/arxiv_data1/oa_pdf/86/b8/biolrep-06-87.PMC4191275.pdf
"Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:87 http://f1000.com/prime/reports/b/6/87",Non-OADS,/arxiv_data1/oa_pdf/86/b8/biolrep-06-87.PMC4191275.pdf
"Björkström NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, Michaëlsson J, Malmberg K, Klingström J, Ahlm C, Ljunggren H: Rapid expansion and long-term persistence of elevated NK cell Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:87 http://f1000.com/prime/reports/b/6/87",OADS,/arxiv_data1/oa_pdf/86/b8/biolrep-06-87.PMC4191275.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:87 http://f1000.com/prime/reports/b/6/87",Non-OADS,/arxiv_data1/oa_pdf/86/b8/biolrep-06-87.PMC4191275.pdf
"Compared to similar literature-basedmethods ( 39,40) and GATACA ( https://gataca.cchmc.org/ gataca/.",Non-OADS,/arxiv_data1/oa_pdf/25/6f/gku678.PMC4191379.pdf
"MicroRNA(miRNA)targetswithweakornon-canonicalinteractionsaremissedbyexistingPARE-basedvalidationtools.Eachexampleshows thetarget-miRNAalignmentatthetop,withscreenshotsbelowfromourwebsite( http://mpss.udel.edu/ );theupperpanelshowsthePAREdata,themiddle panel in each case, phased small RNA production from cleavage sites further substantiates the cleavage events.",OADS,/arxiv_data1/oa_pdf/02/cc/gku693.PMC4191380.pdf
"Loci generating phased sRNAs were identified from published smallRNAdatasetsof Brachypodiumdistachyon andMedicagotruncatula ,whilegenome-widetargetpredictionandvalidationwasperformedusingtheir associatedPAREdatasetsagainstallspecies-specificmiRNAs.GEOaccessionnumbersareindicatedinthetoprowofboxes;asterisksindicatedataei ther fromhttp://mpss.udel.edu/brachy pare2orhttp://mpss.udel.edu/mt pare/.",OADS,/arxiv_data1/oa_pdf/02/cc/gku693.PMC4191380.pdf
"This interface is designed to be easy to use, yet incorporate advanced functionality such as modifiable search parameters, combined searches of sRNA or PAREdatasets,andanalysisoflibrary-baseddata.The comPARE siteisaccessibleat: https://mpss.udel.edu/tools/mirna apps/ comPARE.php .",OADS,/arxiv_data1/oa_pdf/02/cc/gku693.PMC4191380.pdf
"To use this site, shown in Figure 8, first, a user chooses the PARE database for species of interest fromthemainquerypage,additionalinformationaboutthe available databases and included libraries are found at ourlab’s main page http://mpss.udel.edu .",OADS,/arxiv_data1/oa_pdf/02/cc/gku693.PMC4191380.pdf
"Sequence-dependent DNA shape parameters prediction Sequence-dependent DNA helical parameters were ob- tained using the webserver of ‘High-throughput DNAshape prediction’ ( http://rohslab.cmb.usc.edu/DNAshape/ ) (4), which currently provides predictions for Roll, Helical Twist, Minor Groove Widthand Propeller Twist.",OADS,/arxiv_data1/oa_pdf/bb/57/gku695.PMC4191381.pdf
We then counted and aggregated all inter-ligation paired- endtagsbetweenallanchorswithinthesamechromosome.The implemented method is available at http://folk.uio.no/ jonaspau/chiasig/.,OADS,/arxiv_data1/oa_pdf/1c/44/gku738.PMC4191384.pdf
"COMET isfreely available via an anonymous web-based interface at http://comet.retrovirology.lu , and for academic usage as a stand-aloneJavajarfilebyrequesttothecorrespondingau- thor.",OADS,/arxiv_data1/oa_pdf/3b/3e/gku739.PMC4191385.pdf
COMET online tool COMET can be accessed via an on-line interface hosted athttp://comet.retrovirology.lu .,OADS,/arxiv_data1/oa_pdf/3b/3e/gku739.PMC4191385.pdf
CRP-Sant ´ehasenteredintoa licensingagreementwithAdvancedBiologicalLaboratories(ABL)S.A.fortheCOMETsoftware.Thesoftwareremains however freely available for non-commercial research use through adedicated website: http://comet.retrovirology.lu .,OADS,/arxiv_data1/oa_pdf/3b/3e/gku739.PMC4191385.pdf
Densitometric analysis of electrophore-tograms was donewith ImageJ ( http://rsbweb.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/23/3e/gku812.PMC4191397.pdf
"The cell pellet wasisolatedsimilartoChIP-qPCRaspreviouslydescribed (35).DNAwassonicatedto ∼250bpinlength.Cross-linked chromatin was sent to Peconic Genomics with 5 /H9262g anti- MEF2A(SantaCruz)andRabbitIgG(Millipore).Peconic GenomicscompletedChIP-exoaspreviouslydescribed( 31) and the resulting samples were sequenced on the IlluminaHiSeq2000platform.IlluminaCASAVAsoftwarewasused for base calling and sequencing reads were aligned to the mm10 (MBs) or rn5 (CMs) genome assembly using BWA0.5.9(36).Rawdatawerefilteredforaqualityscoreof37us- ing SAMtools ( 37), and duplicates were removed using Pi- card(http://picard.sourceforge.net/ ).MACS1.4.2wasused to do peak calling analysis ( 38).",OADS,/arxiv_data1/oa_pdf/c5/f2/gku813.PMC4191398.pdf
"Box plot of CBP /p300 dependence of expression for genes from (B) associatedwithonlyEPUenhancer-likeelements ≤2kbfromCBPconstitutivepeaks( n=114)oradditionallyassociatedwithatleast10EPUenhancer-like elements >2kbawayfromthenearestCBPconstitutivepeak( n=840).ForB–D,geneexpressionmeasuredbymicroarrayisreportedasthepercentchange inexpressionofCBP /p300dKOMEFsfromWTMEFs.Onlyprobesetsthatwereatleast2-foldabovebackgroundinallWTanddKOsamples( n=3each) wereincludedandduplicateprobesetsforthesamegenewereaveraged.Venndiagramplottedwith http://omics.pnl.gov/software/VennDiagramPlotter.php DP-dependent CBP recruitment near a gene promoter does not reliably predict induced gene expression We next investigated the inducibility of genes that recruit CBP near their TSS in response to DP.",Non-OADS,/arxiv_data1/oa_pdf/10/42/gku827.PMC4191404.pdf
The microscopyimageswereanalyzedbyImmunoRatiosoftware( http://imtmicroscope.uta.fi/immunoratio ).,OADS,/arxiv_data1/oa_pdf/13/f7/gku857.PMC4191422.pdf
"Up/down-regulated genes /transcripts were analyzed using Ingenuity Pathway Analysis (IPA, Ingenuity Systems, http: //www.ingenuity.com )o rU C S C TFBS DAVID (Database for Annotation, Visualization and Integrated Discovery, http://david.abcc.ncifcrf.gov )(41).",OADS,/arxiv_data1/oa_pdf/f7/26/gku861.PMC4191425.pdf
"Potential binding sites for Nova1 were identified using the SpliceAid database (http://www.introni.it/splicing.html ).Large-scalepredictionofNova1bindingsiteclustersinmod- ified exons To predict potential YCAY Nova1 binding sites, 200 nu- cleotides were extracted on both sides of each intron- exon junctions of all regulated exons as in previous stud-ies (20,42).",OADS,/arxiv_data1/oa_pdf/f7/26/gku861.PMC4191425.pdf
"NucleicAcidsResearch,2014,Vol.42,No.18 11823 We next analyzed the nature of the primary rat beta cell transcript networks modified by Nova1(the complete list is accessible at http://lmedex.ulb.ac.be/data.php with a password provided upon request) using IPA (Figure 2D and Supplementary Figure S2A) and the DAVID software (Figure2D).",OADS,/arxiv_data1/oa_pdf/f7/26/gku861.PMC4191425.pdf
"Mice were fed ad libitum Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > Received 6 July 2014 | Accepted 8 October 2014 | Published 10 October 2014© 2014 Molecular Vision 1422Developmentally dynamic colocalization patterns of DSCAM with  adhesion and synaptic proteins in the mouse retina Gabriel Belem de Andrade,1,2 Landon Kunzelman,3 Morgan M. Merrill,1 Peter G. Fuerst1,4 1University of Idaho, Department of Biological Sciences, Moscow, ID; 2CAPES Foundation, Ministry of Education of Brazil,  Brasília-DF , Brazil; 3Department of Biology, Brigham Young University, Idaho, Rexburg, ID; 4University of Washington School of  Medicine, WWAMI Medical Education Program, Moscow, ID Purpose:  The Down syndrome cell adhesion molecule  (Dscam ) gene is required for normal dendrite arborization and  lamination in the mouse retina.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > © 2014 Molecular Vision  1423under a 12 h:12 h light-dark cycle.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
"Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > © 2014 Molecular Vision  1424GluR2 (NeuroMab; 75-002; 1:400), Rabbit anti GluR4 (Cell  Signaling Technologies; 8070; 1:400), Goat anti GluR5 (Santa  Cruz Biotechnology; Sc-7616; 1:100), Mouse anti GlyR  (Synaptic Systems, Göttingen, Germany; 146 011; 1:400),  Mouse anti ß-protocadherin (NeuroMab; 75-185; 1:400),  Rabbit anti Magi2 (Sigma-Aldrich, St. Louis, MO; HPA 013  650; 1:400), Rabbit anti Magi3 (Sigma-Aldrich; HPA 007 923;  1:400), Mouse anti Mitochondria (Ox Phos; Life Technolo - gies; A21348; 1:750), Rat anti N-Catenin (DSHB, IA; 1:200),  Mouse anti Neuroligin 1 (NeuroMab; 75-160; 1:400), Rabbit  anti NMDA 2AB (Millipore; AB1548; 1:400), Rabbit anti  NMDA 2b (NeuroMab; Q00960; 1:400), Mouse anti NR1  (NeuroMab; 75-272; 1:500), Rabbit anti P2X2 (Alomone  labs, Jerusalem, Israel; APR-003; 1:100), Rabbit anti P2X7  (Millipore; AB5246; 1:100), Mouse anti PSD95 (NeuroMab;  75-028; 1:200), Rat anti R-Cadherin (MRCD5; DSHB; 1:200),  Rabbit anti Rim2 (Synaptic System; 140 103; 1:400), Mouse  anti Sap102 (NeuroMab; 75-058; 1:200), Mouse anti Shank  (NeuroMab; 75-089; 1:400), Rabbit anti Synapsin (Cell  Signaling Technology; 5297; 1:400), Mouse anti synapto - tagmin2 (ZIRC, Eugene, OR; 1:500), Mouse anti Syntaxin  I (Sigma-Aldrich; S 0664; 1:1000), Rabbit anti Syntaxin II  (Synaptic Systems; 110-022; 1:200), Rabbit anti Syntaxin III  (Novus Biologicals, Littleton, CO; AB4113; 1:1000), Rabbit  anti Syntaxin IV (Millipore; AB5330; 1:200), Rabbit anti  ZO-1 (Invitrogen; 61-7300; 1:400), Rabbit anti ZO-2 (Invit - rogen; 71-1400; 1:400) and Rabbit anti ZONAB (Invitrogen;  48-2800; 1:400.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
"Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > © 2014 Molecular Vision  1425by 50%, counted independently, were counted again and used  to calculate the percentage overlap.",OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > © 2014 Molecular Vision  1426better assess its role in synaptic organization.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
"Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > © 2014 Molecular Vision  1427detected when we assayed abundant inhibitory synaptic  markers such as bassoon and abundant excitatory markers  such as GluR2, which confirmed the specificity of the assay  (Figure 2F).",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
"Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > © 2014 Molecular Vision  1428MAGI2, connexin 36, 14-3-3 epsilon, syntaxin4 ZONAB,  MAGI3, ZO-2, or 14-3-3 eta (Figure 3A–BB).",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
"Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > © 2014 Molecular Vision  1429P7, P10, and P14 and in the adult (Figure 4).",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > © 2014 Molecular Vision  1430 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
"Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > © 2014 Molecular Vision  1431early developmental time points, when both proteins have a  diffuse localization pattern (Figure 5E).",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > © 2014 Molecular Vision  1432excessive adhesion.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
Molecular Vision  2014; 20:1422-1433 <http://www.molvis.org/molvis/v 20/1422 > © 2014 Molecular Vision  14333.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/mv-v20-1422.PMC4191645.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.,Non-OADS,/arxiv_data1/oa_pdf/e7/98/main.PMC4192139.pdf
http://dx.doi.org/10.1016/j.joca.2014.06.026 1063-4584/ ©2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/98/main.PMC4192139.pdf
This is an open access article under the CC BY-NC-ND l icense (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Osteoarthritis and Cartilage 22 (2014) 1703 e1709,Non-OADS,/arxiv_data1/oa_pdf/e7/98/main.PMC4192139.pdf
"Methods Data used in the preparation of this cross-sectional analysis were obtained from the NIH Osteoarthritis Initiative (OAI) database, which is available for public access at http://www.oai.ucsf.edu/ .",OADS,/arxiv_data1/oa_pdf/e7/98/main.PMC4192139.pdf
"Ann Rheum Dis 2013 Dec 4, http://dx.doi.org/10.1136/annrheumdis-2013- 204052 .",Non-OADS,/arxiv_data1/oa_pdf/e7/98/main.PMC4192139.pdf
"Copyright © 2014The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.Introduction Venous thromboembolism (VTE), which includes pulmo - nary embolism (PE) and deep vein thrombosis (DVT), is an important cause of morbidity and mortality in Western coun -REVIEW http://dx.doi.org/10.4046/trd.2014.77.3.105ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:105-110 105Address for correspondence: Jae Seung Lee, M.D.Department of Pulmonary and Critical Care Medicine, Pulmonary Hypertension and Venous Thrombosis Center, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, KoreaPhone: 82-2-3010-3994, Fax: 82-2-3010-6968E-mail: jsdoc1186@daum.netReceived: Jun.",Non-OADS,/arxiv_data1/oa_pdf/d4/41/trd-77-105.PMC4192307.pdf
"8, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/d4/41/trd-77-105.PMC4192307.pdf
Review of pulmonary thromboembolism http://dx.doi.org/10.4046/trd.2014.77.3.105 107 www.e-trd.org(p<0.001).,Non-OADS,/arxiv_data1/oa_pdf/d4/41/trd-77-105.PMC4192307.pdf
Review of pulmonary thromboembolism http://dx.doi.org/10.4046/trd.2014.77.3.105 109 www.e-trd.orgbenefit of thrombolysis with tenecteplase over placebo in pa - tients with intermediate-risk PE.,Non-OADS,/arxiv_data1/oa_pdf/d4/41/trd-77-105.PMC4192307.pdf
"New therapeutic approaches for patients with advanced  NSCLC are required in order to improve the results of treat -REVIEW http://dx.doi.org/10.4046/trd.2014.77.3.111ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:111-115 111Address for correspondence: Sung Ho Yoon, M.D.Department of Internal Medicine, Chosun University School of Medicine, 309 Pilmun-daero, Dong-gu, Gwangju 501-759, KoreaPhone: 82-62-220-3053, Fax: 82-62-234-9653E-mail: drdbs@chosun.ac.krReceived: May 30, 2014Revised: Jun.",Non-OADS,/arxiv_data1/oa_pdf/d1/81/trd-77-111.PMC4192308.pdf
"16, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/d1/81/trd-77-111.PMC4192308.pdf
Immunotherapy for NSCLC http://dx.doi.org/10.4046/trd.2014.77.3.111 113 www.e-trd.orgstable disease for six months and their median survival time  was 9.6 months.,Non-OADS,/arxiv_data1/oa_pdf/d1/81/trd-77-111.PMC4192308.pdf
Immunotherapy for NSCLC http://dx.doi.org/10.4046/trd.2014.77.3.111 115 www.e-trd.orgcancer.,Non-OADS,/arxiv_data1/oa_pdf/d1/81/trd-77-111.PMC4192308.pdf
"However, the role of engraftment in the mechanism of ac -Copyright © 2014The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2014.77.3.116ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:116-123 116Address for correspondence: Yeon-Mok Oh, M.D., Ph.D. Department of Pulmonary and Critical Care Medicine, Asthma Center, Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, KoreaPhone: 82-2-3010-3136, Fax: 82-2-3010-4650E-mail: ymoh55@amc.seoul.krReceived: May 13, 2014Revised: Jun.",Non-OADS,/arxiv_data1/oa_pdf/4a/e9/trd-77-116.PMC4192309.pdf
"24, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/4a/e9/trd-77-116.PMC4192309.pdf
"Tracking systemic injected MSCs in emphysematous lung http://dx.doi.org/10.4046/trd.2014.77.3.116 117 www.e-trd.orgtion of adult stem cells is controversial because engraftment  rates of adults stem cells are low in recent studies15,16.",Non-OADS,/arxiv_data1/oa_pdf/4a/e9/trd-77-116.PMC4192309.pdf
Tracking systemic injected MSCs in emphysematous lung http://dx.doi.org/10.4046/trd.2014.77.3.116 119 www.e-trd.org(Figure 3B).,Non-OADS,/arxiv_data1/oa_pdf/4a/e9/trd-77-116.PMC4192309.pdf
"Tracking systemic injected MSCs in emphysematous lung http://dx.doi.org/10.4046/trd.2014.77.3.116 121 www.e-trd.orgtifies the relative number of EGFP optimized by beta-actin  genes, but low cell numbers, such as 10 EGFP+ cells per 105  total cells, were undetectable.",Non-OADS,/arxiv_data1/oa_pdf/4a/e9/trd-77-116.PMC4192309.pdf
Tracking systemic injected MSCs in emphysematous lung http://dx.doi.org/10.4046/trd.2014.77.3.116 123 www.e-trd.orginjury in a murine model of neonatal chronic lung disease.,Non-OADS,/arxiv_data1/oa_pdf/4a/e9/trd-77-116.PMC4192309.pdf
"The original diagnosis of BAF is made when multiple Copyright © 2014The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2014.77.3.124ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:124-131 124Address for correspondence: Seung-Ick Cha, M.D.",Non-OADS,/arxiv_data1/oa_pdf/75/b1/trd-77-124.PMC4192310.pdf
"3, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/75/b1/trd-77-124.PMC4192310.pdf
"Anthracofibrosis in COPD exacerbation http://dx.doi.org/10.4046/trd.2014.77.3.124 125 www.e-trd.orgdark pigmentations are observed on the bronchial mucosa on  bronchoscopy2,3.",Non-OADS,/arxiv_data1/oa_pdf/75/b1/trd-77-124.PMC4192310.pdf
Anthracofibrosis in COPD exacerbation http://dx.doi.org/10.4046/trd.2014.77.3.124 127 www.e-trd.orgwhereas categorical variables were compared using either chi- squared test or Fisher’s exact test.,OADS,/arxiv_data1/oa_pdf/75/b1/trd-77-124.PMC4192310.pdf
"Anthracofibrosis in COPD exacerbation http://dx.doi.org/10.4046/trd.2014.77.3.124 129 www.e-trd.orgin nonsmoking elderly women and that among patients pre - senting with COPD exacerbation, the severity of illness and  clinical course are similar regardless of BAF .",Non-OADS,/arxiv_data1/oa_pdf/75/b1/trd-77-124.PMC4192310.pdf
Anthracofibrosis in COPD exacerbation http://dx.doi.org/10.4046/trd.2014.77.3.124 131 www.e-trd.org15.,Non-OADS,/arxiv_data1/oa_pdf/75/b1/trd-77-124.PMC4192310.pdf
"Although polymerase chain reaction (PCR) methods have enhanced the detection of re - spiratory viral infection, PCR cannot help distinguish between CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.3.132ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:132-135 132Address for correspondence: Hyeon-Kyoung Koo, M.D.Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, 170 Juhwa-ro, Ilsanseo-gu, Goyang 411-706, KoreaPhone: 82-31-910-7013, Fax: 82-31-910-7518E-mail: gusrud9@paik.ac.krReceived: May 28, 2014Revised: May 30, 2014Accepted: May 30, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/28/12/trd-77-132.PMC4192311.pdf
"A case of severe rhinovirus pneumonia in adult http://dx.doi.org/10.4046/trd.2014.77.3.132 133 www.e-trd.orgwith patchy consolidations in the whole lung field, but pleural  effusion was not present (Figure 2).",Non-OADS,/arxiv_data1/oa_pdf/28/12/trd-77-132.PMC4192311.pdf
A case of severe rhinovirus pneumonia in adult http://dx.doi.org/10.4046/trd.2014.77.3.132 135 www.e-trd.orginfection in patients with severe pneumonia requiring inten - sive care unit admission.,Non-OADS,/arxiv_data1/oa_pdf/28/12/trd-77-132.PMC4192311.pdf
"This generates airway damage and further impairs airway clearance; eventually chronic microbial colo - nization/infection develops, leading to further infection and  Copyright © 2014The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.3.136ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:136-140 136Address for correspondence: Won-Jung Koh, M.D.Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaPhone: 82-2-3410-3429, Fax: 82-2-3410-3849E-mail: wjkoh@skku.edu *Jung Hoon Kim and Won Jun Song contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/02/d8/trd-77-136.PMC4192312.pdf
"17, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/02/d8/trd-77-136.PMC4192312.pdf
"M. abscessus lung disease and Kartagener syndrome http://dx.doi.org/10.4046/trd.2014.77.3.136 137 www.e-trd.orginflammation with subsequent destruction of the conducting  airways1,2.",Non-OADS,/arxiv_data1/oa_pdf/02/d8/trd-77-136.PMC4192312.pdf
M. abscessus lung disease and Kartagener syndrome http://dx.doi.org/10.4046/trd.2014.77.3.136 139 www.e-trd.orgM.,Non-OADS,/arxiv_data1/oa_pdf/02/d8/trd-77-136.PMC4192312.pdf
"Copyright © 2014The Korean Academy of Tuberculosis and Respiratory Diseases.All rights reserved.Introduction Invasive pulmonary aspergillosis (IP A) has become an im - portant life-threatening infection in severely immunocompro - mised patients with certain risk factors, including prolonged CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.3.141ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:141-144 141Address for correspondence: Ho Joo Yoon, M.D., Ph.D.Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, 222 Wangsimni-ro, Seongdong-gu, Seoul 133-791, KoreaPhone: 82-2-2290-8349, Fax: 82-2-2298-9183E-mail: hjyoon@hanyang.ac.krReceived: May 6, 2014Revised: Jun.",Non-OADS,/arxiv_data1/oa_pdf/66/dc/trd-77-141.PMC4192313.pdf
"17, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/66/dc/trd-77-141.PMC4192313.pdf
"Fatal invasive pulmonary aspergillosis in an immunocompetent patient http://dx.doi.org/10.4046/trd.2014.77.3.141 143 www.e-trd.org7.45, PaO2 of 81.8 mm Hg, and PaCO2 of 38.5 mm Hg.",Non-OADS,/arxiv_data1/oa_pdf/66/dc/trd-77-141.PMC4192313.pdf
"It is approved by the Food and Drug Administration for use in the CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.3.145ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:145-148 145Address for correspondence: Se Jin Kim, M.D.Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, The Armed Forces Capital Hospital, 81 Saemaeul-ro 177beon-gil, Bundang-gu, Seongnam 463-040, KoreaPhone: 82-31-725-6037, Fax: 82-31-706-0987 E-mail: chrisjinny@naver.comReceived: Apr.",Non-OADS,/arxiv_data1/oa_pdf/56/56/trd-77-145.PMC4192314.pdf
"12, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/56/56/trd-77-145.PMC4192314.pdf
"Interstitial pneumonitis caused by valproic acid http://dx.doi.org/10.4046/trd.2014.77.3.145 147 www.e-trd.orgever, he began complaining of fever and dyspnea.",Non-OADS,/arxiv_data1/oa_pdf/56/56/trd-77-145.PMC4192314.pdf
"2004;51(2):241–8, http://dx.doi.org/10.1016/j.jaad.2003.12.040.",OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"1999;8(8):693-8, http://dx.doi.org/10.1023/A:1008968401068.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2003;76(3):886–91, http://dx.doi.org/10.1016/S0003-4975(03)00895-6.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2005;31(4):405-13, http://dx.doi.org/ 10.1097/00042728-200504000-00006.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2006;16(6):598–603, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"1988;38(3):506–7, http://dx.doi.org/10.1212/WNL.38.3.506-a.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2011;25(8):1057–62, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2011;21(6):389–93, http://dx.doi.org/10.1007/s10286-011-0128-4.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2011;86(3):451–6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"Elsevier Inc. 2012;55(6):1696–700, http://dx.doi.org/10.1016/j.jvs.2011.12.039.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"1983;34:429–52, http://dx.doi.org/10.1146/annurev.me.34.020183.002241.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2007;33(s1):S69–S75, http://dx.doi.org/ 10.1111/j.1524-4725.2006.32334.x.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2011;138(10):652–6, http://dx.doi.org/10.1016/j.annder.2011.07.002.",OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2011;64(4):690–5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2013;95(1):264–8, http://dx.doi.org/ 10.1016/j.athoracsur.2012.08.103.",OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"Elsevier Inc. 2012;66(3):387–92, http://dx.doi.org/ 10.1016/j.jaad.2011.01.023.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2010;90(3):291–3, http://dx.doi.org/10.2340/00015555-0828.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2012;35(5):254–7, http://dx.doi.org/10.1097/WNF.0b013e31826248b8.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2003;25(1):298–308, http://dx.doi.org/10.1016/S0149-2918(03)90041-5.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2008;18(2):133–40, http://dx.doi.org/ 10.1016/j.thorsurg.2008.01.002.",OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2011;12(4):545–8, http://dx.doi.org/10.1510/icvts.2010.252015.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"1991;10(3):225–6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/0c/9e/cln-69-09-608.PMC4192402.pdf
"2013;25(9):1105-12, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"2013;37(5):496-500, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"2013;25(1):99-106, http://dx.doi.org/10.1097/MEG.0b013e3283590a2a.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"2010;72(4):728-35, http://dx.doi.org/10.1016/j.gie.",OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"2011;43(7):617-26, http://dx.doi.org/10.1055/s-0030-1256315.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"2010;72(3):628-31, http://dx.doi.org/10.1016/j.gie.2010.04.035.",OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"2010;71(1):195-9, http://dx.doi.org/10.1016/j.gie.",OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"Dig Dis Sci 2012;57(12):3279-85, http://dx.doi.org/10.1007/s10620-012-2270-9.9.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"2013;58(9):2667-72, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"2013;68:297-303, http://dx.doi.org/10.3348/jksr.2013.68.4.297.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrando- mised studies in meta-analyses, 2012:http://www.ohri.ca/programs/ clinical_epidemiology/oxford.asp.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"1998;17(24):2815-34, http://dx.doi.org/10.1002/(SICI)1097- 0258(19981230)17:24 ,2815::AID-SIM110 .3.0.CO;2-8.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"1994;50(4):1088-101, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"2010;72(3):632-6, http://dx.doi.org/10.1016/ j.gie.2010.04.037.",OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"2011;74(2):321-327 e1-3, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/cln-69-09-647.PMC4192403.pdf
"1989;1(8631):175-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2009;104(11):1534-9, http://dx.doi.org/10.1016/j.amjcard.2009.07.022.",OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2010;65(11):1143-7, http://dx.doi.org/10.1590/S1807-593220100 01100016.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2009;151(5):297-304, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2001; 285(22):2864-70, http://dx.doi.org/10.1001/jama.285.22.2864.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"Stroke 2010;41(12):2731-8, http://dx.doi.org/10.1161/STROKEAHA.110.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2011;123: 104-23, http://dx.doi.org/10.1161/CIR.0b013e31820f14c0.15.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2004;21(6):612-6, http://dx.doi.org/10.1093/fampra/ cmh606.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2011;34(10):640-4, http://dx.doi.org/10.1002/clc.20967.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2000;17(4):337-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2006;37(8):1969-74, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2010;138(5):1093-100, http://dx.doi.org/10.1378/chest.10-0134.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2001;285(18):2370-5, http://dx.doi.org/10.1001/jama.285.18.2370.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2000;15(1):54-7, http://dx.doi.org/10.1097/00001573-200001000-00007.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"1991;18(2):349-55, http://dx.doi.org/10.1016/0735- 1097(91)90585-W. 27.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"1999;53(6):1319-25, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2012;67(4):305-11, http://dx.doi.org/10.6061/clinics/ 2012(04)02.",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2012;67(6):543-6, http://dx.doi.org/10.6061/clinics/2012(06)01.Oral anticoagulation in atrial fibrillation Bartholomay E et al.CLINICS 2014;69(9):615-620 620",Non-OADS,/arxiv_data1/oa_pdf/db/8b/cln-69-09-615.PMC4192404.pdf
"2011;28(4):316-9, http://dx.doi.org/10.1136/emj.2009.084616.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2008;13(5):1637-48, http://dx.doi.org/10.1590/S1413-81232008000500027.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2011;45(3):519-28, http://dx.doi.org/10.1590/ S0034-89102011005000022.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2008;12:659-66, http://dx.doi.org/10.1590/S1414-32832008000300016.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
Disponı ´vel em: http://www.portal.saude.,Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
Disponı ´vel em: URL: http://www.cremesp.org.br/pdfs/ DemografiaMedicaBrasilVol2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2010;27(2):147-50, http://dx.doi.org/10.1136/emj.2008.066654.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
Disponı ´vel em: URL: http://portal.mec.gov.br/cne/arquivos/pedf/ CES04.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
J Eletrocardiol [internet] 2013 Aug 9 [acesso em 2013 set 20]; Disponı ´vel em :http://www.jecgonline.com/ article/S0022-0736(13)00355-5/fulltext.,Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2011;26(3):184-93, http://dx.doi.org/10.1097/JCN.0b013e3181efea66.23.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"Stroke 2012;43(10):2666-70, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2009;103(5):598-603, http://dx.doi.org/10.1016/j.amjcard.2008.10.038.",OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2013;32(7): 477-82, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2008;12(3):269-76, http://dx.doi.org/10.1080/ 10903120802100167.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2003;7(2):280-5, http://dx.doi.org/10.1080/10903120390936950.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2002;18(6):424-8, http://dx.doi.org/10.1097/00006565- 200212000-00005.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2010;56(1):81-91, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"2010;34(3):422-9, http://dx.doi.org/10.1590/S0100-55022010000300012.Profile of physicians working at SAMU in Brazil Tallo FS et al.CLINICS 2014;69(9):601-607 606",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"1999;53(1):46-50, http://dx.doi.org/10.1136/jech.53.1.46.52.",Non-OADS,/arxiv_data1/oa_pdf/dd/bc/cln-69-09-601.PMC4192405.pdf
"This review is intended to provide  imaging specialists with practical knowledge on the technical  components, procedural details, and clinical applications for  contrast echocardiography.pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.101 REVIEW J Cardiovasc Ultrasound  2014;22(3):101-110 A Primer on the Methods and Applications  for Contrast Echocardiography   in Clinical Imaging Sang-Hoon Seol, MD and Jonathan R. Lindner, MD Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA Contrast echocardiography is broadly described as a variety of techniques whereby the blood pool on cardiac ultrasound is  enhanced with encapsulated gas-filled microbubbles or other acoustically active nano- or microparticles.",Non-OADS,/arxiv_data1/oa_pdf/e8/46/jcu-22-101.PMC4192406.pdf
"•	Received: September 10, 2014  •	Revised: September 14, 2014  •	Accepted: September 14, 2014     •	Address for Correspondence: Jonathan R. Lindner, Knight Cardiovascular Institute, UHN-62, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd,        Portland, OR 97239, USA   Tel: +1-503-494-8750, Fax: +1-503-494-8550, E-mail: lindnerj@ohsu.edu •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/46/jcu-22-101.PMC4192406.pdf
"Al - though the authors commented in the limitation, this step pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.111 EDITORIAL COMMENT J Cardiovasc Ultrasound  2014;22(3):111-112 Accurate and Reproducible Measurements  of Right Ventricular Function   in Daily Practice Eui-Young Choi, MD, PhD Division of Cardiology, Heart Center, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul,  Korea •	Editorials published in the Journal of Cardiovascular Ultrasound do not necessarily represent the views of JCU or the Korean Society of Echocardiography.",Non-OADS,/arxiv_data1/oa_pdf/11/5d/jcu-22-111.PMC4192407.pdf
"•	Received: August 8, 2014  •	Revised: August 27, 2014  •	Accepted: August 28, 2014    •	Address for Correspondence: Eui-Young Choi, Division of Cardiology, Heart Center, Gangnam Severance Hospital, Yonsei University College of Medicine, 211    Eonju-ro, Gangnam-gu, Seoul 135-720, Korea   Tel: +82-2-2019-3310, Fax: +82-2-2019-2314, E-mail: choi0928@yuhs.ac •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.REFER TO THE PAGE 113-120",Non-OADS,/arxiv_data1/oa_pdf/11/5d/jcu-22-111.PMC4192407.pdf
"Attempts to pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.113 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2014;22(3):113-120 Validation of Global Longitudinal Strain  and Strain Rate as Reliable Markers   of Right Ventricular Dysfunction:  Comparison with Cardiac Magnetic  Resonance and Outcome Jae-Hyeong Park, MD1,2, Kazuaki Negishi, MD1, Deborah H. Kwon, MD1,  Zoran B. Popovic, MD, PhD1, Richard A. Grimm, MD1, and  Thomas H. Marwick, MD, PhD, MPH1,3 1Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA 2Cardiology Division of Internal Medicine, Chungnam National University Hospital, Chungnam National University  College of Medicine, Daejeon, Korea 3Menzies Research Institute Tasmania, Hobart, Australia Background:  Right ventricular (RV) dysfunction in ischemic cardiomyopathy (ICM) is associated with poor prognosis, but  RV assessment by conventional echocardiography remains difficult.",Non-OADS,/arxiv_data1/oa_pdf/53/83/jcu-22-113.PMC4192408.pdf
"•	Received: May 16, 2014  •	Revised: June 24, 2014  •	Accepted: August 20, 2014    •	Address for Correspondence: Thomas H. Marwick, Menzies Research Institute Tasmania, 17 Liverpool St, Hobart, Tas 7000, Australia      Tel: +61-3-6226-7703, Fax: +61-3-6226-7704, E-mail: tom.marwick@utas.edu.au •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/83/jcu-22-113.PMC4192408.pdf
"Regional wall mo - tion abnormalities (R WMAs) on echocardiography are known  to be useful to detect CAD, however, some patients show glob - al hypokinesis rather than RWMA.9) Although noninvasive pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.121 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2014;22(3):121-126 Myocardial Contrast Echocardiography  for the Detection of Coronary Artery  Disease in Patients with Global  Hypokinesis Admitted for First-Onset  Acute Heart Failure: Pilot Study Sung Eun Kim, MD, PhD1, Dae-Gyun Park, MD, PhD1, Ji Yeon Hong, MD2,  Jun Hee Lee, MD, PhD1, Kyoo Rok Han, MD, PhD1, and Dong Jin Oh, MD, PhD1 1Cardiology Division, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea 2Cardiology Division, KEPCO Medical Center, Seoul, Korea Background:  The non-invasive differentiation of ischemic and nonischemic acute heart failure (AHF) not resulting from  acute myocardial infarction is difficult and has therapeutic and prognostic implications.",Non-OADS,/arxiv_data1/oa_pdf/e1/d0/jcu-22-121.PMC4192409.pdf
"•	Received: May 31, 2014  •	Revised: August 31, 2014  •	Accepted: September 1, 2014    •	Address for Correspondence: Dae-Gyun Park, Division of Cardiology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, 150 Seongan-ro,    Gangdong-gu, Seoul 134-701, Korea   Tel: +82-2-2224-2379, Fax: +82-2-488-0114, E-mail: dgpark@hallym.or.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/d0/jcu-22-121.PMC4192409.pdf
"Thus, the goal of this study was to in - vestigate whether assessment of myocardial deformation using pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.127 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2014;22(3):127-133 The Value of Assessing Myocardial  Deformation at Recovery after  Dobutamine Stress Echocardiography Hui-Jeong Hwang, MD, Hyae-Min Lee, MD, In-Ho Yang, MD, Jung Lok Lee, MD,  Hyun Young Pak, MD, Chang-Bum Park, MD,  Eun-Sun Jin, MD, Jin-Man Cho, MD,   Chong-Jin Kim, MD, and Il Suk Sohn, MD Department of Cardiology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine,  Seoul, Korea  Background:  The purpose of this study was to evaluate whether performing an assessment of myocardial deformation using  speckle tracking imaging during the recovery period after dobutamine stress echocardiography (DSE) allows detection of  significant coronary artery disease (CAD) in patients with chest discomfort.",Non-OADS,/arxiv_data1/oa_pdf/dc/1a/jcu-22-127.PMC4192410.pdf
"•	Received: July 1, 2014  •	Revised: August 21, 2014  •	Accepted: August 22, 2014    •	Address for Correspondence: Il Suk Sohn, Department of Cardiology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine,     892 Dongnam-ro, Gangdong-gu, Seoul 134-727, Korea   Tel: +82-2-440-6108, Fax: +82-2-440-7242, E-mail: issohn@khu.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/1a/jcu-22-127.PMC4192410.pdf
"3A) and electrocardiogram showed atrial  fibrillation with rapid ventricular response and left bundle pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.134 CASE REPORT J Cardiovasc Ultrasound  2014;22(3):134-138 Infective Endocarditis Associated with  Transcatheter Aortic Valve Replacement:  Potential Importance of Local Trauma   for a Deadly Nidus Hak Seung Lee, MD, Seung-Pyo Lee, MD, PhD, Ji-Hyun Jung, MD, Hyue Mee Kim, MD,   Chee Hae Kim, MD, Jun-Bean Park, MD, Hyung-Kwan Kim, MD, PhD, Yong-Jin Kim, MD, PhD,  Hyo-Soo Kim, MD, PhD, and Dae-Won Sohn, MD, PhD Cardiovascular Center and Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea Recently, transcatheter aortic valve replacement (TAVR) has emerged as an alternative for the treatment of severe symptomatic  aortic stenosis patients.",Non-OADS,/arxiv_data1/oa_pdf/90/c9/jcu-22-134.PMC4192411.pdf
"•	Received: February 7, 2014  •	Revised: April 26, 2014  •	Accepted: August 20, 2014    •	Address for Correspondence: Seung-Pyo Lee, Cardiovascular Center and Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro,    Jongno-gu, Seoul 110-744, Korea   Tel: +82-2-2072-1980, Fax: +82-2-766-8904, E-mail: splee0624@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/c9/jcu-22-134.PMC4192411.pdf
"There was a highly mobile pedunculated mass (2.5  × 2.0 cm) attached to the interventricular septum protruding pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.139 CASE REPORT J Cardiovasc Ultrasound  2014;22(3):139-143 A Pedunculated Left Ventricular  Thrombus in a Women with Peripartum  Cardiomyopathy: Evaluation by Three  Dimensional Echocardiography Rajiv Bharat Kharwar, MD, Sharad Chandra, DM, FACC,   Sudhanshu Kumar Dwivedi, MD, DM, and Ram Kirti Saran, DM, FACC  Department of Cardiology, King Georges’ Medical University, Lucknow, India Peripartum cardiomyopathy is a cardiac condition characterized by development of heart failure during the last month of preg - nancy or during the first five months of post partum period without any other identifiable cause of heart failure.",Non-OADS,/arxiv_data1/oa_pdf/fd/b3/jcu-22-139.PMC4192412.pdf
"•	Received: February 10, 2014  •	Revised: March 31, 2014  •	Accepted: August 20, 2014    •	Address for Correspondence: Rajiv Bharat Kharwar, Department of Cardiology, King Georges’ Medical University, Chowk, Lucknow 226003, Uttar Pradesh, India      Tel: +91-522-2258949, Fax: +91-522-2258948, E-mail: raj_iv_infusion@yahoo.co.in  •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/b3/jcu-22-139.PMC4192412.pdf
"Electrocardiography showed atrial pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.144 CASE REPORT J Cardiovasc Ultrasound  2014;22(3):144-147 Multiple Cardiovascular Manifestations  in a Patient with Autosomal Dominant  Polycystic Kidney Disease Young Ran Kang, MD*, Jong-Hwa Ahn, MD, Kye Hwan Kim, MD, Young Min Choi, MD,  Jungwoo Choi, MD, and Jeong Rang Park, MD Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University  School of Medicine, Jinju, Korea Autosomal dominant polycystic kidney disease (ADPKD) is a systemic disorder associated with various extrarenal complications.",Non-OADS,/arxiv_data1/oa_pdf/b7/89/jcu-22-144.PMC4192413.pdf
"•	Received: February 23, 2014  •	Revised: April 27, 2014  •	Accepted: August 20, 2014    •	Address for Correspondence: Jeong Rang Park, Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang    National University School of Medicine, 79 Gangnam-ro, Jinju 660-702, Korea   T el: +82-55-750-8058, Fax: +82-55-755-9078, E-mail: park-jr@nate.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/89/jcu-22-144.PMC4192413.pdf
"How -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.148 CASE REPORT J Cardiovasc Ultrasound  2014;22(3):148-150 Native Aortic Valve Thrombosis  Resembling Papillary Fibroelastoma Minkwan Kim, MD1, Suk-Hyun Kim, MD1, Sang Yi Moon, MD1, Eu Gene Jeong, MD1,  Eui Han Jung, MD1, Hwa Seong Nam, MD1, Jae-Hyuk Choi, MD1, and Kyungil Park, MD1,2  1Regional Cardiocerebrovascular Center, Dong-A University Hospital, Busan, Korea 2Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea The differential diagnosis of cardiac mass is important in determining the therapeutic plan and avoiding unnecessary surgical in - tervention.",Non-OADS,/arxiv_data1/oa_pdf/a3/55/jcu-22-148.PMC4192414.pdf
"•	Received: February 26, 2014  •	Revised: June 17, 2014  •	Accepted: August 20, 2014    •	Address for Correspondence: Kyungil Park, Division of Cardiology, Department of Internal Medicine, Dong-A University College of Medicine,    26 Daesingongwon-ro, Seo-gu, Busan 602-715, Korea   Tel: +82-51-240-2733, Fax: +82-51-242-5852, E-mail: cardiopark@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/55/jcu-22-148.PMC4192414.pdf
"Histopathology of the mass revealed mature fat cells with oc -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.151 CASE REPORT J Cardiovasc Ultrasound  2014;22(3):151-154 Malignant Arrhythmia with Benign Tumour:  Fibrolipoma of the Left Ventricle Chakanalil Govindan Sajeev, DM, PhD1, Sajeer Kalathingathodika, MD1,  Anishkumar Nair, MD1, Kader Muneer, DM1, Gopalan Nair Rajesh, DM1,  Vinayakumar Deshabandhu, DM1, Gomathy Subramaniam, MD2,  Rajesh Sadanandan Pillai, MCh3, Kudakkachira Mathew Kuriakose, MCh3, and Mangalath Narayanan Krishnan, DM1 Departments of 1Cardiology, 2Radiodiagnosis, 3Cardiothoracic Surgery, Government Medical College, Kozhikode,  Kerala, India We report a case of young male referred for evaluation of recent onset recurrent syncope.",Non-OADS,/arxiv_data1/oa_pdf/75/64/jcu-22-151.PMC4192415.pdf
"Medical College, Kozhikode, Kerala 673008, India     Tel: +91-049-31206744, Fax: +91-495-2355331, E-mail: drsajeerkt@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/64/jcu-22-151.PMC4192415.pdf
"Transtho - racic echocardiography followed by TEE showed normal LV  size with preserved systolic function, bioprosthetic MV with  acceptable hemodynamic and mobility and no paravalvular re -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.155 CASE REPORT J Cardiovasc Ultrasound  2014;22(3):155-157 Infective Left Atrial Dissecting Flap   after Cardiac Surgery Maryam Nabati, MD, Sasan Tabiban, MD, Ali Ghaemian, MD,   Babak Bagheri, MD, and Mojtaba Shokri, MSc Department of Cardiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran Left atrial dissection (LatD), defined as the forced separation of the left atrial (LA) wall layers by blood, is a rare and severe compli - cation of cardiac surgery.",Non-OADS,/arxiv_data1/oa_pdf/ca/71/jcu-22-155.PMC4192416.pdf
"•	Received: April 8, 2014  •	Revised: May 18, 2014  •	Accepted: August 20, 2014    •	Address for Correspondence: Maryam Nabati, Department of Cardiology, Fatemeh Zahra Teaching Hospital, Faculty of Medicine, Mazandaran University of    Medical Sciences, Artesh Boulevard, Sari 48188-13771, Iran   Tel: +98-11-3332-4002, Fax: +98-11-3332-4002, E-mail: dr.mr.nabati@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/71/jcu-22-155.PMC4192416.pdf
"Mid-ventricular obstructive hypertrophy cardiomyopathy  comprises a rare subtype of hypertrophic cardiomyopathies  (HCM), accounting for only 1% of cases.1) It is characterized  by the presence of a pressure gradient between the apical and pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.158 Mid-Ventricular Hypertrophic Obstructive  Cardiomyopathy Complicated by an Apical  Aneurysm, Presenting as Ventricular  Tachycardia Emmanouil Petrou, MD, Stamatis Kyrzopoulos, MD, Eftychia Sbarouni, MD,   Dimitris Tsiapras, MD, and Vassilis Voudris, MD Division of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece KEY WORDS:  Hypertrophic obstructive cardiomyopathy  · Apical aneurysm  · Ventricular tachycardia.",Non-OADS,/arxiv_data1/oa_pdf/0f/f1/jcu-22-158.PMC4192417.pdf
"•	Received: June 9, 2014  •	Revised: July 4, 2014  •	Accepted: August 20, 2014    •	Address for Correspondence: Emmanouil Petrou, Division of Cardiology, Onassis Cardiac Surgery Center, 356 Syggrou Ave., Kallithea, Athens 17674, Greece      Tel: +30-694-511-2509, Fax: +30-210-275-1028, E-mail: emmgpetrou@hotmail.com  •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.IMAGES IN CARDIOVASCULAR ULTRASOUND J Cardiovasc Ultrasound  2014;22(3):158-159 Fig.",Non-OADS,/arxiv_data1/oa_pdf/0f/f1/jcu-22-158.PMC4192417.pdf
"Additionally pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.160 Unusual Cardiac Infiltration in Diffuse  Large B-Cell Lymphoma Sherif Moustafa, MBBCh1,2, David J. Patton, MD3, Nanette Alvarez, MD4,  Timothy Prieur, MD4, Michael S. Connelly, MBBS4,  Mohammed Alnasser, BSc5, and Farouk Mookadam, MD2 1Department of Cardiovascular Diseases, Prince Salman Heart Center, King Fahad Medical City, Riyadh, Kingdom of  Saudi Arabia 2Division of Cardiovascular Diseases, Mayo Clinic Arizona, Scottsdale, AZ, USA 3Section of Pediatric Cardiology, Department of Pediatrics, Alberta Children’s Hospital, University of Calgary,  Calgary, AB, Canada 4Adult Congenital Heart Disease Clinic, Peter Lougheed Hospital, Division of Cardiovascular Diseases, Calgary, AB,  Canada 5Department of Radiology, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia KEY WORDS:  Diffuse B-cell lymphoma  · Cardiac involvement  · Echocardiography  · Computed tomography  ·                              Magnetic resonance.",Non-OADS,/arxiv_data1/oa_pdf/55/e8/jcu-22-160.PMC4192418.pdf
"•	Received: June 11, 2014  •	Revised: June 30, 2014  •	Accepted: August 20, 2014    •	Address for Correspondence: Sherif Moustafa, Division of Cardiovascular Diseases, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259,    USA   Tel: +1-480-301-6907, Fax: +1-480-301-8018, E-mail: sherifmoustafamd@yahoo.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.IMAGES IN CARDIOVASCULAR ULTRASOUND J Cardiovasc Ultrasound  2014;22(3):160-161 Fig.",Non-OADS,/arxiv_data1/oa_pdf/55/e8/jcu-22-160.PMC4192418.pdf
"Therefore, 3-dimensional  TEE is the simple and informative tool for evaluation of pul - monic valve morphology and function.pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2014 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2014.22.3.162 Three-Dimensional Echocardiographic  Views of Bicuspid Pulmonic Valve Sung Woo Cho, MD1,2, Byung Gyu Kim, MD1, Deok Hee Kim, MD1, Byung Ok Kim, MD1,  Choong Won Goh, MD1, Kun Joo Rhee, MD1, and Young Sup Byun, MD1 1Division of Cardiology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of  Medicine, Seoul, Korea 2Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology,  Daejeon, Korea KEY WORDS:  Bicuspid pulmonic valve  · Atrial septal defect  · Transesophageal echocardiography.",Non-OADS,/arxiv_data1/oa_pdf/84/eb/jcu-22-162.PMC4192419.pdf
"•	Received: June 20, 2014  •	Revised: July 26, 2014  •	Accepted: August 20, 2014    •	Address for Correspondence: Young Sup Byun, Division of Cardiology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of    Medicine, 1342 Dongil-ro, Nowon-gu, Seoul 139-707, Korea   Tel: +82-2-950-1212, Fax: +82-2-950-1248, E-mail: ysbyun@paik.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.IMAGES IN CARDIOVASCULAR ULTRASOUND J Cardiovasc Ultrasound  2014;22(3):162-163 Fig.",Non-OADS,/arxiv_data1/oa_pdf/84/eb/jcu-22-162.PMC4192419.pdf
"1992;7(2):30-45, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/56/d5/cln-69-09-585.PMC4192420.pdf
"2005;5:42-47, http://dx.doi.org/10.1016/j.jassh.2004.11.",OADS,/arxiv_data1/oa_pdf/56/d5/cln-69-09-585.PMC4192420.pdf
"1992;90(1):112-7, http://dx.doi.org/10.1097/00006534-199207000- 00017.",Non-OADS,/arxiv_data1/oa_pdf/56/d5/cln-69-09-585.PMC4192420.pdf
"1993;18(4):756-7, http://dx.doi.org/10.1016/0363-5023(93)90333-X.",Non-OADS,/arxiv_data1/oa_pdf/56/d5/cln-69-09-585.PMC4192420.pdf
"2013;32(6):885-8, http://dx.doi.org/10.1007/s10067-013-2206-6.",Non-OADS,/arxiv_data1/oa_pdf/56/d5/cln-69-09-585.PMC4192420.pdf
"2011;63(2):277-85, http://dx.doi.org/10.1002/acr.20342.Cutaneous hand sensations in systemic sclerosis Silva PG et al.CLINICS 2014;69(9):585-588 588",Non-OADS,/arxiv_data1/oa_pdf/56/d5/cln-69-09-585.PMC4192420.pdf
"2011;52 Suppl 3:33-9, http://dx.doi.org/10.1111/j.1528-1167.2011.03034.x.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2013;13(2):62-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2011;69(1):91-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2012;53(8):1411-20, http://dx.doi.org/10.1111/j.1528- 1167.2012.03584.x.5.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"1993;34(5):910-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2012;26(9):761-72, http://dx.doi.org/10.2165/ 11633090-000000000-00000.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"1995;27(6):461-6, http://dx.doi.org/10.1016/ 0197-0186(95)80003-4.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2006;56(1):103-10, http://dx.doi.org/10.1016/j.neures.2006.06.003.",OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2006;27(9):458-60, http://dx.doi.org/10.1016/j.tips.2006.07.001.",OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2001;25(4):402-8, http://dx.doi.org/10.1006/meth.2001.1262.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"1996;7(13):2181-5, http://dx.doi.org/10.1097/00001756-199609020-00025.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2004;17(3):385-402, http://dx.doi.org/10.1016/j.nbd.",OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2010;224(1):219-33, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2009;84(1):56-66, http://dx.doi.org/10.1016/j.eplepsyres.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2011;31(42):14850-60, http://dx.doi.org/10.1523/JNEUROSCI.3922-11.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2012;2(1):60, http://dx.doi.org/10.1186/2191-219X-2-60.",Non-OADS,/arxiv_data1/oa_pdf/7d/05/cln-69-09-621.PMC4192421.pdf
"2002;36(6):1104-11, http://dx.doi.org/10.1067/mva.2002.129638.",Non-OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2009;38(1):35-41, http://dx.doi.org/10.1016/j.ejvs.2009.02.012.",OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2010;52(3):760-7, http://dx.doi.org/10.1016/j.jvs.2010.01.049.",OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2004;27(5):477-83, http://dx.doi.org/10.1016/j.ejvs.2003.",OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2010;39(5):529-36, http://dx.doi.org/10.1016/j.ejvs.2010.",OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2012;56(2):285-90, http://dx.doi.org/10.1016/j.jvs.2012.01.043.",OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2007;392 (6):725-30, http://dx.doi.org/10.1007/s00423-006-0141-6.",Non-OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2008;47(4):695-701, http://dx.doi.org/10.1016/j.jvs.2007.12.007.",OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2012;56(1):2-7, http://dx.doi.org/10.1016/j.jvs.2011.12.085.",OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2006;32(2):115-23, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2010;52(4):873-7, http://dx.doi.org/10.1016/j.jvs.2010.04.064.",OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2007;69(4):554-71, http://dx.doi.org/10.1002/ccd.21081.",Non-OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2007;21(6):676-86, http://dx.doi.org/10.1016/j.avsg.2007.07.011.",OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2011;53(6):1520-7, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
"2011;42(1):54-8, http://dx.doi.org/10.1016/j.ejvs.2011.03.033.Treatment of juxtarenal aortic aneurysms Belczak SQ et al.CLINICS 2014;69(9):641-646 646",Non-OADS,/arxiv_data1/oa_pdf/09/97/cln-69-09-641.PMC4192422.pdf
Available at http://www.who.int/classi ﬁcations/icd/en/ index.html.,OADS,/arxiv_data1/oa_pdf/71/d8/UPS-118-256.PMC4192423.pdf
Available at http://www.socialstyrelsen.se/publikationer 2011//Documents/halsoekonomiskt-veten-skapligt-underlag-vuxentandvardpdf 2011.,Non-OADS,/arxiv_data1/oa_pdf/71/d8/UPS-118-256.PMC4192423.pdf
Available at http://www.sas.,Non-OADS,/arxiv_data1/oa_pdf/71/d8/UPS-118-256.PMC4192423.pdf
"2004;34(13):929-38, http://dx.doi.org/10.2165/00007256- 200434130-00004.2.",Non-OADS,/arxiv_data1/oa_pdf/07/2e/cln-69-09-589.PMC4192424.pdf
"2011;97:47-80, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/07/2e/cln-69-09-589.PMC4192424.pdf
"1957;16(4):494-502, http://dx.doi.org/10.1136/ard.16.4.",Non-OADS,/arxiv_data1/oa_pdf/07/2e/cln-69-09-589.PMC4192424.pdf
"2009;17(9):1156-62, http://dx.doi.org/10.1016/j.joca.2009.01.009.",OADS,/arxiv_data1/oa_pdf/07/2e/cln-69-09-589.PMC4192424.pdf
"2010;122 Suppl 2:40-3, http://dx.doi.org/10.1007/s00508-010-1341-1.",Non-OADS,/arxiv_data1/oa_pdf/07/2e/cln-69-09-589.PMC4192424.pdf
"1998;17(4):819-31, viii, http://dx.doi.org/10.1016/S0278-5919(05)70122- 8.",Non-OADS,/arxiv_data1/oa_pdf/07/2e/cln-69-09-589.PMC4192424.pdf
"2007;35(10):1756-69, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/07/2e/cln-69-09-589.PMC4192424.pdf
"2011;196(1):W61-5, http://dx.doi.org/10.2214/AJR.",Non-OADS,/arxiv_data1/oa_pdf/07/2e/cln-69-09-589.PMC4192424.pdf
"2012;126(24):2890-909, http://dx.doi.org/10.1161/CIR.0b013e318276fbcb.",Non-OADS,/arxiv_data1/oa_pdf/15/35/cln-69-09-654.PMC4192425.pdf
"2004;109:733-9, http://dx.doi.org/10.1161/01.CIR.0000112642.63927.54.",Non-OADS,/arxiv_data1/oa_pdf/15/35/cln-69-09-654.PMC4192425.pdf
"2005;19(2):103-9, http://dx.doi.org/10.1038/sj.jhh.1001786.",Non-OADS,/arxiv_data1/oa_pdf/15/35/cln-69-09-654.PMC4192425.pdf
"2005;103(3):158-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/35/cln-69-09-654.PMC4192425.pdf
"2010;63(1):54-9, http://dx.doi.org/10.1016/S0300-8932(10)70009-9.",Non-OADS,/arxiv_data1/oa_pdf/15/35/cln-69-09-654.PMC4192425.pdf
"2013;8:1611-6, http://dx.doi.org/10.2147/CIA.S52778.Copyright /C2232014 CLINICS – This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licen ses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/35/cln-69-09-654.PMC4192425.pdf
"2013;68(12):1481–7, http://dx.doi.org/10.6061/clinics/2013(12)02.",Non-OADS,/arxiv_data1/oa_pdf/38/7b/cln-69-09-653.PMC4192426.pdf
"2013;64(5):395–6, http://dx.doi.org/10.1177/0003319712475206.",Non-OADS,/arxiv_data1/oa_pdf/38/7b/cln-69-09-653.PMC4192426.pdf
"2013;64(4):314–20, http://dx.doi.org/10.1177/0003319712464814.",Non-OADS,/arxiv_data1/oa_pdf/38/7b/cln-69-09-653.PMC4192426.pdf
"2013;64(5):395–6, http://dx.doi.org/10.1177/0003319712475206.",Non-OADS,/arxiv_data1/oa_pdf/38/7b/cln-69-09-653.PMC4192426.pdf
"2012;33(24):3098–104, http://dx.doi.org/10.1093/eurheartj/ehs295.",Non-OADS,/arxiv_data1/oa_pdf/38/7b/cln-69-09-653.PMC4192426.pdf
"2013;20(6):601, http://dx.doi.org/ 10.5551/jat.17384.",Non-OADS,/arxiv_data1/oa_pdf/38/7b/cln-69-09-653.PMC4192426.pdf
"2008;90(2):203-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"2005;91:153-58, http://dx.doi.org/10.1002/jso.20323.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"2006;56(5)282-91, http://dx.doi.org/10.3322/canjclin.56.5.282.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"2001;72(300):1-31, http://dx.doi.org/10.1080/000164701753740096.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"1997;66(2):81-7, http://dx.doi.org/10.1002/(SICI)1096-9098(199710) 66:2,81::AID-JSO2 .3.0.CO;2-H. 10.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"2008;466(12):3093-100, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"1981;47(5):1005-22, http://dx.doi.org/10.1002/1097-0142 (19810301)47:5 ,1005::AID-CNCR2820470532 .3.0.CO;2-9.16.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"2010;408(11):3003-11, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"2013;2013:498604, http://dx.doi.org/10.1155/2013/498604.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"2002;235(3):424- 34, http://dx.doi.org/10.1097/00000658-200203000-00015.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"2006;13(1):110-7, http://dx.doi.org/10.1245/ ASO.2006.03.030.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"2000;231(5):655- 63, http://dx.doi.org/10.1097/00000658-200005000-00005.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"1994;65(1):47-50, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"2010;468(11):3028-34, http://dx.doi.org/10.1007/ s11999-010-1392-7.",Non-OADS,/arxiv_data1/oa_pdf/84/58/cln-69-09-579.PMC4192427.pdf
"2011; 66(12):2179-81, http://dx.doi.org/ 10.1590/S1807-59322011001200028.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2013;46(1):15-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2007;78(1):87-96, http://dx.doi.org/10.1902/jop.2007.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"1997;30(5):297-306, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"6):159-79, http://dx.doi.org/10.1111/j.1600-051X.2005.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"1988;4(3):127-31, http://dx.doi.org/10.1111/j.1600-9657.1988.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2000;15(3):139-50, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2000;16(5):218-21, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"Curr HIV/AIDS Rep. 2007;4(1):16-21, http://dx.doi.org/10.1007/s11904-007-0003-z.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2008;3(4):417-8, http://dx.doi.org/10.1097/COH.0b013e32830341fc.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2008;22(12):931-94, http://dx.doi.org/10.1089/apc.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2006;19(1):146-51, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2007;13(1):110-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2005;76(6):915-22, http://dx.doi.org/10.1902/jop.2005.76.6.915.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2000;33(2):113-20, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2000;33(6):509-15, http://dx.doi.org/10.1046/j.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2003;36(3):181-92, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2004;37(8):525- 30, http://dx.doi.org/10.1111/j.1365-2591.2004.00826.x.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"2005;100(3):369-74, http://dx.doi.org/10.1016/j.tripleo.2005.03.029.38.",OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"1999;15(5):210-5, http://dx.doi.org/ 10.1111/j.1600-9657.1999.tb00776.x.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"1998;185(3):137-40, http://dx.doi.org/10.1038/sj.bdj.4809750.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"1995;28(1):12-8, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"1997;13(6):259-64, http://dx.doi.org/10.1111/j.1600-9657.1997.tb00052.x.CLINICS 2014;69(9):627-633 Periradicular lesion in HIV-infected patients Fontes TV et al.",Non-OADS,/arxiv_data1/oa_pdf/c3/8f/cln-69-09-627.PMC4192428.pdf
"1993;3(4):185-91, http://dx.doi.org/10.1007/BF01623674.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"1997;7(1):7-22, http://dx.doi.org/10.1007/BF01623454.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"1975;111:175- 80, http://dx.doi.org/10.1097/00003086-197509000-00025.7.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"IEEE Trans Biomed Eng 2005;52(9):1597-608, http://dx.doi.org/10.1109/TBME.2005.851507.",OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"2006;38(4):530-9, http://dx.doi.org/10.1016/j.bone.2005.10.012.",OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"1990;14(3):92-101, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"1996;17(3):201-11, http://dx.doi.org/10.1088/0967-3334/17/3/006.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"1997;339:190-6, http://dx.doi.org/10.1097/00003086-199706000-00026.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"2011;29(3):444-51, http://dx.doi.org/10.1002/jor.21258.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"2006;32(6):875-82, http://dx.doi.org/10.1016/j.ultrasmedbio.2006.02.1413.",OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"2008;55(6):1243-55, http://dx.doi.org/10.1109/TUFFC.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"1991;78(4):719-27, http://dx.doi.org/10.1093/biomet/78.4.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"2004;19(3):168-79, http://dx.doi.org/10.1053/j.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"2012;30(7):1076-82, http://dx.doi.org/10.1002/jor.22039.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"1994;54(2):91-5, http://dx.doi.org/10.1007/BF00296057.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"1991;36(11):1529-37, http://dx.doi.org/10.1088/0031-9155/36/11/012.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"1995;194(1):77-81, http://dx.doi.org/10.1148/radiology.194.1.7997586.",Non-OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"2013;53(2):350-62, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/21/cb/cln-69-09-634.PMC4192429.pdf
"2013; 68(6):851-7, http://dx.doi.org/10.6061/clinics/2013(06)21.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
"2009;24:(2)205-17, http://dx.doi.org/10.1590/S0102-763820 09000200018.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
"2003;6:(3)299-305, http://dx.doi.org/10.1079/PHN2002427.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
"2013;10(1)10:2, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
"Med Sci Sports Exerc 2006;38:(2)887-893, http://dx.doi.org/10.1249/01.mss.0000218135.79476.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
"2000;101(7):828-33, http://dx.doi.org/10.1161/01.CIR.101.7.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
"2009;90:(9)1628-34, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
"2006;13:(1)80-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
"2010;95:431-40, http://dx.doi.org/10.1113/expphysiol.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
"1989;9:(3) 202-6, http://dx.doi.org/10.1097/00008483-198905000-00004.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
"2010;95:(1)69-79, http://dx.doi.org/10.1113/ expphysiol.2009.049056.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
"2003;35:(6)1033-41, http://dx.doi.org/10.1249/01.MSS.0000069752.",Non-OADS,/arxiv_data1/oa_pdf/6a/c6/cln-69-09-595.PMC4192430.pdf
Available from: http://www.jpmrs.org/pdf/ pdf_PMJ_249.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/76/78/ni-2014-2-5492.PMC4192436.pdf
Availablefrom: http://www.jcam.com.tr/files/KATD- 2276.pdf 17.,OADS,/arxiv_data1/oa_pdf/76/78/ni-2014-2-5492.PMC4192436.pdf
THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE108 REVIEW http://dx.doi.org/10.5653/cerm.2014.41.3.108 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(3):108-114 Empirical medical therapy in idiopathic male  infertility: Promise or panacea?,Non-OADS,/arxiv_data1/oa_pdf/fe/ca/cerm-41-108.PMC4192450.pdf
"In contrast, empirical medical treat -Received: Jul 25, 2014 ∙ Revised: Sep 1, 2014 ∙ Accepted: Sep 5, 2014 Corresponding author:  Ju Tae Seo Department of Urology, Kwandong University College of Medicine,   17 Seoae-ro 1-gil, Jung-gu, Seoul 100-380, Korea Tel: +82-2-2000-7585  Fax: +82-2-2000-7787  E-mail: jtandro@cgh.co.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/ca/cerm-41-108.PMC4192450.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.3.108 Clin Exp Reprod Med 2014;41(3):108-114 110(CI) in the Cochrane review was 0.99 (odds ratio [OR], 1.56; 95% CI,  0.99–2.19).",OADS,/arxiv_data1/oa_pdf/fe/ca/cerm-41-108.PMC4192450.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.108 Clin Exp Reprod Med 2014;41(3):108-114 112that treatment with oral antioxidants caused a significant increase in  the live birth rate compared with control treatments [41].,Non-OADS,/arxiv_data1/oa_pdf/fe/ca/cerm-41-108.PMC4192450.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.3.108 Clin Exp Reprod Med 2014;41(3):108-114 114tyl-cysteine for improving semen parameters in infertile men: a  double-blind, placebo controlled, randomized study.",Non-OADS,/arxiv_data1/oa_pdf/fe/ca/cerm-41-108.PMC4192450.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE115 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.3.115 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(3):115-119 Vitrification solution without sucrose for  cryopreservation in mouse blastocysts Jong Kil Joo1, Young Ju Lee1, Ju Eun Jeong1, Seung Chul Kim1, Gyoung Rae Ko2, Kyu Sup Lee1 1Department of Obstetrics and Gynecology, Pusan National University School of Medicine and Medical Research Institute, Pusan National University  Hospital, Busan; 2Infertililty Center, Pusan National University Hospital, Busan, Korea Objective:  This study was designed to investigate the survival rate of vitrified mouse blastocysts depending on the presence or absence of su - crose in vitrification solution.",Non-OADS,/arxiv_data1/oa_pdf/a4/8d/cerm-41-115.PMC4192451.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/8d/cerm-41-115.PMC4192451.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.3.115 Clin Exp Reprod Med 2014;41(3):115-119 116cation solution and the long equilibration time for dehydration, due  to the relatively huge volume of the blastocoele cavity [11,16,17].",Non-OADS,/arxiv_data1/oa_pdf/a4/8d/cerm-41-115.PMC4192451.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.115 Clin Exp Reprod Med 2014;41(3):115-119 118ies have been conducted.,OADS,/arxiv_data1/oa_pdf/a4/8d/cerm-41-115.PMC4192451.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE120 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.3.120 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(3):120-124 Interaction between thyroglobulin and ADAMTS16  in  premature ovarian failure Jung-A Pyun, Sunshin Kim, KyuBum Kwack Department of Biomedical Science, College of Life Science, CHA University, Seongnam, Korea  Objective:  The aim of the present study was to examine whether interactions between polymorphisms in the thyroglobulin and ADAM metal - lopeptidase with thrombospondin type 1 motif, 16 ( ADAMTS16 ) genes are associated with the development of premature ovarian failure (POF).",Non-OADS,/arxiv_data1/oa_pdf/91/c3/cerm-41-120.PMC4192452.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/c3/cerm-41-120.PMC4192452.pdf
"1.07, http://pngu.mgh.harvard.edu/~purcell/plink/).",Non-OADS,/arxiv_data1/oa_pdf/91/c3/cerm-41-120.PMC4192452.pdf
"SNPs located in coding  regions, which had minor allele frequencies of 0.01 in Chinese and Jap - anese subjects, were selected from the National Center for Biotechnol - ogy Information SNP database (http://www.ncbi.nlm.nih.gov/proj - Table 1.",OADS,/arxiv_data1/oa_pdf/91/c3/cerm-41-120.PMC4192452.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.120 Clin Exp Reprod Med 2014;41(3):120-124 122ects/SNP/).,OADS,/arxiv_data1/oa_pdf/91/c3/cerm-41-120.PMC4192452.pdf
"We investigated whether the structures coded for by TG and AD- AMTS16  would be changed by the missense SNPs by using a protein  secondary structure prediction program, Jpred3 (http://www.comp - bio.dundee.ac.uk/www-jpred/) [31,32].",OADS,/arxiv_data1/oa_pdf/91/c3/cerm-41-120.PMC4192452.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.120 Clin Exp Reprod Med 2014;41(3):120-124 124menopause.,OADS,/arxiv_data1/oa_pdf/91/c3/cerm-41-120.PMC4192452.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE125 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.3.125 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(3):125-131 Relationship between reactive oxygen species and  autophagy in dormant mouse blastocysts during  delayed implantation Hyejin Shin1, Soyoung Choi1, Hyunjung Jade Lim1,2  1Department of Biomedical Science and Technology, 2Department of Veterinary Medicine, Institute of Biomedical Science and Technology,   Konkuk University, Seoul, Korea  Objective:  Under estrogen deficiency, blastocysts cannot initiate implantation and enter dormancy.",Non-OADS,/arxiv_data1/oa_pdf/ea/8c/cerm-41-125.PMC4192453.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/8c/cerm-41-125.PMC4192453.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.125 Clin Exp Reprod Med 2014;41(3):125-131 126tion by prolactin [6].,OADS,/arxiv_data1/oa_pdf/ea/8c/cerm-41-125.PMC4192453.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.125 Clin Exp Reprod Med 2014;41(3):125-131 128mancy (Figures 2B and 4A).,OADS,/arxiv_data1/oa_pdf/ea/8c/cerm-41-125.PMC4192453.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.125 Clin Exp Reprod Med 2014;41(3):125-131 130[17].,OADS,/arxiv_data1/oa_pdf/ea/8c/cerm-41-125.PMC4192453.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE132 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.3.132 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(3):132-136 Observation of sperm-head vacuoles and sperm  morphology under light microscope Yong-Seog Park1, Sol Park1, Duck Sung Ko1, Dong Wook Park1, Ju Tae Seo2, Kwang Moon Yang3 1Laboratory of Reproductive Medicine, 2Department of Urology, 3Department of Obstetrics and Gynecology, Cheil General Hospital and Women’s  Healthcare Center, Kwandong University College of Medicine, Seoul, Korea Objective:  The presence of sperm-head vacuoles has been suspected to be deleterious to the outcomes of assisted reproductive technology  (ART).",Non-OADS,/arxiv_data1/oa_pdf/09/3e/cerm-41-132.PMC4192454.pdf
"To clearly identify a vacuole in the Received: Jul 14, 2014 ∙ Revised: Aug 26, 2014 ∙ Accepted: Sep 11, 2014 Co-corresponding authors: Yong-Seog Park   Laboratory of Reproductive Medicine, Cheil General Hospital and Women’s  Healthcare Center, Kwandong University College of Medicine, 17 Seoae-ro 1-gil,  Jung-gu, Seoul 100-380, Korea Tel: +82-2-2000-7590  Fax: +82-2-2265-5621  E-mail: arkangel@daum.net Ju Tae Seo Department of Urology, Cheil General Hospital and Women’s Healthcare Center,  Kwandong University College of Medicine, 17 Seoae-ro 1-gil, Jung-gu, Seoul  100-380, Korea  Tel: +82-2-2000-7585 Fax: +82-2-2000-7781  E-mail: jtandro@cgh.co.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/3e/cerm-41-132.PMC4192454.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.3.132 Clin Exp Reprod Med 2014;41(3):132-136 134ence between group A and groups B, C ( p< 0.05) (Table 1).",OADS,/arxiv_data1/oa_pdf/09/3e/cerm-41-132.PMC4192454.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.132 Clin Exp Reprod Med 2014;41(3):132-136 136quality.,OADS,/arxiv_data1/oa_pdf/09/3e/cerm-41-132.PMC4192454.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE137 BRIEF COMMUNICATION http://dx.doi.org/10.5653/cerm.2014.41.3.137 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(3):137-139 An effective method for improving outcomes in  patients with a fertilization defect Hye Jin Yoon1, Hyung Jun Kim1, In Hee Bae1, Soo Jin Chae1, San Hyun Yoon2, Won Don Lee1, Jin Ho Lim1 1Maria Reproductive Center, Department of Obstetrics and Gynecology, Maria Fertility Hospital, Seoul; 2Maria Research Center, Seoul, Korea The effect of artificial oocyte activation (AOA) with a calcium ionophore on intracytoplasmic morphologically selected sperm injection (IMSI)  was examined in patients with histories of repeated failed implantation attempts.",Non-OADS,/arxiv_data1/oa_pdf/5f/42/cerm-41-137.PMC4192455.pdf
"Received: Aug 4, 2014 ∙ Revised: Sep 15, 2014 ∙ Accepted: Sep 16, 2014 Corresponding author:   Hye Jin Yoon  Maria Reproductive Center, Department of Obstetrics and Gynecology, Maria  Fertility Hospital, 20 Cheonho-daero, Dongdaemun-gu, Seoul 130-812, Korea  Tel: +82-2-2250-5506  Fax: +82-2-2250-5549  E-mail: dahamaria@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/42/cerm-41-137.PMC4192455.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.3.137 Clin Exp Reprod Med 2014;41(3):137-139 138Normal spermatozoa were confirmed when the shapes of the nuclei  were smooth and symmetrical with an ovular configuration, and the  average lengths and widths were 4.75 ± 0.28 µm and 3.28 ± 0.20 µm,  respectively [4].",OADS,/arxiv_data1/oa_pdf/5f/42/cerm-41-137.PMC4192455.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE140 CASE REPORT http://dx.doi.org/10.5653/cerm.2014.41.3.140 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(3):140-145 Spontaneous ovarian hyperstimulation syndrome  following a thawed embryo transfer cycle  Mi Kyoung Kim1,2, Hyung Jae Won1,2, Sung Han Shim1,3, Dong Hyun Cha2,3, Tae Ki Yoon1,2 1Fertility Center of CHA Gangnam Medical Center, 2Department of Obstetrics and Gynecology, 3Genetics Laboratory, CHA Gangnam Medical Center,  CHA University, Seoul, Korea  This article reports a case of spontaneous ovarian hyperstimulation syndrome (OHSS) following a thawed embryo transfer cycle.",Non-OADS,/arxiv_data1/oa_pdf/71/4e/cerm-41-140.PMC4192456.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/4e/cerm-41-140.PMC4192456.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.140 Clin Exp Reprod Med 2014;41(3):140-145 142 Figure 1.,OADS,/arxiv_data1/oa_pdf/71/4e/cerm-41-140.PMC4192456.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.140 Clin Exp Reprod Med 2014;41(3):140-145 144tion 680 predicts severity in OHSS patients.,Non-OADS,/arxiv_data1/oa_pdf/71/4e/cerm-41-140.PMC4192456.pdf
Available from: http://www.gynera.ro/ wp-content/uploads/2013/03/OHSS-LONG_GUIDELINES.pdf.,Non-OADS,/arxiv_data1/oa_pdf/71/4e/cerm-41-140.PMC4192456.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE97 REVIEW http://dx.doi.org/10.5653/cerm.2014.41.3.97 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(3):97-107 The role of autophagy in the placenta as a regulator  of cell death Jin-Sung Gong1, Gi Jin Kim1,2 1Department of Biomedical Science, 2CHA Placenta Institute, CHA University, Seoul, Korea The placenta is a temporary fetomaternal organ capable of supporting fetal growth and development during pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/71/d5/cerm-41-97.PMC4192457.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/d5/cerm-41-97.PMC4192457.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.97 Clin Exp Reprod Med 2014;41(3):97-107 98gregated nuclei.,OADS,/arxiv_data1/oa_pdf/71/d5/cerm-41-97.PMC4192457.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.97 Clin Exp Reprod Med 2014;41(3):97-107 100plex by binding to the Atg12-Atg5 complex.,OADS,/arxiv_data1/oa_pdf/71/d5/cerm-41-97.PMC4192457.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.3.97 Clin Exp Reprod Med 2014;41(3):97-107 102After fertilization, the embryo is nourished solely through diffusion  for a week until the neovascularization and vascular remodeling pro - cess is established.",Non-OADS,/arxiv_data1/oa_pdf/71/d5/cerm-41-97.PMC4192457.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.97 Clin Exp Reprod Med 2014;41(3):97-107 104more throughout gestation and hypertension of 140/90 mm Hg or  more after 20 weeks of gestation.,Non-OADS,/arxiv_data1/oa_pdf/71/d5/cerm-41-97.PMC4192457.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.3.97 Clin Exp Reprod Med 2014;41(3):97-107 106blood glucose and amino acid levels.,OADS,/arxiv_data1/oa_pdf/71/d5/cerm-41-97.PMC4192457.pdf
- Korean J Orthod 2014;44:54-61 http://dx.doi.org/10.4041/kjod.2014.44.5.227227www.e-kjo.orgpISSN 2234-7518 eISSN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/59/23/kjod-44-227.PMC4192523.pdf
"228 www.e-kjo.org http://dx.doi.org/10.4041/kjod.2014.44.5.227This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.Also, it is always a good practice to implement a healthy  oral hygiene regimen including a periodic scaling to  control any inflammation in the tissue surrounding  the insertion site.",Non-OADS,/arxiv_data1/oa_pdf/59/23/kjod-44-227.PMC4192523.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.5.229",Non-OADS,/arxiv_data1/oa_pdf/99/9a/kjod-44-229.PMC4192524.pdf
Nabha et al • Metal artifacts in cone-beam computed tomography www.e-kjo.org 230 http://dx.doi.org/10.4041/kjod.2014.44.5.229 INTRODUCTION   Three-dimensional (3D) computed tomography (CT)  provides accurate and detailed information for diag- nosis and treatment planning of dentofacial defor mities.,OADS,/arxiv_data1/oa_pdf/99/9a/kjod-44-229.PMC4192524.pdf
"Nabha et al • Metal artifacts in cone-beam computed tomography www.e-kjo.org 231 http://dx.doi.org/10.4041/kjod.2014.44.5.229   For quantitative assessment, maximum linear dis- crepancy, area, and intensity of artifacts were measured.",OADS,/arxiv_data1/oa_pdf/99/9a/kjod-44-229.PMC4192524.pdf
Nabha et al • Metal artifacts in cone-beam computed tomography www.e-kjo.org 232 http://dx.doi.org/10.4041/kjod.2014.44.5.229 of the software (Figure 2C and 2D).,OADS,/arxiv_data1/oa_pdf/99/9a/kjod-44-229.PMC4192524.pdf
Nabha et al • Metal artifacts in cone-beam computed tomography www.e-kjo.org 233 http://dx.doi.org/10.4041/kjod.2014.44.5.229 segmentation threshold value also followed the default  value of the program which is used as a routine in cli- nical practice.,OADS,/arxiv_data1/oa_pdf/99/9a/kjod-44-229.PMC4192524.pdf
Nabha et al • Metal artifacts in cone-beam computed tomography www.e-kjo.org 234 http://dx.doi.org/10.4041/kjod.2014.44.5.229 Orthop 2009;136:857-67.,OADS,/arxiv_data1/oa_pdf/99/9a/kjod-44-229.PMC4192524.pdf
Nabha et al • Metal artifacts in cone-beam computed tomography www.e-kjo.org 235 http://dx.doi.org/10.4041/kjod.2014.44.5.229 27.,OADS,/arxiv_data1/oa_pdf/99/9a/kjod-44-229.PMC4192524.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.5.236",Non-OADS,/arxiv_data1/oa_pdf/ad/8f/kjod-44-236.PMC4192525.pdf
Jee et al • Treatment effect of preformed NiTi/SS archwire www.e-kjo.org 237 http://dx.doi.org/10.4041/kjod.2014.44.5.236 INTRODUCTION   Anchorage control is essential for a good outcome  in extraction cases.,Non-OADS,/arxiv_data1/oa_pdf/ad/8f/kjod-44-236.PMC4192525.pdf
Jee et al • Treatment effect of preformed NiTi/SS archwire www.e-kjo.org 238 http://dx.doi.org/10.4041/kjod.2014.44.5.236 (n = 16; mean age = 21.5 ± 3.6 years) groups.,OADS,/arxiv_data1/oa_pdf/ad/8f/kjod-44-236.PMC4192525.pdf
Jee et al • Treatment effect of preformed NiTi/SS archwire www.e-kjo.org 239 http://dx.doi.org/10.4041/kjod.2014.44.5.236 ment and maintenance of normal posterior occlusion  in the preformed C-wire group (Figure 4).,OADS,/arxiv_data1/oa_pdf/ad/8f/kjod-44-236.PMC4192525.pdf
"Jee et al • Treatment effect of preformed NiTi/SS archwire www.e-kjo.org 240 http://dx.doi.org/10.4041/kjod.2014.44.5.236 lip protrusion, vertical or horizontal skeletal pattern,  and positional changes of the first molars and central  incisors were assessed.",OADS,/arxiv_data1/oa_pdf/ad/8f/kjod-44-236.PMC4192525.pdf
"Jee et al • Treatment effect of preformed NiTi/SS archwire www.e-kjo.org 241 http://dx.doi.org/10.4041/kjod.2014.44.5.236 slight extrusion of the mandibular teeth was observed  in both groups (MP-L1v and MP-L6v, p < 0.01 for the  conventional C-wire group; MP-L6v, p < 0.05 for the  preformed C-wire group), except in the anterior region  in the preformed C-wire group.",Non-OADS,/arxiv_data1/oa_pdf/ad/8f/kjod-44-236.PMC4192525.pdf
"Jee et al • Treatment effect of preformed NiTi/SS archwire www.e-kjo.org 242 http://dx.doi.org/10.4041/kjod.2014.44.5.236 DISCUSSION   Various protocols using different wires and brackets  have been developed to control tooth movements, such as biometric and bidimensional systems.14,15 These sys- tems concern posterior “play” and three-dimensional  control of anterior teeth during space closure.13  Preformed C-wires are an effective option for posterior  Figure 9.",Non-OADS,/arxiv_data1/oa_pdf/ad/8f/kjod-44-236.PMC4192525.pdf
Jee et al • Treatment effect of preformed NiTi/SS archwire www.e-kjo.org 243 http://dx.doi.org/10.4041/kjod.2014.44.5.236 sliding mechanics and good torque control of anterior  teeth while applying light alignment forces.,Non-OADS,/arxiv_data1/oa_pdf/ad/8f/kjod-44-236.PMC4192525.pdf
"Jee et al • Treatment effect of preformed NiTi/SS archwire www.e-kjo.org 244 http://dx.doi.org/10.4041/kjod.2014.44.5.236   Several factors influence the choice of archwire pro- gression, such as personal preference, cost, and wire  characteristics for ideal force generation.",Non-OADS,/arxiv_data1/oa_pdf/ad/8f/kjod-44-236.PMC4192525.pdf
Jee et al • Treatment effect of preformed NiTi/SS archwire www.e-kjo.org 245 http://dx.doi.org/10.4041/kjod.2014.44.5.236 en-masse  retraction against a temporary skeletal  anchorage device in the treatment of bimaxillary  protrusion.,OADS,/arxiv_data1/oa_pdf/ad/8f/kjod-44-236.PMC4192525.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.5.246",Non-OADS,/arxiv_data1/oa_pdf/4f/43/kjod-44-246.PMC4192526.pdf
"Oh et al • Anodization, cyclic precalcification, heat treatment on Ti6Al4V miniscrews www.e-kjo.org 247 http://dx.doi.org/10.4041/kjod.2014.44.5.246 INTRODUCTION   Anchorage control is very important for successful  orthodontic treatment since unwanted tooth movement  often leads to repeated interventions that increase the  overall treatment time.",Non-OADS,/arxiv_data1/oa_pdf/4f/43/kjod-44-246.PMC4192526.pdf
"Oh et al • Anodization, cyclic precalcification, heat treatment on Ti6Al4V miniscrews www.e-kjo.org 248 http://dx.doi.org/10.4041/kjod.2014.44.5.246 mersed in SBF for 3 days while looking for hydro  xya- patite (HA) precipitation.",OADS,/arxiv_data1/oa_pdf/4f/43/kjod-44-246.PMC4192526.pdf
"Oh et al • Anodization, cyclic precalcification, heat treatment on Ti6Al4V miniscrews www.e-kjo.org 249 http://dx.doi.org/10.4041/kjod.2014.44.5.246 used in this study.",Non-OADS,/arxiv_data1/oa_pdf/4f/43/kjod-44-246.PMC4192526.pdf
"Oh et al • Anodization, cyclic precalcification, heat treatment on Ti6Al4V miniscrews www.e-kjo.org 250 http://dx.doi.org/10.4041/kjod.2014.44.5.246 cipitation obtained on nanotubular Ti6Al4V was dense  and homogeneous.",OADS,/arxiv_data1/oa_pdf/4f/43/kjod-44-246.PMC4192526.pdf
"Oh et al • Anodization, cyclic precalcification, heat treatment on Ti6Al4V miniscrews www.e-kjo.org 251 http://dx.doi.org/10.4041/kjod.2014.44.5.246 almost entirely covered with newly formed bone and the  BIC% is 84.00 ± 8.47% ( p < 0.05).",Non-OADS,/arxiv_data1/oa_pdf/4f/43/kjod-44-246.PMC4192526.pdf
"Oh et al • Anodization, cyclic precalcification, heat treatment on Ti6Al4V miniscrews www.e-kjo.org 252 http://dx.doi.org/10.4041/kjod.2014.44.5.246 increasing the surface roughness compared with UT and  AH groups, the surface wettability was also improved,  leading to enhanced cell reaction.20 Thereby, APH- treated Ti6Al4V surfaces form a biocompatible interface  making the alloy an excellent material for osseo- integrated miniscrews.",Non-OADS,/arxiv_data1/oa_pdf/4f/43/kjod-44-246.PMC4192526.pdf
"Oh et al • Anodization, cyclic precalcification, heat treatment on Ti6Al4V miniscrews www.e-kjo.org 253 http://dx.doi.org/10.4041/kjod.2014.44.5.246 2010;138:8. e1-8.",OADS,/arxiv_data1/oa_pdf/4f/43/kjod-44-246.PMC4192526.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.5.254",Non-OADS,/arxiv_data1/oa_pdf/21/7c/kjod-44-254.PMC4192527.pdf
Kim et al • Idiopathic scoliosis and facial form www.e-kjo.org 255 http://dx.doi.org/10.4041/kjod.2014.44.5.254 INTRODUCTION   Facial esthetics has become increasingly important  in the orthodontic field as an increasing number of  patients are seeking orthodontic treatment not for better  masticatory function and stability alone but also for  aesthetic concerns.,Non-OADS,/arxiv_data1/oa_pdf/21/7c/kjod-44-254.PMC4192527.pdf
Kim et al • Idiopathic scoliosis and facial form www.e-kjo.org 256 http://dx.doi.org/10.4041/kjod.2014.44.5.254 respectively.,OADS,/arxiv_data1/oa_pdf/21/7c/kjod-44-254.PMC4192527.pdf
Kim et al • Idiopathic scoliosis and facial form www.e-kjo.org 257 http://dx.doi.org/10.4041/kjod.2014.44.5.254 numbers for each parameter.,OADS,/arxiv_data1/oa_pdf/21/7c/kjod-44-254.PMC4192527.pdf
Kim et al • Idiopathic scoliosis and facial form www.e-kjo.org 258 http://dx.doi.org/10.4041/kjod.2014.44.5.254   The parameters of facial asymmetry from the frontal  cephalometric measurements were not related with the  curve types based on the Lenke classification.,OADS,/arxiv_data1/oa_pdf/21/7c/kjod-44-254.PMC4192527.pdf
Kim et al • Idiopathic scoliosis and facial form www.e-kjo.org 259 http://dx.doi.org/10.4041/kjod.2014.44.5.254 teristics were associated with asymmetry in patients  with idiopathic scoliosis.,OADS,/arxiv_data1/oa_pdf/21/7c/kjod-44-254.PMC4192527.pdf
"Kim et al • Idiopathic scoliosis and facial form www.e-kjo.org 260 http://dx.doi.org/10.4041/kjod.2014.44.5.254 cephalogram, ANS-menton angle alone is not sufficient  for an evaluation of asymmetry because of the variation  in ANS.9-11 Besides this, no relationship was found with  other cephalometric measures of asymmetry.",OADS,/arxiv_data1/oa_pdf/21/7c/kjod-44-254.PMC4192527.pdf
Kim et al • Idiopathic scoliosis and facial form www.e-kjo.org 261 http://dx.doi.org/10.4041/kjod.2014.44.5.254 and the location and number of vertebral curves.,OADS,/arxiv_data1/oa_pdf/21/7c/kjod-44-254.PMC4192527.pdf
Kim et al • Idiopathic scoliosis and facial form www.e-kjo.org 262 http://dx.doi.org/10.4041/kjod.2014.44.5.254 15.,Non-OADS,/arxiv_data1/oa_pdf/21/7c/kjod-44-254.PMC4192527.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.5.263",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/kjod-44-263.PMC4192528.pdf
"Shimizu et al • Periodontium under occlusal hypofunction www.e-kjo.org 264 http://dx.doi.org/10.4041/kjod.2014.44.5.263 INTRODUCTION   The compact bone lining the tooth socket, where  periodontal ligament (PDL) fibers attach, is known  as bundle bone or alveolar bone proper.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/kjod-44-263.PMC4192528.pdf
Shimizu et al • Periodontium under occlusal hypofunction www.e-kjo.org 265 http://dx.doi.org/10.4041/kjod.2014.44.5.263 in 10% buffered formalin (Wako Pure Chemical Ind.,OADS,/arxiv_data1/oa_pdf/9b/f0/kjod-44-263.PMC4192528.pdf
Shimizu et al • Periodontium under occlusal hypofunction www.e-kjo.org 266 http://dx.doi.org/10.4041/kjod.2014.44.5.263 root was thinner in the hypofunction group than in the  control group.,OADS,/arxiv_data1/oa_pdf/9b/f0/kjod-44-263.PMC4192528.pdf
Shimizu et al • Periodontium under occlusal hypofunction www.e-kjo.org 267 http://dx.doi.org/10.4041/kjod.2014.44.5.263 proper in this hypofunction model may have risen from  suppression of bone formation and/or acceleration of  bone resorption by cellular components of the PDL.,Non-OADS,/arxiv_data1/oa_pdf/9b/f0/kjod-44-263.PMC4192528.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Case Report pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.5.268",Non-OADS,/arxiv_data1/oa_pdf/9b/ea/kjod-44-268.PMC4192529.pdf
"Freitas et al • Treatment of Class II malocclusion www.e-kjo.org 269 http://dx.doi.org/10.4041/kjod.2014.44.5.268 INTRODUCTION   According to Angle,1 a Class II malocclusion is charac- terized by the distal occlusion of the mandibular first  molar in relation to the maxillary first molar; in a Class  II division 1 malocclusion, the maxillary incisors addi- tionally exhibit proclination.",Non-OADS,/arxiv_data1/oa_pdf/9b/ea/kjod-44-268.PMC4192529.pdf
Freitas et al • Treatment of Class II malocclusion www.e-kjo.org 270 http://dx.doi.org/10.4041/kjod.2014.44.5.268 division 1 malocclusion in a female patient outside the  maximum pubertal growth peak who was treated by  orthodontic camouflage using the MPA and MEAW  technique.,Non-OADS,/arxiv_data1/oa_pdf/9b/ea/kjod-44-268.PMC4192529.pdf
Freitas et al • Treatment of Class II malocclusion www.e-kjo.org 271 http://dx.doi.org/10.4041/kjod.2014.44.5.268 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/9b/ea/kjod-44-268.PMC4192529.pdf
Freitas et al • Treatment of Class II malocclusion www.e-kjo.org 272 http://dx.doi.org/10.4041/kjod.2014.44.5.268 on each side (Figure 3).,Non-OADS,/arxiv_data1/oa_pdf/9b/ea/kjod-44-268.PMC4192529.pdf
Freitas et al • Treatment of Class II malocclusion www.e-kjo.org 273 http://dx.doi.org/10.4041/kjod.2014.44.5.268 less than a millimeter distally from the maxillary tubes  (Figure 3).,Non-OADS,/arxiv_data1/oa_pdf/9b/ea/kjod-44-268.PMC4192529.pdf
Freitas et al • Treatment of Class II malocclusion www.e-kjo.org 274 http://dx.doi.org/10.4041/kjod.2014.44.5.268 removed after an additional 6 months of use.,Non-OADS,/arxiv_data1/oa_pdf/9b/ea/kjod-44-268.PMC4192529.pdf
Freitas et al • Treatment of Class II malocclusion www.e-kjo.org 275 http://dx.doi.org/10.4041/kjod.2014.44.5.268 surgery may cause complete condylar resorption in 10%  of surgical cases.13 Patients treated with orthodontic  camouflage also report less functional problems in the  temporomandibular joint than those treated by orthog- nathic surgery.,Non-OADS,/arxiv_data1/oa_pdf/9b/ea/kjod-44-268.PMC4192529.pdf
"Freitas et al • Treatment of Class II malocclusion www.e-kjo.org 276 http://dx.doi.org/10.4041/kjod.2014.44.5.268 greater success of treatment of a bilateral half cusp Class  II malocclusion, as in the present case, than treatment  with extraction resulting in a bilateral full cusp Class II  malocclusion.15 According to Franchi et al.,28 the peak  in skeletal growth occurs between stages 3 and 4 of  cervical vertebral maturation in 93.5% of individuals.",Non-OADS,/arxiv_data1/oa_pdf/9b/ea/kjod-44-268.PMC4192529.pdf
Freitas et al • Treatment of Class II malocclusion www.e-kjo.org 277 http://dx.doi.org/10.4041/kjod.2014.44.5.268 6.,Non-OADS,/arxiv_data1/oa_pdf/9b/ea/kjod-44-268.PMC4192529.pdf
